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ABSTRACT 
 
Ligand-Protein Interactions in Cytochromes 
Jaclyn Catalano 
 
 Cytochromes are found in all living beings and play an essential role in life 
processes.  The two proteins studied in this thesis, cytochrome P450 carries out 
enzymatic reactions, metabolizes drugs, and synthesizes steroids while cytochrome c553 is 
a protein involved in electron transfer and photosynthesis. Despite the diverse functions 
cytochromes have, they all have the same core, a heme porphyrin that makes this class of 
proteins very interesting and worth studying.  
 The cryogenic crystal structure of cytochrome P450 BM-3, a bacterial model 
enzyme for mammalian P450s, shows the substrate N-palmitoylglycine (NPG) too far 
away from the heme to be the catalytically relevant binding mode. Previous evidence 
suggests that the substrate moves as a function of temperature and molecular dynamics 
simulations have shown that at room temperature the ligand is positioned correctly for 
chemistry.  However, how the substrate moves and the correct position of the substrate is 
not known. In order to gain more insight on the position of the substrate, we conducted 
solid-state nuclear magnetic resonance (SSNMR) experiments, enzymatic assays, and 
solved a new crystal structure.  Enzymatic assays determined there is a kinetic preference 
for room temperature and a large difference in Km and Kd, indicates multiple 
conformations of the ligand, some of which are unproductive.  SSNMR experiments also 
provided evidence for multiple conformations since changes in the chemical shift of NPG 
showed the terminal region of the ligand is moving as a function of temperature and the 
solvent exposed region of the ligand has dynamics between multiple conformations.  In 
addition, our new crystal structure shows the first structural evidence of the solvent 
exposed end of NPG interacting with Arg47, which is involved in substrate binding 
shown by our R47E mutation.  However, in our cryogenic crystal structure the ligand is 
still in a conformation not amenable for catalysis.  Therefore, we also laid the foundation 
to obtain structural information on the enzyme at room temperature by assigning the 
ligand, identifying important alanine marker peaks, and determining the best method is 
selectively labeled samples with TEDOR experiments.  
In addition, cytochrome c553 was used as a model to evaluate the role of the 
thioether linkages in c-type cytochromes. Since c-type and b-type cytochromes are the 
most abundant and c-type cytochromes are biosynthesized from apo-protein and b-type 
heme, the fundamental question arises as to why Nature has made the covalent 
attachment in c-type cytochromes. We performed thermodynamic analyses and structural 
studies of a c-to-b conversion in a mutated cytochrome c, in which the thioether bonds 
cannot form, to determine the covalent attachment is necessary for structure and function 
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Introduction to Cytochrome P450 
   2 
1.1 Overview 
  Cytochrome P450 is a very important enzyme that metabolizes drugs and other 
xenobiotics and synthesizes steroids and vitamins. The bacterial model widely used to 
study mammalian P450s, cytochrome P450 BM-3, shows the substrate, N-
palmitoylglycine (NPG), in a conformation not productive for chemistry. The question 
arises as to what causes the substrate to move into the correct position.  Previous 
evidence suggests that the substrate moves as a function of temperature.  However, how 
the substrate moves and the correct position of the substrate is not known. In order to 
gain more insight on the position of the substrate, we conducted solid-state nuclear 
magnetic resonance (SSNMR) experiments to look at the changes in the chemical shift of 
NPG as a function of temperature, obtained enzymatic evidence on the chemistry of the 
enzyme, solved a new crystal structure showing NPG interacting with Arg47, and laid the 
foundation to obtain structural information on the enzyme at room temperature.  Any 
knowledge learned about the active site can help in designing drugs that can be better 
metabolized and aid in synthetically engineering the enzyme to hydroxylate non-natural 
substrates.  
1.2 Importance of Cytochrome P450  
 P450 was discovered accidently when it was co-purified with cytochrome b5 and 
then exposed to carbon monoxide [1, 2]. Klingenberg named the enzyme when he 
observed it bound to carbon monoxide, which has a Soret band (maximum absorbance 
peak) at 450 nm and the “P” refers to pigment [3]. Cytochrome, which means cellular 
pigment, was added to its name when Sato and Omura isolated P450 and determined that 
   3 
it was a heme protein [4]. Since 1963 when Estabrook published the function of P450 as 
performing hydroxylation, it has been one of the most studied proteins [5]. Cytochrome 
P450s are involved in the biosynthesis and metabolism of hormones, cholesterol, vitamin 
A and D, hydroxylation or epoxidation of long chain fatty acids, synthesis of secondary 
metabolites in plants and insects, and activation and detoxification of drugs and other 
xenobiotics, such as pesticides, dyes, antioxidants, anesthetics, solvents, and petroleum 
products. P450s are mostly a beneficial enzyme, however, it has also been shown that 
P450s can turn some substrates into toxic and carcinogenic compounds. P450s are of 
interest to the pharmaceutical industry, organic chemists, and other chemical fields. 
P450s’ numerous functions and substrates underscore the need to understand its structure 
and how this enzyme functions.  
 Humans have a variety of P450s in their body; some are substrate specific and 
some are able to metabolize a wide array of substrates. P450s are located in the gonad 
and adrenal glands for steroid synthesis, in the liver and gut for detoxification of drugs, 
and other xenobiotics and in low concentrations in all tissues. P450s are of particular 
interest to the pharmaceutical industry since it is involved in Phase I metabolism of 
drugs. Phase I metabolism is involved in both bioactivation and inactivation by making a 
lipophillic compound more polar and water soluble. P450s can also be altered or inhibited 
by certain supplements or food, such as grapefruit juice. Therefore, knowledge about 
P450s’ active sites can help in the search for inhibitors and allow drug metabolism to be 
tuned for maximal efficacy.  
 At about the same time P450 was being discovered, organometallic chemists were 
discovering metal complexes that functionalized unreactive C-H bonds [6, 7]. Little did 
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they know that in nature, P450s were performing the same chemistry. C-H activation is 
still a popular area of study in organic chemistry; research groups are constantly finding 
new ways to functionalize C-H bonds and achieve the same substrate specificity, 
stereoselectivity, enantioselectivity, and catalytic efficiency as P450s.  In addition to 
hydroxylation, P450s can also perform epoxidation of C=C double bonds, aromatic 
hydroxylation [8], dealkylation, cleavage of acyl carbon bonds, phenol coupling [9], and 
more. Besides making metallic complexes to mimic the enzymes, P450s have also been 
engineered to activate C-H bonds that are not its natural substrates, such as converting 
octane to octanol or indole to indigo [10]. Cytochrome P450s have also been used in 
biosensors [11], synthesis of drugs and fragrances, and for bioremediation [12]. P450s 
have been used to add functional groups onto drugs since the 1950s [13], and are 
continually used to synthesize steroids, antibiotics, and anticancer drugs [14]. P450s have 
also been involved in bioremediation for the breakdown of insectides, pesticides, and 
other agrochemicals [15, 16], in addition to polycyclic aromatic hydrocarbons (PAH’s) 
[17] and halogenated pollutants [18, 19]. Mutants of the natural enzymes are able to 
catalyze reactions even faster. Therefore, knowledge of P450s’ active site can extend the 
applications of P450.  
1.3 Nomenclature & Classification 
 Currently there are over 9,000 known sequences of P450s. Cytochrome P450s are 
found in all living things ranging from archaea to mammals.  It is believed that P450s 
evolved from one single ancestral protein [20]. In order to efficiently name all these 
P450s, the enzymes are classified by the similarity of their sequence.  Genes encoding the 
enzyme and the enzymes are named by the following system: they are named first by the 
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abbreviation “CYP”, followed by an Arabic number indicating the gene family, a letter 
indicating the subfamily, and a number for the gene in the order it was identified.  For 
example CYP3A4, the most abundant CYP in the human liver, is family 3, subfamily A, 
gene 4. In order to be in the same family, 40% sequence identity is needed and 55% for 
the same subfamily. 
 Cytochrome P450s are composed of at least two-component systems, one 
containing the heme domain and another for the reductase domain, which usually 
involves binding of NAD(P)H. There are four classes of P450 proteins, classified by how 
the enzyme transfers elections to the heme [21]. Class I includes P450s found on the 
membranes of mitochondria or in bacteria and have three components.  Class I enzymes, 
such as P450cam, requires two proteins to transport electrons from nicotinamide adenine 
dinucleotide (phosphate) (NAD(P)H) to the P450 heme, flavin adenine dinucleotide 
(FAD) or flavin mononucleotide (FMN) and a iron-sulfur redox protein, such as 
ferredoxin.  In class II enzymes, there is no iron-sulfur redox protein involved in 
transferring electrons, the electrons are transferred directly from the reductase domain 
(FAD and FMN domains) or cytochrome b5 to the heme, thus making these two-
component systems. Class II enzymes include most mammalian liver P450s.  The enzyme 
of study, BM-3, is in class II, but is unique because it is a one-component system.  BM-3 
is catalytically self sufficient, since its FMN, FAD, and heme domains are all part of a 
single peptide chain. Class III enzymes are characterized by their substrate containing 
oxygen and providing its own source of electrons, for example human thromboxane 
synthase (CYP5A1).  Finally, class IV enzymes receive electrons directly from 
NAD(P)H, such as P450nor or nitric oxide reductase.    
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1.4 P450 Cycle 
1.4.1 Overview of Cycle   The P450 catalytic cycle (Figure 1.1) was proposed by Estabrook et al. in 1971 
through observations made by optical absorption spectroscopy [22]. Since 1971, some 
modifications have been made to the original cycle, but it is still the widely accepted 
mechanism for P450s. The most common P450 reaction is RH + H+ + NAD(P)H + O2 → 
ROH + H2O + NAD(P)+.  In step 1, the enzyme is in its resting state with water 
coordinated to a low spin Fe(III).  As the ligand binds, water is displaced (step 2), 
creating a high spin Fe(III) state.  From this step a peroxide shunt with the addition of 
hydrogen peroxide can occur and the cycle skips from step 2 to step 6.  However, the 
more likely next step involves the addition of one electron (step 3) leading to the reduced 
high spin Fe(II) state.   The reduced form of the enzyme can bind carbon monoxide (CO) 
and form a diamagnetic CO bound state, which has the signature Soret band at 450 nm.  
However, instead of CO, oxygen binds to the iron for the catalytic cycle to continue (step 
4), forming an unstable low spin ferric superoxy complex.  Step 5, with the addition of 
the second electron, forms a low spin peroxo iron complex.  With the addition of a 
proton, a hydroperoxy iron complex is formed in step 6. The addition of a second proton 
and the removal of water constitutes step 7, forming a low spin highly reactive ferryl π 
cation radical compound I, which has never been isolated.  The last step of the cycle 
involves the ligand being bound to the oxygen-iron complex and product formation. The 
product is released and the enzyme returns to its resting state.  
 The rate-limiting step in the catalytic cycle varies per enzyme, however, evidence 
supports that it is likely to be either step 4-5, the addition of a second electron [23]; steps 
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7-8, C-H bond breaking [24, 25]; or steps 8-1, the release of the product[26]. In 
cytochrome P450cam, the rate-limiting step is the transfer of the second electron, which 
comes from Putidaredoxin binding to P450cam, causing a structural change to also allow 
the protonation of the distal oxygen. The breaking of the C-H bond has also been linked 
to the rate-limiting step through isotope studies.  In addition, the release of the product 
may be a rate-determining step, which is supported by formation of polyhydroxy and 
polyhydroxy-ketone products [26]. 
 
Figure 1.1 - A proposed P450 Cycle. 1. Resting State of the enzyme with water bound to 
form low spin Fe(III). 2. The substrate binds and removes the water causing a spin state 
change to high spin Fe(III). At this point hydrogen peroxide can add and follow the 
pathway of the peroxide shunt. 3. The first electron is added reducing the iron, high spin 
Fe(II). At this point carbon monoxide can add to form low spin Fe(II). 4. Oxygen binds 
forming a superoxy complex. 5. A second electron is added. 6. Addition of the first 
proton to form a hydroperoxy iron complex. 7. Addition of the second proton and 
removal of water, to form compound I, which has never been isolated. 8. Product is 
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1.4.2 Mechanism of C-H Activation 
 The proposed mechanisms involved with the C-H activation of the ligand from 
step 7 (compound I) to step 8 (the product bound state) include concerted [27], rebound 
[28], or from step 6 to 8, cationic [29, 30], as shown in Figure 1.2.  In the concerted 
mechanism, partial bounds are formed between the oxygen and carbon and hydrogen of 
the substrate, followed by the breaking of the C-H bond and a new C-O and O-H bond. In 
the rebound mechanism, the hydrogen of the substrate binds to the oxygen, breaking the 
C-H bond and forming a substrate radical. The substrate radical then attacks the oxygen 
and forms step 8.  However, the radical can also undergo rearrangement through the free 
radical rearrangement pathway. The cationic mechanism involves step 6, where instead 
of water being removed by the addition of the proton, the OH is inserted into the C-H 
bond and another hydrogen coordinates to the oxygen. In the next step the extra hydrogen 
on the substrate is transferred to the oxygen. 
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Figure 1.2 – Proposed mechanisms for CH activation. The concerted mechanism forms 
partial bonds with the carbon and hydrogen of the substrate with the oxygen bound to 
heme, causing the C-H bond to break. The rebound mechanism involves formation of a 
radical, caused by a radical cleavage of the C-H bond of the substrate that can also be 
rearranged (free radical rearrangement). The carbon radical is then added to the oxygen to 
form step 8, the product bound state before the product is released. The catonic 
mechanism does not involve compound I. From the hydroperoxy iron complex (6) an OH 
is inserted into the C-H bound of the substrate followed by proton transfer.  
1.4.3 Regulated Catalytic System  
 In order to prevent the catalytic cycle from occurring and producing reactive 
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the resting state. When the substrate is bound and water is removed as the sixth ligand, 
the high spin form is favored and results in a more positive heme iron reduction potential 
(steps 1 and 2 in the cycle). The change in heme reduction potential then allows for 
electron transfer from the reductase domain and oxygen to bind (steps 3 and 4 in the 
cycle). This mechanism ensures that electron transfer occurs only if the substrate is 
bound. Therefore, significant catalytic control is afforded by substrate binding modes on 
the oxidized enzyme. This is the subject of this thesis. Also, this mechanism may be a 
way to prevent catalysis of non-preferred substrates by the substrate’s inability to 
displace the water, which is necessary for the catalytic cycle to occur.  
 In addition, regulation of unproductive electron transfer also occurs in the 
reductase domain, which was shown by pre-incubation with NADPH [31].  Catalytic 
activity was reduced with longer periods of pre-incubation with NADPH, which caused 
the formation of a three-electron reduced form of the reductase that was then inefficient 
to reduce the heme compared to the four-electron reduced form. In addition, regulation of 
mammalian CYP3A4 is determined by substrate concentration [32].  CYP3A4 
cooperatively binds multiple substrates and this allosteric effect increases catalysis.  For 
example when there is low substrate concentration, a lower turnover rate is observed 
compared to high concentrations of the substrate.  
1.5 Structures of P450s 
Cytochrome P450cam from Pseudomonas putida was the first P450 crystal 
structure solved in 1985 with camphor bound at 2.6 Å resolution at 18oC [33]. Many of 
the P450s that have been crystallized are bacterial P450s, since mammalian P450s are 
difficult to crystallize because they are membrane associated and have poor solubility in 
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water. The structure of the first mammalian P450 was solved in 2000 after a significant 
amount of protein engineering in order to make the enzyme soluble [34]. The P450s that 
have been crystallized mostly have the same overall topology crystallizing as trigonal 
prisms with a similar distribution of helices and beta sheets observed, usually four β 
sheets and 13 α helices. The central core is a four helix bundle with three parallel helices 
D, I, and L and anitparallel helix E.  There are two sets of structurally conserved β sheets 
that form the hydrophobic substrate access channel: β sheet 1 is composed of 5 strands 
and β sheet 2 is composed of 2 strands. There is also a structural conserved coil that is 
called the meander, which is the C terminus of the K’ helix right before the heme binding 
region [35]. However only a few amino acids are conserved in P450s, some have less 
than 15% sequence identity [21]. All P450s have a conserved cysteine that forms a 
thiolate bond to the heme. The cysteine is part the following sequence that forms the 
heme binding loop Phe-X-X-Gly-X-(His/Arg)-X-Cys-X-Gly.  The I Helix contains a 
highly conserved threonine (in BM-3 Thr268), which is preceded by an acidic residue 
and involved the formation of the oxygen binding pocket, (Ala/Gly)-Gly-X-(Glu/Asp)-
Thr. Also, the K helix has a conserved Glu-X-X-Arg motif. 
 Cytochrome P450s are induced fit enzymes, where large structural changes are 
observed when comparing X-ray structures of substrate bound and free. This is in 
agreement with the fact that the substrate recognition sites are flexible. Some substrates 
bind tightly to P450 because they have low solubility in water. Gotoh based on the 
structure of P450cam identified six specific substrate recognition sites (SRS): 1) the helix 
B’ and flanking area, 2) the C-terminal end of the helix F, 3) the N-terminal end of helix 
G, 4) the mid-portion of helix I, 5) β4 hairpin, and 6) K helix β2 connecting region [36]. 
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These substrate recognition sites, shown in Figure 1.3 have become targets for 
mutagenesis studies. Variations in these regions across P450s are specific to their 
substrates, redox partners, and cellular attachments.  
 
Figure 1.3 – Crystal structure of P450cam with bound camphor (black) showing the 
substrate recognition sites. SRS1 (red) is the helix B’ and flanking area, SRS2 (orange) is 
the C-terminal end of the helix F, SRS3 (yellow) is the N-terminal end of helix G, SRS4 
(green) is the mid-portion of helix I, SRS5 (blue) is the β4 hairpin, and SRS6 (purple) is 
K helix β2 connecting region.  
 
1.6 Cytochrome P450 BM-3 
1.6.1 Model System 
Mammalian P450s are both difficult to crystallize and also difficult to study, 
generally. The most studied and well-characterized P450 is P450cam from Pseudomonas 
putida. Even though P450cam has provided information on oxidation states, 
thermodynamics, and electron transfer in P450s, it has a different redox system and low 
sequence homology to eukaryotic P450s.  In 1981, Fulco et al. identified cytochrome 
P450 BM-3, which has high sequence identity to its corresponding CYP4A mammalian 
fatty acid hydroxylases, and has become a model system for human P450s [31, 37]. 
Cytochrome P450 BM-3 is the third P450 purified form Bacillus megaterium, thus 
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gaining its name BM-3.  Cytochrome P450 BM-3 unlike P450cam also belongs to the 
same class as most mammalian P450s. BM-3 also expresses well in E.coli producing 
good yields for experiments. Figure 1.4 shows that the heme binding domain of BM-3 
(BMP) and mammalian CYP34A’s overall structure are similar. Cytochrome P450 BM-3 
(CYP102A1) is a 119 kDa protein that is soluble and its reductase domain (FMN and 
FAD) and heme domain are in a single peptide chain. BM-3’s exact function is not 
known, however it hydroxylates fatty acids with high efficiency. BM-3 with arachidonate 
as a substrate has the highest catalytic activity determined for a P450 mono-oxygenase, 
17,000 min-1.  The high efficiency can be explained by BM-3 being self-sufficient and 
having high efficiency of electron transfer. The heme domain is a 55 kDa protein and has 
been isolated by itself.  BMP has been crystallized and is used in our lab for SSNMR 
studies because it is easier to work when studying the active site. However, BMP is not 
catalytically active by itself. Therefore, in this thesis, BMP is used for structural studies 
and BM-3 is used for enzymatic studies. 
 
Figure 1.4 – Alignment of BMP (1JPZ-magneta) with CYP3A4 (1W0F-green), showing 
BMP is a good model for mammalian P450 since they share the same overall fold. 
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 1.6.2 Reductase Domain P450 BM-3 
 No direct evidence on how BM-3’s reductase domain transfers electrons to the 
heme is known except that a thermodynamically unstable anionic FMN semiquinone 
reduces the iron. The structure of the BM-3 reductase domain is not known but insights 
from the structure of rat cytochrome P450 reductase (CPR) reveal how electron transfer 
occurs within the enzyme. In rat CPR, a hinge that links the FAD and FMN domains 
moves from a closed conformation, where electrons are transferred from FAD to FMN to 
open conformation, where electrons are then transferred from FMN to the heme.  The 
crystal structure of the FMN domain bound to BMP shows FMN binds on the distal face, 
where the sulfur of Cys 400 is bound to the heme [38].  However, in this crystal structure 
FMN is too far away (18 Å) from the heme to efficiently transfer electrons at a fast rate. 
Remodeling this structure to include the movement of the hinge between the FMN and 
FAD to an open confirmation moves FMN to 8 Å, which is in agreement with the 
calculated distance needed to transfer electrons at the rate of catalysis [39]. 
 BM-3 closely resembles eukaryotic nitric oxide synthase (NOS) because they both 
bind NADPH having a CPR with a heme that is axially coordinated by cysteinate and 
water.  NOS catalyzes the reductive activation of molecular oxygen forming nitric oxide 
and citrulline from arginine. NOS is active as a dimer with intermolecular electron 
transfer; FMN from one monomer transfers electrons to the heme of the other monomer 
in the dimer. It has been proposed that BM-3 also functions in the same way as a dimer, 
which was supported by a decrease in activity of lauric acid under low concentrations of 
protein [40]. 
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1.6.3 Water in P450 BM-3 
 Water is very important in the P450 mechanism.  Water is coordinated to the heme 
in the resting state and the movement of this water is linked to the start of the catalytic 
cycle and it is also proposed that water is involved in the proton transfer steps in the 
catalytic cycle. The mechanism for proton transfer in the enzymatic cycle is not known.  
One hypothesis, similar to P450terp, protons are transferred from the hydrogen bonding 
network of the I-helix [41].  Other proposals include, the protons come from solvent 
molecules in the active site or as in P450cam from the conserved threonine (Thr268 in 
BM-3) in the active site [42].  
 When the substrate binds a change in the confirmation of the I-helix occurs.  In the 
substrate free form, the I helix has a 13o kink caused by a water molecule that is inserted 
between Ile263-Glu267 and Ala264-Thr268.  Substrate binding causes changes in the I 
helix (5o kink), which causes the water that is bound in the heme to be displaced and join 
the hydrogen bonding network of Ala264 and Thr269. In addition, Ile263 can hydrogen 
bond with Glu267. The resulting changes of I-helix cause a 1.7 Å shift of the Ala264 
carbonyl away from the heme iron [43]. 
1.6.4 Chemistry in P450 BM-3  
The chemistry of BM-3 with NADPH and O2 catalyzes hydroxylation reactions at 
ω-1, ω-2, and ω-3 positions.  No ω hydroxylation has been reported.  Oxidation at ω-1, 
ω-2, and ω-3 positions (C-H bond strength ~397.7 kJ/mol) are thermodynamically more 
favorable than the ω position (C-H bond strength ~410.3 kJ/mol). The carbon length of 
substrates is between C12-C20, where substrates include fatty acids, alcohols, and amides 
as shown in Table 1.1. In addition, both hydroxylation and epoxidation reactions are 
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possible for palmitoleic acid and other monounsaturated fatty acids. The presence of a 
double bond does not influence the rate of the reaction, however the position and 
geometry of the bond affects the ratio of epoxidation to hydroxylation [44]. The product 
distribution depends on chain length and position of double bond if present.  Cytochrome 
P450 BM-3 under low substrate concentration conditions (compared to the concentration 
of oxygen) has been shown to further hydroxylate the metabolized product to 
polyhydroxy- or hydroxy-ketone products [26, 45]. 
Table 1.1 - Common P450 BM-3 substrates and their representative products.  P450 BM-
3 can perform both hydroxylations and epoxidations. EET is epoxyeicosatrienoic acid 
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1.6.5 Binding Pocket of P450 
Cytochrome P450 BM-3 has not been crystallized as a full enzyme. The crystal 
structure of substrate free cytochrome P450 BMP was solved in 1993, followed by BMP 
with palmitoleic acid [46] and NPG [43] bound. The crystal structure of BMP bound to 
the FMN domain was also solved [38]. The crystal structure of the heme domain of 
cytochrome P450 BM-3 shows the binding site is a long hydrophobic channel that is 8-
10 Å in diameter.  The F and G loop forms one side of the substrate channel while the 
other side is the 310 helix (residues 16-20) and the Arg47 β-sheet. The two sides of the 
channel are closer together in the substrate bound structure indicating a closure of the 
substrate channel [46]. Figure 1.5 shows the position of important amino acids and their 
change in conformation upon substrate binding. At one end of the binding pocket Phe87 
forms van der Waals interactions with the heme which prevents ω hydroxylation of the 
fatty acid [47] and is involved in the regiospecificity of the enzyme [46, 48, 49].  Phe87 is 
named the “gate keeper” since it flips from parallel to perpendicular to the heme as the 
substrate binds. Pro25 is also important for substrate recognition [17] and Leu181 and 
Leu437 interact with the alkyl chain of the substrate [50].  Phe42, which is part of the 
hydrophobic patch, forms a lid over the active site and is important for catalysis [49]. 
Arg47 and Tyr51 have been postulated to be involved in substrate recognition and 




Figure 1.5 – Important amino acids in the binding pocket of P450 BM-3 are identified in 
the comparison between IJPZ (blue) where NPG (green) is bound and 1BVY (pink) 
without substrate. There is a closure of the substrate access channel upon ligand binding 
shown by the movement of Phe42. Phe87, the “gate keeper”, also moves upon substrate 
binding. Arg47 and Tyr51 are involved in coordination of the substrate. Pro25 has also 
been shown to be involved substrate recognition. Leu437 and Leu181 have been shown 
to interact with the alkyl chain of the substrate. Ile263 through Glu267 are amino acids in 
the I-helix that are involved in coordination of the water bound to the heme.  
 
1.7 Crystal Structure Puzzles 
 One problem that arises is that both palmitoleic acid and NPG (Figure 1.7) bound 
to BMP show the substrate positioned too far away from the heme to be a catalytically 
active binding mode, approximately 7.5 Å away, compared to P450cam where camphor 
is 4.2 Å away from the heme in the crystal structure [51]. The distant substrate is not 
unique to cytochrome P450 BM-3, it is also present in mammalian P450s as shown in 
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Figure 1.6.  In the case of palmitic acid bound to CYP2C8 the substrate is bound at the 
dimer interface, a non-productive binding pocket [52]. In the crystal structure of 
eukaryotic cytochrome P450 3A4 progesterone is 18 Å away [53] and in P450 2C9 S-
warfarin is 10 Å away [54].  However in the case of P450 2C9, unlike S-warfarin, 
flurbiprofen is 4.9 Å [55]. Therefore the position of the substrate is both enzyme and 
substrate dependent.   
 
Figure 1.6 – Crystal structures of substrates bound to P450.  Camphor (orange) is bound 
to P450cam (2CPP) in a catalytically active position, whereas NPG (green) bound to 
BMP (1JPZ), palmitoleic acid bound to BMP (1FAG-magneta) and CYP2C8 (1PQ2-red), 
S-warfarin (blue) bound to CYP2C9 and progesterone (aqua) bound to CYP3A4 are too 
far away (7.6 – 20 Å) from the heme for chemistry to occur. 
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Figure 1.7 – NPG showing hydroxylation occurring at ω-1, ω-2, and ω-3 positions. 
 
The question arises as to how the substrate moves to the correct position for 
catalysis to occur. Two possible hypotheses include that the substrate movement is 
coupled to the reduction of the heme iron and/or the substrate position is temperature 
dependent.  Roberts et al. tested the first hypothesis by paramagnetic relaxation 
techniques and showed the substrate moved 6 Å upon reduction [56, 57].  Previous 
members of the McDermott group have supporting evidence of the second hypothesis by 
optical absorption experiments showing a temperature dependent spin state change 
(Figure 1.8) and SSNMR experiments showing a non-Curie temperature dependence of 
the chemical shift of the terminal methyl of NPG [58-60]. All of these experiments 
indicate that the substrate moves, however there is no information on how it repositions 
or structural evidence of the new binding site.  Isotope studies have shown that the 
substrate is very mobile in the binding pocket [61]. The enzyme may be plastic and the 
substrate moves in the binding pocket, giving P450 ability to catalyze a variety of 
substrates. SSNMR studies on the ligand will be able to provide answers to this question. 
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Figure 1.8 - Temperature dependent spin state change for NPG-BM-3 under saturating 
concentrations of NPG. At 35oC (red) the Soret band is at 394 nm, evidence of high spin 
Fe(III). As temperature is cooled, the Soret band moves to 418 nm, similar to the resting 
state of the enzyme, showing the substrate can no longer displace the water.  We 
hypothesize that at low temperature the substrate has moved into the distal conformation.  
1.8 Evidence of the Temperature Dependence on Substrate Position 
1.8.1 Spin State Change 
Both Michael Harris and Tijana Jovanovic observed temperature dependence of 
the spin state of the system using optical absorption spectroscopy studying both the full 
length and heme binding domain of cytochrome P450 BM-3 and human CYP3A4.  The 
resting state of the enzyme is low spin Fe(III) heme and the six coordinating ligand is 
water.  The other five ligands are the 4 nitrogens in the porphyrin ring and the sulfur of 
Cys400.  The optical absorption spectrum of the resting state of the enzyme shows the 
Soret peak at 418 nm and when ligand is bound the Soret peak shifts to 394 nm, 
indicative of the high spin state.  It is proposed that binding of the ligand and displacing 
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the coordinating water facilitate the change in spin state.  As shown in Figure 1.8, Harris 
and Jovanovic observed that at high temperature (37oC) cytochrome P450 BM-3 is 
mostly in the high spin state and as the temperature is decreased a mixed spin state is 
seen with absorbance both at 394 and 418 nm, proposing that the absorbance at 418 nm 
corresponds to a ligand confirmation where the water can coordinate to the heme again. 
At room temperature a mixed spin state was also observed for P450cam [62, 63]. One can 
argue that the ligand is no longer bound at lower temperatures, however X-ray data 
shows the ligand bound at temperatures below -20oC [43] and SSNMR data collected in 
our lab also show the ligand is bound at low temperature [59]. A change in spin state 
occurs upon binding but what happens if this binding is unproductive. It is not clear if the 
substrate has to be in the right position for the spin state to change. The extent of spin 
state conversion, although dependent on temperature, in most cases is not correlated with 
the dissociation constant or the amount of reductant used [64, 65].  
1.8.2 Non-Curie Temperature Dependence 
 Harris and Jovanovic studied the temperature dependence on the chemical shift of 
the terminal methyl of NPG in cytochrome P450 BMP and BM-3, respectively. Since 
BM-3 is paramagnetic, the expression for the isotropic chemical shift is a linear function 
of inverse temperature, which is referred to as Curie-law dependence. The plot of 
chemical shift vs inverse temperature should be linear with the y-intercept the chemical 
shift of the diamagnetic compound and the slope is the Curie factor.  They observed a 
non-Curie temperature dependence on the chemical shift of the terminal methyl of NPG 
by deuterium and carbon SSNMR.  The non-Curie dependence suggests that ligand is not 
stationary over temperature. This is in comparison to studies of cytochrome P450cam 
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bound to adamantane-d16, where the deuterium chemical shift of adamantane bound to 
P450cam showed Curie behavior [66].   
1.8.3 Evidence for Multiple Conformations of Phe87 and NPG 
 Phe 87 is called the “gate keeper”, because its ring has to flip in order for the 
ligand to come close to the active site, as shown in Figure 1.9.  Jovanovic selectively 
labeled 13CO-Leu, 15N-Phe, 15N-Gly (LFG) in order to assign Phe87 since there is only 
one Leu-Phe pair in the sequence.  Jovanovic observed that both 13CO Leu86- 15N Phe87 
chemical shift changes when the ligand is bound and also changes with temperature 
(recorded spectra at 0 and -30oC).  The change in chemical shift cannot be explained only 
by paramagnetic shifts, which are observed close to the heme; therefore there must be a 
conformation change. At 15oC there are two cross peaks for 13CO Leu86- 15N Phe87 
indicating some form of dynamics between two rotamer states possibly prohibiting the 
ligand from coming close to the heme and a ring flip up allowing the ligand to move 




Figure 1.9 – The possible proximal (pink) and distal conformations (green) of NPG 
bound to BM-3. The distal conformation of NPG is from the crystal structure 1JPZ, 
showing the substrate too far away for chemistry to occur.  The proximal conformation is 
from MD simulations showing it is possible at room temperature for the ligand to be 
closer to the heme. For NPG to be in the proximal conformation, Phe87’s ring has to flip 
up.  SSNMR data also supports that Phe87 is dynamic. 
 
In order to prove this hypothesis and interpret the SSNMR data molecular 
dynamics (MD) simulations were performed using an induced-fit enzyme model, which 
allowed flexibility of both the ligand and the protein at biological temperature [67]. 
However, C1 of NPG was held constant, which as discussed in Chapter 3 may also be 
dynamic. One simulation result showed movement of Phe87 and Leu75 allowing the 
ligand to approach closer to the heme, with ω-1 at 3.6 Å, ω-2 at 4.4 Å, and at ω-3 5.8 Å, 
thus showing that with the movement of Phe87 at biological temperature, the ligand can 
energetically be in a conformation that is productive for chemistry. MD simulations also 
looked at the population of Phe87 as a function of ω-1 distance and the Phe87 torsional 
angle.  The results showed three populations: one corresponding to the distal state in the 
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crystal structure, another to the proposed proximal state, and third a new proximal state. 
The two proximal states were then identified as proximal locked and proximal free, 
respectively. In the locked proximal state the terminal atoms form an interaction with 
Phe87, where as in the free proximal state the terminal atoms are not prevented by Phe87 
and are able to feely move towards and away from the heme, leading to entropic 
stabilization of this state.  All three states exist at all the temperatures sampled with the 
changes in population based on temperature. However, the interconversion between the 
different states occurs rapidly at room temperature and the locked ligand state is the 
intermediate between the distal and proximal free ligand state. 
 Molecular Dynamics simulations were also performed to calculate populations 
and order parameters of the ligand by replica exchange molecular dynamics (REMD) 
trajectories [68]. Order parameters can also be calculated from NMR but using REMD 
simulations an experiment can cover a wider distribution of bond-vector orientations in 
order to calculate order parameters. Order parameters were calculated at room 
temperature for the proximal (high temperature conformation), distal state (low 
temperature conformation), and the whole trajectory of conformations.  The results 
showed that the order parameters for the distal state were higher than for the proximal 
state and the proximal state was in good agreement with the whole trajectory. Therefore, 
at room temperature the ligand is predominately in the proximal state. The MD 
simulations support Jovanovic’s experimentally determined order parameters for the 
C17-C18 bond of NPG-CD3 bound to BM-3 at both 23oC and -52oC, with order 
parameters between 0.35 to 0.57 and 0.74-0.80, respectively [69]. The population 
distribution was also tabulated as a function of temperature, at -13oC, 29oC, and 45oC, 
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and showed that at -13oC the proximal state has a population of 32% and then gradually 
progresses to 90 % at 45oC [67], which is in agreement with optical absorption data on 
the spin state as shown in Figure 1.8. It is important to note that both proximal and distal 
states exist at all temperatures sampled.  
1.9 Outline of Thesis 
In my thesis work, I have employed a variety of methods to learn about the 
conformation of NPG bound to BM-3 as a function of temperature. In Chapter 2, we 
examined the chemistry of the enzyme as a function of temperature, monitored by optical 
absorption spectroscopy, solution NMR, and gas chromatography-mass spectrometry 
(GC-MS).   In Chapter 4, we tried to capture a room temperature crystal structure, 
although unsuccessful, we were able to obtain structural evidence of NPG interacting 
with Arg47, an amino acid hypothesized to be involved in substrate positioning (Chapter 
3).  Through mutations of R47E, we believe that Arg47 is also involved in initial binding 
of the substrate. In Chapter 5, we looked at the dynamics of the ligand by SSNMR 
through changes in chemical shift as a function of temperature. In addition, we 
established methods that will be helpful in determining structural evidence of a room 
temperature conformation of NPG bound to BMP by SSNMR.   
In Chapter 6, I examined the reason for covalent linkages in c-type cytochromes, 
by mutating cytochrome c553-b (P450 is a b-type cytochrome). In order to answer the 
fundamental question why nature has made c-type cytochromes, the cysteines in c553 
were mutated to alanines to prevent covalent attachment and a complete biophysical 
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Chapter 2  
 
Temperature Dependence of the Chemistry 
of BM-3 
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2.1 Introduction  
2.1.1 Importance of Studying the Chemistry of BM-3 
Crystal structures of numerous P450 isoforms show the substrate too far away 
from the heme iron that the complex cannot be capable of the complete reaction cycle [1-
4]. The crystal structure of N-Palmitoylglycine (NPG) bound to cytochrome P450 BMP 
shows NPG’s ω-1 carbon 7.6 Å from the heme iron, unlike P450cam where the substrate 
is 4.2 Å away and considered the best model for a productive complex [2, 5-8].  One 
proposed explanation for the distant substrates is that there is a temperature dependence 
on the binding mode.  This hypothesis is supported by molecular dynamics and solid-
state NMR studies [9-13]. Since P450 is an enzyme, kinetic assays and analysis of the 
products as a function of temperature should provide insight on the temperature 
dependence of the ligand’s conformation.  
The first step in the P450 cycle is the ligand binding which displaces the water at 
the heme and results in changing the spin state of the iron. This change in spin state is an 
important step in the cycle and without it catalysis does not occur. The change in the spin 
state can be monitored by optical absorption spectroscopy. Jovanovic and Harris have 
shown that at lower temperatures the heme is predominately in the low spin state 
indicative of water still bound to the heme and at higher temperatures (37oC) the heme is 
mostly in the high spin state ready for the next step in the catalytic cycle (Figure 2.3). 
Therefore, our hypothesis is that at 37oC we would expect to see more product formation 
and faster enzymatic activity than at lower temperatures, such as 10oC and 25oC, where a 
mixed spin state is observed.  
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2.1.2 Previous Research on Temperature Dependence of BM-3 
Cytochrome P450 BM-3 is the third P450 isolated from Bacillus megaterium 
(BM). The first study of BM in 1974 to discover its function, is the first and only 
evidence of a temperature dependence in the chemistry of the enzyme [14]. BM performs 
hydroxylation at the ω-1, ω-2, or ω-3 position of a fatty acid with the consumption of 
nicotinamide adenine dinucleotide phosphate (NADPH) and O2, as seen in Figure 2.1.  
BM cannot perform hydroxylation at the ω position due to Phe87, since a BM-3 F87A 
mutant has been shown to perform ω-hydroxylation on laurate [15]. Miura and Fulco 
compared the percentage of product formed along with the distribution of products at 0, 
20, 30, and 37oC by gas-radiochromatography reported in Table 2.1 [14]. The results 
showed that 30oC was an optimal temperature for the amount of hydroxypalmitate 
formed and the distribution of isomers did not vary significantly with temperature.  It is 
important to note that the data presented in Table 2.1 includes all the P450s in BM and 
not just BM-3.  However, there may be an optimal temperature for P450 BM-3’s activity 
and a temperature dependence on the distribution of products. 
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Figure 2.1 - P450 BM-3 with NADPH and oxygen can perform hydroxylation on fatty 
acids, such as NPG.  For NPG, hydroxylation occurs at three positions ω-1, ω-2, and ω-3.  
 
 Hydroxypalmitate Distribution   of Isomers %  
Temperature oC formed % ω-1 ω-2 ω-3 
10 50 29 49 22 
20 82 31 50 19 
30 85 33 49 18 
37 81 29 49 22 
Table 2.1 - Temperature dependence on amount of hydroxypalmitate formed and the 
distribution of isomers for crude cell extracts of cytochrome BM [14]. These experiments 
were performed with all the enzymes in BM not just BM-3.  The results showed that 
there is a temperature dependence on the amount of hydroxypalmitate formed, with less 
formed at 10oC. However, there is no significant difference in distribution of products as 
a function of temperature. 
 
A literature search showed no other experiments on P450 BM-3 where a 
temperature comparison was conduced. Table 2.2 compares product distributions from 
various research groups performed at different temperatures [16-20]. The product 
distribution of palmitic, myristic, and lauric acid, just observing BM-3, is temperature 
dependent.  However, a different trend in product distribution as a function of 
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(C12) acid.  Since these experiments were done under different conditions, we repeated 
these experiments to see if we observed the same temperature trend when a set of 
consistent data was taken.       
 
Palmitic ω-1 (%) ω-2 (%) ω-3 (%) 
Average 20oC[17, 19]  21.7 45.6 32.2 
                   37oC[20] 31.5 47.5 21 
Difference 9.8 1.9 -11.2 
 
Myristic ω-1 (%) ω-2 (%) ω-3 (%) 
Average 20oC[16, 17] 55.8 22.8 20.5 
Average 37oC[18, 20] 44.8 31.5 25.3 
Difference -10 8.7 4.8 
 
Lauric ω-1 (%) ω-2 (%) ω-3 (%) 
RT[17] 48 26 26 
Average 37oC[18, 20] 35.5 29 35.5 
Difference -12.5 3 9.5 
 
Table 2.2 - Product distribution based on temperature for BM-3 with palmitic, myristic, 
and lauric acid. The difference was calculated by subtracting the 37oC percentage from 
the room temperature (20-25oC) percentage. In the case of two references, the 
percentages were averaged. All the substrates show a temperature dependence on product 
distribution. For palmitic acid more ω-1 is produced at higher temperature, which is the 
reverse from myristic and lauric acid. It is important to note that these enzymatic 
reactions were not preformed under the same conditions, which led to the need to repeat 
these results. 
  
2.1.3 Methods to Study the Chemistry of BM-3 
In order to verify whether there is a temperature dependence on the chemistry of 
BM-3, we used NPG as a ligand because it is more soluble and has a higher affinity for 
BM-3 than other substrates, such as palmitic acid.  BM-3 carries out hydroxylation 
reactions with the addition of NADPH and O2, where both can be monitored to track the 
course of the reaction and determine the rate. The amount of NADPH consumed is 
measured by the decrease in optical absorbance at 340 nm and an oxygen electrode can 
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measure O2 consumption [21].  In order to determine the type of products formed further 
analysis is needed.  For example, the use of 14C labeled substrate and thin layer 
chromatography [22], silylation of the products followed by gas chromatography-mass 
spectrometry (GC-MS) analysis [23], solution NMR of high performance liquid 
chromatography (HPLC) fractions [15, 24], or esterification with fluorinated compounds 
and then separated by HPLC [25].  For our experiments, we followed the course of the 
enzymatic reaction at different temperatures by monitoring the depletion of NADPH by 
optical absorption spectroscopy and then analyzed our products by GC-MS and solution 
NMR. 
 Schwaneberg and coworkers developed a spectroscopic assay that reports directly 
on product formation [26]. As shown in Figure 2.2, cytochrome P450 BM-3 can convert 
p-nitrophenoxycarboxylic acids (pNCA) into their ω-oxycarboxylic acids and the 
chromophore p-nitrophenolate, which has an absorbance at 410 nm. Therefore, we used 
pNCA-11 as a substrate to measure activity along with NPG at different temperatures. 
However, in the case of NPG we still need to use traditional methods, monitoring 




Figure 2.2 – Mechanism of pNCA-11 with BM-3 showing that hydroxylation causes the 
formation of p-nitrophenolate, which absorbs at 410 nm and can be monitored by optical 
absorption spectroscopy. 
2.2 Materials and Methods 
BM-3 Preparation.  Samples of cytochrome P450 BM-3 were prepared by following 
an already established procedure [12]. The plasmid, BM-3 in a pProEx-1 vector with an 
N-terminal hexa-histidine tag (gift from Dr. Julian Bill Peterson, UT Southwestern 
Medical Center at Dallas) was transformed into competent E. coli BL21 (DE3) cells 
(Invitrogen Corporation, Carlsbad, CA). The cells were plated onto LB/agar with 50 
µg/ml ampicillin and grown overnight at 37oC. Fresh colonies were used to inoculate a 
preculture of 250 ml of LB media with 5 ml of 1 mg/ml hemin in 0.1 M NaOH and 250 
µl of 100 mg/ml ampicillin. The preculture was grown at 37oC shaking at 200 rpm until 
the optical density (OD) at 595 nm was 0.8. Five milliliters of preculture were used to 


























100 mg/ml ampicillin. Isopropyl-β-D-thiogalactopyranoside (IPTG - 238 mg/l) was 
added to the culture when an absorbance at 595 nm of 0.8 was reached.  The cells were 
harvested (5,000xg for 20 minutes) after 14 hours of incubation at 37oC and resuspended 
in 50 mM Tris-HCl pH 7.4 with 10 % glycerol before freezing at -80oC.   
The cells were thawed on ice and 5 ml (per liter of culture) of protease inhibitor 
cocktail for purification of histidine tagged proteins (Sigma-Aldrich) was added.  The 
cells were lysed by three passages through a French pressure cell and then 
ultracentrifuged for 2 hours at 50,000xg at 4oC.  The protein supernatant was purified by 
fast protein liquid chromatography (FPLC) [Amersham Pharmacia Biotech (APB), 
Uppsala, Sweden]. The protein was loaded onto a DEAE 650M column to separate the 
DNA and excess heme from the protein, with 50 mM Tris-HCl pH 7.4 and 0.1 mM 
phenylmethyl sulfonyl fluoride (PMSF) in isopropanol.  The protein was first washed 
with the same buffer with the addition of 100 mM NaCl and then eluted with 250 mM 
NaCl.  Fractions that contained the protein (reddish tint) were collected, concentrated by 
a gas pressure cell (Amicon) with a YM30 Filter (Millipore) and the buffer was 
exchanged to 50 mM sodium phosphate, pH 7.4, 100 mM NaCl, 10 mM β-
mercaptoethanol and 0.1 mM PMSF. The protein was stored at 4oC overnight. The 
protein was loaded onto a Ni-CAM resin with the previous phosphate buffer and washed 
with the addition of 10 mM imidazole and 30 mM imidazole.  The protein was eluted 
with 100 mM imidazole and protein fractions (reddish color) were collected.  The protein 
was concentrated and imidazole was dialyzed out.    
Synthesis of pNCA-11 and NPG. The substrates p-nitrophenoxyundecanoic acid 
(pNCA-11) and NPG were synthesized according to previously published procedures [26, 
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27]. In the first step of the synthesis of pNCA-11, p-nitrophenolate was added to methyl 
11-bromoundecanoate, which formed pNCA-11 ester.  The pNCA-11 ester was then 
hydrolyzed to pNCA-11 by a mixture of immobilized Peudomonas cepacia and Candida 
Antarctica lipase B. NPG was synthesized from palmitic acid (labeled or unlabeled) and 
glycine. The products were confirmed by solution NMR. 
Binding Constant. The binding constant of pNCA-11 to BM-3 was determined by 
additions of 1/10 of an equivalent of pNCA-11 in DMSO to a solution of 1.54 µM BM-3 
in 0.1 M Tris buffer pH 8.2 and monitored by optical absorption spectroscopy.  The 
binding constants for NPG at 10oC, 25oC, and 37oC, were determined using 1.11 µM 
BM-3 in 50 mM KPi pH 7.4 with additions of 1/10 of an equivalent of NPG in 50 mM 
K2CO3.  The absorbance at 394 nm was subtracted from the absorbance at 418 nm, ΔA394-
418, to maximize the change in absorbance due to binding and plotted against the 
concentration of pNCA-11 or NPG added. The data was fit in IGOR Pro [28] to Equation 
2.1 to obtain the dissociation constant, Kd, 
                      (2.1) 
 
where Bmax represents the absorbance at saturation and is an adjustable parameter.   
Temperature Dependence of the Spin State.  Optical absorption spectra of enzyme-
pNCA-11 mixtures at temperatures between -5 and 40°C were taken under the same 
conditions used in previous NPG studies to analyze the spin state conversion with 
temperature [9]. An excess of pNCA-11 (178 µM) was added to a solution of BM-3 (4.5 







Kd + pNCA #11[ ]
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solution was equilibrated for 30 minutes at the indicated temperature before a 
measurement was taken.  
Modeling of pNCA-11. The possible conformations of pNCA-11 in the enzyme’s 
active site were modeled with MOE (Molecular Operating Environment [Chemical 
Computing Group]) software using the predicted room temperature structure determined 
by molecular dynamics simulations, 1F7.pdb [29]. This was done with the assistance of 
Dr. Andras Bauer in the lab of Professor Brent Stockwell (Columbia University, New 
York). 
Enzymatic Assays.  Activity was determined at temperatures between 4 and 40°C 
in intervals of 4.5°C using an established spectrophotometric assay procedure [26]. 
Samples of 500 µl consisting of BM-3, NPG or pNCA-11, and buffer (Table 2.3), were 
incubated in cuvettes with a path length of 1 cm for 5 minutes at the given temperature. 
After the addition of NADPH solution, the increase in absorbance at 410 nm was 
monitored for pNCA-11 until the reaction was completed. In the case of NPG, the 
decrease in absorbance of NADPH at 340 nm was recorded. Reactions without substrate 
were also carried out to quantify uncoupled electron transfer.  Reactions were also run at 
low temperatures (from 4 to -9.5°C, decreasing by steps of 4.5°C) using 30% glycerol 0.1 
mM Tris buffer pH 8.2. In addition, to test the stability of the enzyme at 40°C, samples 
using the concentrations in Table 2.3 were also incubated at 40oC for a set amount of 
time and then NPG was added while cooling back to room temperature for 5 minutes. 
After five more minutes NADPH was added and the reaction was monitored by the 




Table 2.3 – Stock concentrations of pNCA-11 and NPG, BM-3, NADPH, and Tris-HCl 
pH 8.2 and their concentration in the cuvette.  
 
From the raw absorbance data (A) at 410 nm for pNCA-11 and 340 nm for 
NADPH, the velocity of the reaction (ν) was determined, using the appropriate extinction 
coefficient for the reactant (ε), and the slope of the first 30 seconds of data, as shown in 
Equation 2.2 and 2.3. Equation 2.2, determines the concentration of NADPH or pNCA-
11 (c) per second (s). 
 (2.2) 
where b is the path length, which is 1 cm. The extinction coefficient for NADPH at 340 
nm is 6,200 M-1 cm-1 and for pNCA at 410 nm is 13,200 M-1 cm-1 [26, 30]. Equation 2.3 
defines the rate as concentration per minute (min). 
 (2.3) 
 
In order to determine Km and kcat, experiments in 500 µL of 50 mM KPi with 0.1 µM 
BM-3, concentrations from 0.1 - 250 µM of NPG in 50 mM K2CO3 were incubated for 5 
minutes before the addition of 200 µM of NADPH to start the reaction. The reaction was 























BM-3 in Tris pH 8.2 5  0.02 0.2 1 
pNCA-11 in DMSO or 
NPG in 50 mM K2CO3 
3.75 12 90 450 
NADPH in water 83.3 1.2 200 1000 
Tris-HCl  pH 8.2 408 100  - 
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10oC, 25oC, and 37oC. The Km and Vmax were determined by Michaelis-Menten kinetics 
as shown in Equation 2.4,  
     (2.4) 
 
where Vmax is the maximum reaction rate, and Km, the Michaelis constant. Plotting the 
velocity of the reaction per enzyme concentration as a function of NPG concentration, kcat 
can replace Vmax, since kcat=Vmax/[Enzyme]. Equation 2.5 was used to fit our data. Error 
bars were calculated from the standard deviation of the rate in smaller time intervals (5 
seconds) for the first 30 seconds. 
     (2.5) 
 
GC-MS Samples.  Gas Chromatography-Mass Spectroscopy (GC-MS) samples 
were prepared using previous protocols [2, 17]; 3 ml of 50 mM KPi pH 7.4 with 0.8 µΜ 
of P450 BM-3 and 1 mM NPG were added to a large volume cuvette.  NADPH (1.2 mM) 
was added to the solution to start the reaction, except in the case of the control reaction. 
The reaction was monitored by the depletion of NADPH at 340 nm and reaction 
temperatures were maintained with a 1:1 water/ethylene glycol flow system. After 2 
hours, 1 M oxalic acid was added until the solution was acidified to pH 4 (~100 µl) to 
stop the reaction. The solution was then extracted three times with 3 ml of ethyl acetate 
and the organic fractions were washed three times with 1 ml H2O and dried with Na2SO4. 
The resulting mixture was filtered then dried. The samples were dissolved in methanol-d4 




















distinguish the type of product formed a silylating reagent was added: 50 µl of N,O 
Bis(trimetyhlsilyl)trifluoro-acetamide (BSTFA). After 10 minutes the reaction was 
filtered, and then injected in the GC (Varian 3900) using a temperature gradient of 
10oC/min from 100oC to 300oC. The amount of hydroxylated product formed was 
calculated using the integration function in Interactive Graphics version 6.2 and the 
identity of the peaks were confirmed by GC-MS. The GC-MS data was collected with 
assistance from Dr. Arun Sundaresan in the lab of Professor Nicholas Turro (Columbia 
University, New York). 
Solution NMR.  The NPG-BM-3 enzymatic reaction was performed using 
previously adapted protocols [15, 24].  In a D2O buffer of 0.1 M KPi pH 8.0, BM-3 (0.2 
µM) with 1 mM NPG (or 13C16 NPG) and 1 mM NADPH were incubated overnight at the 
indicated temperatures; samples were then acidified to stop the reaction. Solution NMR 
was then run on the crude enzyme samples in D2O. The samples were then extracted 
following the procedure above for the GC-MS samples except after drying the residue 
was resuspended in deuterated methanol and another 1H NMR was taken. In order to 
obtain the percentage of product, peaks were integrated and then error bars were 
calculated by taking the standard deviation of multiple data sets. 
All optical absorption spectra were taken using a Shimadzu UV-1601 optical 
absorbance spectrophotometer with UVProbe software (Shimadzu). All spectra were 
normalized to buffer and 700 nm. The sample temperature was maintained with a 
calibrated 1:1 water/ethylene glycol bath flow system. Solution NMR experiments were 
preformed on a 300 WB MHz Bruker DRX, a 400L AV III nano bay, or a 400SL AV III 
single bay.  
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Some of this work was done in collaboration with a summer undergraduate 
student, Igor Dikiy, and a post baccalaureate student Claribel Nunez. 
2.3 Results and Discussion 
2.3.1 Temperature Dependence on Enzyme Kinetics 
BM-3 bound to NPG has a temperature dependent spin state conversion [9]. As 
temperature is increased, the heme iron changes from low spin (418 nm) to high spin 
(394 nm) due to the displacement of water[31], as seen in Figure 2.3. pNCA-11 does not 
induce the same change in spin state with temperature and only produces a slight increase 
in high spin heme iron at 394 nm. (Figure 2.3) The difference between NPG and pNCA-
11 could be due to the ligand fitting differently into the binding pocket since pNCA-11 
has a bulky aromatic ring. We modeled a possible binding conformation for pNCA-11 in 
the predicted room temperature conformation of BM-3 using MOE.  One of the 
calculated models is shown in Figure 2.4, where the position of hydroxylation in pNCA-
11 is closest to the heme iron (5 Å).  Another reason as to why pNCA-BM-3’s spin state 
looks different is that pNCA-11 due to solubility is added to BM-3 in DMSO, which has 
been shown to coordinate to the heme [32].  
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Figure 2.3 - Comparison of the temperature dependence in the spin state of NPG-BM-3 
(right) and pNCA-11-BM-3 (left). pNCA-11-BM-3 does not have the same percentage of 
high spin at 37oC indicating that pNCA-11 may be binding differently than NPG. 
Another explanation would be that pNCA-11 is added to BM-3 in DMSO due to its 
solubility and DMSO can also coordinate to the heme [32]. 
 
 
Figure 2.4 - pNCA-11 (green) bound to BMP in the predicted room temperature 
conformation (1F7) using Molecular Operating Environment (MOE), showing the 
position of hydroxylation close to the heme. The “gatekeeper” Phe87 is in pink. 
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Figure 2.5 – Titration of pNCA-11 into BM-3 and the curve fit of the binding constant of 
pNCA-11. The red spectrum is the start of the titration with zero pNCA-11 and the black 
spectrum is the end of the titration at a saturation of pNCA-11. The Kd was determined to 
be 0.305 ± 0.064 µM at room temperature, which is similar to the binding constant of 
NPG, 0.369 ± 0.052 µM.  
 
The dissociation constant for pNCA-11 with BM-3 was determined to be about 
0.306 µM ± 0.064 µM at 25oC, compared to 0.369 µM ± 0.052 µM for NPG and 2 µM 
for palmitic acid, a commonly characterized BM-3 substrate. It is interesting that pNCA-
11 and NPG have a similar binding constant especially since pNCA-11 has a bulky 
aromatic ring. As seen in Figure 2.5, pNCA-11 induces a mixed spin state at high 
concentrations in contrast to NPG. In addition, as stated above DMSO may also be 
affecting the spin state. We also determined the Kd of NPG bound to BM-3 at three 
temperatures (Table 2.4 and Figure 2.6) to see if there was a temperature dependence on 
binding. From our experiments, we observed that at 25oC the binding is only slightly 
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tighter than at 10oC and 37oC, such that if we observed a temperature dependence on the 
rate of the reaction in this range it will not be because of different binding affinities. 
 
  
Figure 2.6 – Determination of Kd for NPG-BM-3 at 10oC, 25oC, and 37oC.  The 
difference in absorbance (394 nm - 418 nm) was plot against the concentration of NPG. 
The Kd for each temperature is reported in Table 2.4. 
 
Activity assays over a range of temperatures showed that for both pNCA-11 and 
NPG there was an optimal temperature between 25-30oC, seen in Figure 2.7. The rate for 
the NPG-NADPH assay is about seven times faster than the rate for the pNCA assay, 
which is not expected since their Kd is similar. This can be explained by the fact that 
pNCA-11 does not bind the same way as NPG, since pNCA-11-BM-3 is in a mixed spin 
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state under these conditions and/or pNCA-11 is not able to leave the binding pocket as 
quickly to allow the next substrate to bind and react.  Control experiments were 
conducted without substrate present to test for uncoupled electron transfer, i.e. if the 
electrons are consumed and no product is formed.  The results of these experiments 
showed that there is no detected uncoupled electron transfer within error. The 
consumption of NADPH for BM-3 without substrate was 4.9 ± 4.3 mole of NADPH per 
min per mole of enzyme at 25oC, as shown in Figure 2.7. 
  
Figure 2.7 - Activity (velocity) of NPG (blue squares), pNCA-11 (green triangles), 
pNCA-11+ glycerol (purple triangles) and NADPH only (red diamonds). BM-3 has a 
higher activity for NPG than pNCA-11, which is expected since pNCA-11 has a bulky 
aromatic ring. BM-3 for both substrates has higher activity between 22-30oC. At 
temperatures below 4oC there is no enzymatic activity within error. In addition, no 
uncoupled electron transfer is occurring as shown by the NADPH only (red diamonds) 
assay without any substrate.   
 
In order to determine BM-3’s activity at low temperature, 30% glycerol was 
added to our samples.  Glycerol was chosen as a cryoprotectant because it was shown to 




















pNCA + glycerol 
NADPH only 
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showed the expected decreased in activity at 4oC due to the addition of glycerol and that 
within error below -5oC there is no activity, as shown in Figure 2.7. 
The activity reported in Figure 2.7 is dependent on the concentration of substrate. 
In order to more accurately determine the enzymatic rate we performed experiments at 
concentrations of NPG from 0.1 to 250 µM to determine the kcat and Km. The Km of NPG 
-BM-3 at 25oC showed the same trend as Kd having the smallest value as shown in Table 
2.4. However, there is an order of magnitude difference between Kd and Km, which can 
be explained by most of the substrate binding in an unproductive conformation or another 
step besides substrate binding in the P450 cycle is rate determining.  The values for kcat 
match the trend seen in Figure 2.7, showing that the velocity of the reaction at 37oC has 
the lowest activity and the maximum activity is at 25oC (Figure 2.8).  The decrease in 
activity was expected at 10oC due to a lower percentage in the high spin state.  However, 
at 37oC the rate was expected to be faster because there is a higher percentage of BM-3 in 
the high spin state.  Therefore there has to be inefficiency somewhere else in the P450 
cycle preventing catalysis at 37oC. 
 10oC 25oC 37oC 
Kd (µM) 0.599 ±0.048 0.369±0.052 0.505±0.072 
kcat (min-1) 822± 101 1509 ± 139 217± 28 
Km (µM) 84.3 ± 36.8 5.36 ± 2.75 51.6 ± 30 
kcat/Km 9.75 281.5 4.2 
Table 2.4 - Kd, kcat and Km values of BM-3 with NPG.  These values show that the 
binding constant (Kd) is similar at all three temperatures and the highest activity and 




Figure 2.8 – Determination of kcat and Km for NPG-BM-3 at 10oC, 25oC, and 37oC.  The 
velocity of the reaction was plot against the concentration of NPG and fit using Equation 
2.5. The kcat and Km are reported in Table 2.4. 
 
As shown in Figure 2.7 and 2.8, as temperature decreased, the activity gradually 
decreased, which can be explained by a smaller population in the high spin state as shown 
in Figure 2.3. However, as the temperature increased the rate seemed to drop off 
drastically to almost no activity at 40oC. Possible explanations for no activity at high 
temperature could be that the enzyme is degrading or the substrate is moving into a 
position not amenable for hydroxylation.  In order to figure out what is happening at 
40oC, we conducted another experiment; the samples were incubated for the indicated 
amount of time at 40oC as shown in Figure 2.9, then cooled to room temperature where 
the activity was tested.  After ten minutes at 40oC, the enzyme had minimal activity. The 
incubation time of five minutes was not long enough to fully warm the sample to 40oC 
from room temperature and therefore, still showed some activity. These results indicate 
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that the enzyme is unfolding or the ligand moves into an unproductive conformation.  
Our results are consistent with Salazar et al. who reported a melting temperature (Tm) of 
the enzyme to be 43oC monitoring carbon monoxide binding [33], and Munro et al. 
reported a Tm of 48oC by differential scanning calorimetry [34]. From our experiment, 
besides the outlier of 30 minutes, it does not seem like the unfolding is reversible under 
the constraints of our experiment.  Since we are incubating the enzyme for a period of 
time we should also take into consideration that the flavin domain (NADPH binding 
domain) can dissociate (Kd 0.030 µM) in low concentrations of protein [35].  Future 
experiments including circular dichroism (CD) spectroscopy and additional enzyme 
assays giving the enzyme more time to refold at room temperature after heating to 40oC 
could answer whether the enzyme is unfolding and if it is reversible.  Knowledge of this 
temperature dependence on BM-3’s stability was helpful in planning the temperature 
ranges of our SSNMR experiments (Chapter 5). 
 
Figure 2.9- Activity of NPG-BM-3 at 25oC after incubation at 40oC at the indicated time, 
shows the enzyme may be partially unfolding or the ligand moved into an unproductive 
binding mode preventing catalysis.  Besides the outlier at 30 minutes, it does not appear 
under these experimental conditions that the unfolding is reversible. Concentrations are 



















Time at 40 oC 
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2.3.2 Temperature Dependence of the Product Distribution  
Previous studies have shown that the product distribution can be determined by a 
variety of methods [14, 15, 22-25]. For our studies we used solution NMR and GC-MS. 
Oliver et al. saw product formation by solution NMR for laurate in a crude enzyme 
sample in D2O.  Therefore, solution NMR is an easy way to see product formation.  First 
the 1H NMR of NPG (Figure 2.9) was assigned, where H4 (2.23 ppm), H5 (1.56 ppm), 
and H18 (0.85 ppm) were distinguishable from the bulk protons (1.23 ppm) on the fatty 
acid chain. Marker peaks of product formation for 1H NMR include H14-18, with the best 
being H18, as predicted by MestReNova (Mestrelab Research) in Table 2.5. For ω-2 and 
ω-3 product, H18’s chemical shift is expected to shift slightly from starting material and 
a larger shift is expected for the ω-1 product. 1H solution NMR was done on the 
enzymatic reactions performed at three temperatures (10, 25, 37oC) in D2O both on the 
crude sample (Figure 2.11) and after the products were extracted from the enzyme 
(Figure 2.12).  
 
Figure 2.10 – The structure of NPG showing the numbering of the protons and carbons 
and where product formation occurs at ω-1, ω-2, ω-3. For 13C NMR, 13C16-NPG was used 
where C3-18 (red) were 13C enriched. 
  
Enzymatic reactions were carried out in D2O as described in the Materials and 
Methods (Section 2.2), which allowed for 1H NMR experiments on the crude samples 
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(Figure 2.11) and showed product formation. H4 and H5’s chemical shift should not be 
affected by product formation and therefore these peaks were not expected to move.  The 
protons on the ω-methyl (H18) are the best reporters for product formation.  For ω-2 and 
ω-3 product, H18’s chemical shift was expected to shift slightly from starting material, 
which can be seen by the multiplet at 0.85 ppm in Figure 2.11.  A larger shift was 
expected for the ω-1 product, however this peak, which should be a doublet, overlaps 
with NADPH. Even though there are overlapping NPG proton peaks with protein and 
with NADPH, the comparison of the spectra for 10oC and 25oC are very similar 
indicating the ligand behaves in the same way at these two temperatures.  In addition, in 
the spectrum for 37oC there is still some starting material present, as shown by the 
similarity in the red and blue spectrum (control) in Figure 2.11.  For the D2O samples, 
overlapping peaks prevented analysis of the product distribution with temperature and 
therefore other methods need to be used in order to obtain these results. 
The enzymatic reactions were extracted into ethyl acetate separating product and 
starting material from protein and NADPH, enabling us to clearly see product formation 
by 1H NMR (Figure 2.12).  Comparisons of the 1H spectra, like the samples in D2O 
(Figure 2.11), show that 10oC and 25oC are identical and at 37oC less product is formed 
shown by the similarity of the 37oC spectrum with that of starting material. In Figure 
2.12, H18 ω-1’s doublet is clearly resolved however, H18 ω−2, ω-3, and starting 
material’s triplets all overlap with each other. The peaks at approximately 0.96 ppm were 
also in the control experiment and therefore are not product peaks.  Initial 2D COSY 
experiments at 25oC shows separation of H18 from ω-2 and ω-3. However, ω-3 also 
overlaps slightly with starting material, Figure 2.13.  From these 1D 1H NMR 
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experiments, we determined relative product ratios, through integration of the peaks in 
the 1H NMR spectra.  We integrated H18 ω-1 and the overlapping peaks of H18 ω-2 and 
ω-3 plus starting material, to get the percentage of ω-1 in Table 2.6.  In additon, we 
integrated part of the peaks corresponding to H18 of ω-2 and ω-3 from 0.86 to 0.90 ppm, 
to get the lower limit on the percentage of ω-2 and ω-3.  Similar results for the 
percentage of products were obtained for 10oC and 25oC, but less is observed for 37oC 
(Table 2.6). This is different from the trend for ω-1 observed for palmitic acid (Table 
2.2), where more ω-1 is formed at 37oC than room temperature.  However, since starting 
material is taken into consideration, the lower percentages for 37oC could also be due to 
less product formation.  
 
 Assigned  Predicted  
 Starting Material (ppm) ω-1 (ppm) ω-2 (ppm) ω-3 (ppm) 
H14 1.23   1.44,1.45 
H15 1.23  1.44,1.45 3.34 
H16 1.23 1.44,1.46 3.28 1.44,1.46 
H17 1.23 4.03 1.43,1.45 1.38 
H18 0.85 1.23 0.89 0.89 
Table 2.5 – The assigned 1H chemical shifts for NPG and the predicted 1H chemical shifts 
corresponding to the three different hydroxylation products of BM-3 with NPG. H18 is 
the best reporter on product formation and in order to distinguish the ω-2 and ω-3 




Figure 2.11 – 1H spectra of NPG-BM-3 hydroxylation product mixtures showing product 
formation in D2O.  The enzymatic reactions were carried out at three different 
temperatures 10oC (green), 25oC (yellow), and 37oC (red), and a control without NADPH 
(blue) was also conducted. The 1H spectra of 10oC and 25oC  reaction products are mostly 
identical, except that there seems to be more product formation for 25oC, shown by the 
increase in intesity around  1.3-1.4 ppm. The 1H spectrum of the products from the 
reaction at 37oC has peaks indicating product formation (0.85 and 1.35 ppm) and that all 
the starting material may not have reacted (0.8 ppm).  Overall, more signal averaging is 
needed to obtain a quantitative answer on the percentage of product produced at each 





Figure 2.12 - 1H NMR spectra of the extracted products of NPG-BM-3 showing product 
formation and identification of the three products. The enzymatic reaction was carried out 
at 10oC (green), 25oC (yellow), and 37oC (red), and a control without NADPH (blue) was 
also conducted. The 1H spectra of 10oC and 25oC are very similar as also shown in Figure 
2.11.  The spectrum of products from the reaction at 37oC shows that there still is some 
starting material present. The peaks around 0.96 ppm are also in the control and are not 
product peaks. The spectra were recorded on a 400 MHz Bruker magnet and referenced 
to methanol. 
 
Temperature Relative % ω-2 + ω-3 Relative % of ω−1 
10oC >34.0 ± 2.1 25.7 ± 10.8 
25oC >38.6 ± 2.9 25.1 ± 8.8 
37oC >32.9 ± 1.6 20.7 ± 0.7 
Table 2.6 - Relative percentages of products based on the spectra in Figure 2.12. The 
percentages were calculated by integrating over the H18 peak for ω-1 (1.08-1.15 ppm) 
and then over the overlaping peaks of ω−2, ω−3, and starting material (0.82-0.91 ppm).  
The relative percentage of ω-1 was determined by using the integration of 
ω−1 normalized by the total integration for H18 (ω-1, ω−2, ω−3, and starting material) at 
each temperature. The lower limit of the percentage of ω-2 and ω-3 was found by 
integrating from 0.86-0.90 ppm over the total integration. These numbers show that less 
product is formed at 37oC and the percentage of ω−1 may be higher for NPG than 




Figure 2.13 – 2D 1H COSY of the extracted NPG-BM-3 enzymatic reaction at 25oC. The 
spectrum shows evidence for product formation as well as resolution of peaks for the ω-2 
and ω-3 product.  The chemical shift for H17 ω-1 has not been assigned. 2D 1H COSY 
spectra will be useful for comparing ω-2 and ω-3 product formation. The spectra were 
recorded on a 400 MHz Bruker magnet and referenced to methanol. 
 
Predicted 13C chemical shifts (Table 2.7) show separation of ω-2 and ω-3 for C18 
and therefore carbon NMR may be a useful technique to determine product distribution. 
Initial 13C experiments were carried out with labeled NPG, where C3-C18 were enriched 
with 13C (13C16-NPG) at room temperature and 37oC (Figure 2.14 and 2.15).  Based on 
Table 2.7, we can rationalize our data such that we can see all three products as shown in 
Figure 2.14.  From the 13C spectral intensities it appears that the ratio of products are ω-2 
>ω-1>ω-3, which is different from the reported ratios for palmitic acid in Table 2.2, ω-
2>ω-3>ω-1.  This is also in agreement with the relative integration of our 1H data 
showing a higher percentage of ω-1 for NPG than palmitic acid. The discrepancy 
 60 
between the product ratios for NPG and palmitic acid could be due to the peak for C18 ω-
1 overlapping with C17 of starting material or NPG is a longer ligand than palmitic acid 
and may have different product ratios. The same experiment was repeated at 37oC and 
evidence of starting material was seen in the spectrum (Figure 2.15). This is similar to the 
1H spectrum at 37oC where there was also starting material present. Due to low 
resolution, we are unable to determine relative ratios of the products at 37oC (the 
spectrum at 25oC had more signal averaging). 
 
Figure 2.14 - 13C NMR spectrum of the enzymatic reaction of BM-3 with 13C16 NPG at 
25oC.  The 13C spectrum shows evidence of all three products, which were assigned based 
on predictions in 13C chemical shifts shown in Table 2.7. The ratio of products based on 
intensity is ω-2>ω-1>ω-3 compared to palmitic acid where the ratio is ω-2>ω-3>ω-1.  










 Assigned  Predicted  
  Starting Material (ppm) ω-1 (ppm) ω-2 (ppm) ω-3 (ppm) 
C12 32.28   31.88 
C13 32.38  31.88 27.99 
C14 32.38 31.88 27.99 39.88 
C15 32.38 27.57 39.44 78.12 
C16 34.30 41.77 75.61 40.62 
C17 25.10 70.82 32.8 21.41 
C18 16.42 25.53 11.25 16.8 
Table 2.7 - 13C predicted chemical shifts of NPG for both the starting material and 
products. From the predicted shifts, we should see all three products (Figure 2.14), even 
though the chemical shift of C18 for ω-3 and starting material are similar, evidence of a 
peak at 73 ppm (predicted 78 ppm) showed evidence for ω-3 product formation. 
 
 
Figure 2.15 - 13C NMR on the enzymatic reaction of BM-3 with 13C16 NPG at 
25oC(green), 37oC(red), and no NADPH(blue).  From the two peaks at 31.2 ppm 
(product) and 32.8 (starting material) we could conclude that starting is still present at 
37oC.  The resolution is lower at 37oC because not all of the ligand reacted and therefore, 
it is hard to make a comparison on the distribution of products at 37oC. The spectra were 
obtained on a 300wb Bruker magnet. 
 
GC-MS is another method to determine product distribution. In order to make 
sure the samples run efficiently in the instrument and to be able to distinguish the three 
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products formed, products are silylated with N,O Bis(trimetyhlsilyl)trifluoro-acetamide 
(BSTFA). The mass-to-charge (m/z) ratios of ions after silylation, an addition of a 
trimethysilyl (TMS) group, would be 117 for ω-1, 131 for ω-2 and 145 for ω-3 product. 
For the starting material the m/z should be 385, which would reflect an addition of a 
TMS group to the carboxylic acid. However, we also see evidence of an additional TMS 
added with the m/z of 458. A TMS group could be adding to either the nitrogen or the 
other carbonyl (C3) of NPG. For our products with the addition of TMS on the alcohol 
and carboxylic acid, the total molecular weight should be 473, plus a possible third TMS 
would be 546, however our detector was not set for masses this high. By comparing the 
differences in the mass spectra for the three peaks observed in Figure 2.16, we can 
determine which peak belongs to which product by looking for the m/z ratios described 
earlier.   The peaks in Figure 2.16 were integrated and the product distribution is listed in 
Table 2.8. The product distribution for 10oC and 25oC are very similar. Data were not 
obtained for 37oC because the peaks were within the signal to noise of the experiment. 
This is supported by our solution NMR experiments, which also show that less product is 
formed at 37oC.  In contrast to our solution NMR experiments, our GC data shows more 
ω-3 product formation than ω-1.  Due to overlapping peaks in both solution NMR and 
GC, more extensive curve fitting would have to be performed to obtain more accurate 
percentages of the product distribution. 
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Figure 2.16 – GC trace and mass spectra of the NPG-BM-3 products at 10oC. The GC 
trace shows starting material along with the three product’s retention times. The product 
peaks were identified by GC-MS. These mass spectra correspond to the peaks in GC 




NPG ω-1  % ω-2  % ω-3  % 
10oC 18.9 ± 0.34 47.8 ± 0.57 33.2 ± 1.40 
24oC 21.0 ± 0.33 47.7 ± 0.91 31.3 ± 0.96 
Literature RT 21.7 45.6 32.2 
Literature 37oC 31.5 47.5 21 
Table 2.8 – GC results showing the product distribution for 10oC and 25oC for NPG, 
compared to the literature values for palmitic acid at room temperature and 37oC. Our 
results are in agreement with the reported room temperature product distribution for 
palmitic acid. In addition, the same trend is seen; as temperature increase there is an 
increase in ω-1 and a decrease in ω-3. We were unable to get data at 37oC because our 
peaks were within the signal to noise of the experiment.  
 
2.4 Conclusions  
The percentage of high spin at 10, 25 and 37oC is reported in Table 2.9, showing 
that BM-3 at 37oC has the highest percentage in the high spin state, which is the 
necessary state for catalysis to occur.  Therefore, at 37oC we expected to see more 
product formation than at lower temperatures, such as 10oC and 25oC where a mixed spin 
state is observed. However, we observed the opposite, we saw more product formation 
and a higher kcat at 10oC and 25oC than at 37oC.  Less product formation at 37oC was seen 
in 1H and 13C solution NMR spectra along with our GC-MS data, showing that a 
considerable amount of starting material was still present. In addition to NPG, pNCA-11 
also showed maximum activity at temperatures between 25-30oC and diminished activity 
at 37oC.  We propose the decrease in activity at 37oC is caused by parts of the enzyme 
unfolding or the ligand is in an unproductive conformation preventing catalysis from 
occurring. In either case, the percentage of high spin is not directly correlated to product 
formation.  The lower activity at 10oC compared to 25oC can be explained by a smaller 
population in the right binding mode, which is in agreement with the temperature 
dependence of the spin state. 
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The Kd and Km were determined at 10, 25, 37oC.  The smallest Kd and Km was for 
25oC, which is in agreement with the kcat being the fastest at this temperature.  However, 
there is an order of magnitude difference between Kd and Km, indicating that most of the 
binding we are observing from the Kd may be in an unproductive conformation or there 
could be multiple intermediates of the enzyme-substrate complex. This is in agreement 
with the data at 37oC, showing that a change in spin state, although necessary for 
catalysis, does not always lead to product formation. 
The second part of our study was to see if we could learn about the temperature 
dependence on the conformation of NPG through differences in product distribution. 
Initial studies on the temperature dependence on the product distribution, showed that 
there is only a slight difference in the product distribution at 10oC and 25oC as shown by 
GC-MS and 1H solution NMR. The exact percentages from these two techniques cannot 
be directly compared since only relative percentages were determined from 1H NMR 
spectra, however they are compared in Table 2.9. These results are very interesting since 
the product distribution at 10oC and 25oC are relatively the same suggesting that at these 
temperatures NPG bound to BM-3 has similar behavior. Currently no conclusion can be 
made for 37oC, since less product formation was observed, but we hope to increase the 
enzyme and NADPH concentration in order to favor product formation and help in 
determining the product distribution. Overall, there are multiple conformations for the 
ligand shown by the difference in Km and Kd, however since there is no temperature 
dependence on the product distribution within error, there may be one preferred 





% HS  
MD 
% HS  
UV-vis Method ω-1 ω-2 ω-3 
10oC 60 89.6 GC 18.9 ± 0.34 47.8 ± 0.57 33.2 ± 1.4 
   1H NMR 25.7 ± 10.8 34 ± 2.1 
25oC 74 98.3 GC 21.0 ± 0.33 47.7 ± 0.91 31.3 ±0.96 
   1H NMR 25.1 ± 8.8 38.6 ± 2.9 
37oC 82 100 1H NMR 20.7 ± 1.0 32.9 ± 1.6 
Table 2.9 – Comparison of the percentages of product determined by GC and 1H NMR. 
The percentage of the population of NPG-BM-3 in the high spin state were determined 
previously by MD [10] and by optical absorbance data [36]. These two methods cannot 
be directly compared since for the 1H NMR it is only a relative percentage with starting 
material taking into consideration. However, this data shows that there is a slight 
temperature dependence of ω-1 and ω-3 and none for ω−2. 
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Before a crystal structure of cytochrome P450 BM-3 was ever published, 
researchers speculated that in addition to a hydrophobic pocket there was a charged 
residue in the binding pocket, since P450 BM-3 is inactive to n-hydrocarbons and fatty 
methyl esters, but reactive to fatty alcohols, acids, and amides [1]. When the crystal 
structure of the heme domain of cytochrome P450 BM-3 (BMP) was solved it showed the 
binding site as a long hydrophobic channel that is 8-10 Å in diameter and the beginning 
of the channel contains the only charged residue, Arg47.  The two sides of the channel 
are closer together in the substrate bound structure indicating a closure of the substrate 
channel [2]. The F and G loops form one side of the substrate channel while the other 
side is the 310 helix (residues 16-20) and the Arg47 β-sheet, shown in Figure 3.1.  At the 
solvent exposed end of the ligand, a variety of protein side chains have been proposed to 
interact with the ligand: Arg47, Gln73, Ala74, and Tyr51. However, structural evidence 
for the substrate interacting with Arg47 has not been seen in the prior X-ray crystal 
structures. 
Since we are interested in the conformation and dynamics of NPG in P450 BM-3, 
as part of this study we resolved the X-ray structure at cryogenic temperatures. In our 
crystal structure we were able to trap an important conformation of NPG, showing it 
hydrogen bonding to Arg47. In order to gain further insight on the role of Arg47, we 
mutated it to a glutamic acid to see how reversing the charge on the side chain would 






Figure 3.1 - The binding pocket of NPG bound to cytochrome P450 BMP using pdb file 
1JPZ.  The binding pocket and access channel are colored in cyan, NPG in orange, heme 
in gray, and Tyr51 and Arg47 in red. Tyr51 and Arg47 have been proposed to be 
involved in initial binding and substrate positioning. This figure shows that arginine is in 
a key position to attract substrates to the binding pocket. 
3.1.2 Enzymatic Evidence for a Key Role of Arg47  
Previous researchers performed site directed mutagenesis of arginine to glutamic 
acid (R47E), alanine (R47A), glycine (R47G) and phenylalanine (R47F) to gain insight 
on the role of Arg47, which is still not known. Table 3.2 and Figure 3.2 show a collection 
of mutation data on Arg47 from multiple references using the substrates shown in Table 
3.1. Mutations of Arg47 had an effect on kcat, Kd and Km [3-6]. Most mutations of Arg47 
showed a decreased kcat with all substrates except for lauric acid, which is the smallest 
natural substrate. In addition, all mutations of Arg47 caused an increase in Km and Kd, 
which shows that Arg47 may be involved in the binding of the substrate.  
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Table 3.1 - P450 Substrates and their representative products that were used in R47E 
mutagenesis studies. Cytochrome P450 BM-3 can perform both hydroxylation and 
epoxidation. EET is epoxyeicosatrienoic acid and EETA is epoxyeicosatetraenoic acid. 
 
The size/length of the substrate matters in how strongly it interacts with Arg47 as 
shown by a mutation of Arg47 (positively charged) to glutamic acid (negatively charged) 
prevented catalysis of both arachidonic (AA), which is the fastest substrate for BM-3 at 
17,000 min-1, and eicosapentaenoic (EPA) acid and the typical spectrum indicative of 
type I substrate binding was not observed. Type I binding is defined by an increase in 
absorbance at 394 nm and a decrease in absorbance at 418 nm, which is indicative of the 
ligand binding and the displacement of the water coordinating to the heme, changing the 
spin state of the heme [4]. However, the R47E mutant catalyzed negatively charged fatty 
Substrates Representative Hydroxylation/Epoxidation Products 
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acids: laurate(C12), myristate (C14), and palmitate (C16), and the corresponding 
positively charged trimethylammonium (TMA) compounds: C12TMA, C14TMA, and 
C16TMA shown in Table 3.2 and Figure 3.2 [6].  
MD simulations have also demonstrated that Arg47 may play a role in expulsion 
of the ligand after catalysis [7].  Arg47 has been shown to play a role in selecting and 
steering substrates into the active site. In comparing the differences in kcat for the 
substrates (fatty acids vs TMA), the wild type was able to discriminate between the two 
differently charged substrates whereas the mutant could not. For example the ratio of kcat 
of C16 to C16TMA for the wild type was 81:1 compared to the mutant 1.6:1.  A possible 
explanation for this is that side chain of arginine is longer than glutamic acid, which 
enables it to interact with and discriminate substrates [8].  
The role of Arg47 may also include positioning of substrates for catalysis. For the 
R47A mutant with AA an increased rate of epoxidation and decreased rate of 
hydroxylation compared to the wild type was observed. Since the rate of epoxidation 
increased, the absence of Arg47 allowed the substrate to penetrate further into the binding 
pocket allowing chemistry to occur more favorably at C15 compared to C18, which 
supports that Arg47 is involved in substrate positioning. In addition for EPA, the rate of 
catalysis increased, in forming the epoxidation product, 17,18 EETA [4]. This may also 







kcat C8 C10 C12 C14 C16 C20 
R47A[3-5] 
    
0.77-
1.17   0.71 
0.62-
0.82 
R47G[5]     0.53     0.28 
R47E[4, 6]     1.12 0.13 0.15  NR 
R47E-TMA[6]     1.38 6.86 20  
Y51A[3]     0.33     0.24 
R47A/Y51A[3]     0.07   0.03 0.1 
F87A/L188K/A74G/R47F[9] 4.4 1.27 1.04       
       
Km C8 C10 C12 C14 C16 C20 
R47A[5]     2.98    4 
R47G[5]     2.25     2.09 
R47E[6]     14.7 2.57 2.86   
R47E-TMA[6]     0.121 0.264 1.8   
Y51A             
R47A/Y51A             
F87A/L188K/A74G/R47F[9] 1.47 1.02 0.39       
       
kcat/Km C8 C10 C12 C14 C16 C20 
R47A[5] 
    0.26    
0.15-
0.2 
R47G[5]     0.24     0.14 
R47E[6]     0.08 0.05 0.05   
R47E-TMA[6]     11.36 25.98 11.11   
Y51A             
R47A/Y51A             
F87A/L188K/A74G/R47F[9] 2.99 1.25 2.67       
Table 3.2 – Ratio of mutant to wild-type values for kcat, Km, and kcat/Km for previous 
mutants. In order to efficiently compare values in different studies everything is 
normalized to wild-type values for that substrate. The comparison of different mutant 
studies showed that the effect of the mutation is dependent on substrate length. R47E 
affected activity the most except for laurate (C12). Mutation of Y51 affected activity but 
with the additional mutation of Y51A/R47A diminished most of the activity. Engineering 
the enzyme to catalyze non-natural substrates showed that with the additional mutation of 
R47F, the highest activity for pNCA-8 was observed.  For all substrates, Km increased 
which shows that Arg47 may be involved in initial binding and the opposite effect was 
seen for the TMA compounds except palmitate. C12 is laurate (wt kcat=5140, Km=288), 
C14 is mystrate (wt kcat=3300 min-1, Km=7 µM), C16 is palmitate (wt kcat=4860 min-1, 
Km=1.4 µM), and C20 is arachidonic acid (wt kcat=17100 min-1, Km=4.7 µM)[5, 6]. For 
R47E-TMA the substrates were trimethyl ammonium compounds: C12TMA (wt kcat=96 
min-1, Km=782 µM), C14TMA (wt kcat=135 min-1, Km=87 µM), and C16TMA (wt kcat=60 
min-1, Km=5 µM)[6].  C8-C12 for the F87A/L188K/A74G/R47F is pNCA-8 to pNCA-12 




Figure 3.2 - kcat of mutants showing the decrease in rate compared to wild type. If 
multiple studies were done on the same mutant and substrate by different researchers, the 
kcat’s were normalized to the highest wild type rate and then averaged.  This comparison 
shows that C20 has the highest wild type rate and C12 is the least affected by the 
mutations.  Note that there was no reaction for the C20 substrates with the mutant R47E. 
 
Knowing the role of Arg47 can aid in designing enzymes to catalyze different 
substrates. Qing-Shan Li et al. engineered P450 BM-3 to catalyze shorter substrates C8-
C10 (specifically pNCA) and one of the mutations was R47F, in addition to V26T, 
A74G, L188K, and F87A.  Wild type BM-3, along with the mutants F87A and 
F87A/L188K, cannot catalyze p-NCA-8. With another mutation F87A/L188K/A74G the 
enzyme is able to catalyze pNCA-8, however it is optimal with the additional mutation of 
R47F.  The increase in activity is indicative of eliminating the possible carboxylate 
binding site making R47F part of the “hydrophobic patch” that is solvent exposed and 
may aid in guiding the hydrophobic substrate into the binding pocket [9]. 












3.1.3 Previous Crystal Structures and Tyr51 
Mutagenesis studies have shown that Arg47 may be involved in initial binding of 
the substrate and steering the substrate into the active site [10, 11] and positioning and 
stabilizes the substrate in the active site [3, 5]. However, evidence from previous crystal 
structures supports that Arg47 it is too mobile and too far away from the substrate to have 
any significant role [2, 11] and instead Tyr51 is important. The crystal structure of 
palmitoleic acid bound to cytochrome P450 (1FAG) shows Arg47’s side chain has 
different conformations in the asymmetrical unit and not all of them are oriented towards 
the substrate, indicating some motion [2]. However, the fact that Arg47 is mobile, may be 
necessary for cytochrome BM-3 to coordinate and hydrolyze substrates of different 
lengths [12]. Also, in the 1JPZ and 1FAG crystal structures the Arg47 guanidinium group 
is too far away from the carbonyl group of NPG to form a hydrogen bond, 4.5 Å and 5.2 
Å, respectively [2, 11]. Instead of Arg47, palmitoleic acid in 1FAG and NPG in 1JPZ is 
hydrogen bonding to Tyr51, whose electron density is well defined [2, 13] 
Comparing the sequence of BM-3 with fatty acid ω-hydroxylases, Tyr51 is 
conserved whereas Arg47 is not [8], however the exact role of Tyr51 is not known. 
Mutation of Tyr51 to alanine along with the double mutation R47A/Y51A decrease the 
rate of activity and increase binding constants for lauric (C12), palmitoleic (C16), and 
arachidonic (C20) acid shown in Table 3.2 and Figure 3.2. However, Y51A and 
R47A/Y51A mutations caused a more significant decrease in the rate for all three 
substrates compared to R47A [3]. Analysis of the products for AA showed that ω-1 
hydroxylation occurred for Y51A and R47A/Y51A, which is not a wild type or R47A 
product.  For the double mutant R47A/Y51A and for R47A, a larger percentage of 
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epoxidation, 14,15 EET was produced compared to the wild type, which was not true for 
Y51A [3]. Therefore, Arg47 may be more involved in initial binding and preventing large 
substrates from penetrating too far into the binding pocket, whereas Tyr51 may be more 
involved in positioning of the substrate at the time of catalysis.  Although mutations of 
Y51F showed only a slight decrease in activity, therefore the effect of the mutation of 
Y51A may be a result of the difference in size and hydrophobicity and not necessarily the 
hydroxyl group [5].  
In conclusion, together Arg47 and Tyr51 are important for monooxygenation with 
high regioselectivity in correctly positioning some substrates.  The arginine and tyrosine 
pair is not unique to cytochrome P450 BM-3.  An Arg-Tyr pair is used to stabilize 
binding of lactate in L-lactate cytochrome c oxidoreductase from Saccharomyces 
cerevisiae [14]. Similarly flavocytochrome b2 from Hansenula anomala and L-mandelate 
dehydrogenase from Rhodotorula graminis have an important Arg-Tyr pair; and spinach 
glycolate oxidase has a Arg-Ser pair [15].  
Arg108 in CYP2C9 [16] plays a similar role as Arg47 in BM-3.  CYP2C9 is 
found in the human liver and is involved in metabolizing commonly prescribed drugs 
such as S-warfarin, phenytoin, and many other non-steroid anti-inflammatory drugs [17]. 
Mutant studies of R108F showed barely any activity towards acidic substrates, S-warfarin 
and diclofenac, and type I binding was not observed [18]. Also, R108A showed no 
activity towards diclofenac [19]. However, the crystal structure of CYP2C9 bound to S-
warfarin shows Arg108 pointing away from the substrate [20]. Two explanations were 
proposed regarding how Arg108 can have an important effect on enzyme activity but not 
appear in contact with the substrate in the crystal structure; 1) it can be involved in initial 
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binding of the substrate or 2) since the published crystal structure shows the substrate in 
an inactive binding pocket 10 Å away from the heme iron, an active conformation may 
show the substrate coordinated to Arg47.  The second hypothesis is shown in the crystal 
structure of flurbiprofen with CYP2C9 because the substrate is in catalytically active 
conformation and interacting with Arg108, shown in Figure 3.3 [16].  
 
Figure 3.3 – Comparison of NPG bound to NPG and flurbiprofen bound to CYP2C9, 
showing both the substrates interacting with arginine.  The arginines in the binding 
pocket are in different locations in each enzyme to accommodate the difference in size of 
the substrates. 
 
The same logic can also be applied to Arg47 in BM-3 to explain why previously 
published crystal structures do not support the role of Arg47.  Previous mutagenesis 
studies show that Arg47 is essential for positioning larger substrates for catalysis, since 
R47E is inactive towards AA and EPA, and a different ratio of AA products were formed 
for R47A. In addition, Arg47 is involved for initial binding since Km and Kd increased for 
all mutants as shown in Table 3.2 and Figure 3.2. It also appears that Tyr51 also has a 
role in substrate positioning and catalysis, however the function of Tyr51 is not explored 
in this thesis. Our hypothesis is that Arg47 helps in binding of substrates and for larger 
substrates, such as NPG, it positions them correctly for catalysis.  If so, our solved crystal 
structure would represent an important step in the mechanism for catalysis. 
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3.2 Materials and Methods 
 Crystal Structure Methods. Natural abundance cytochrome P450 BMP was 
expressed in E. coli B21 DE3 cells and purified as stated in Chapter 2. After purification, 
cytochrome P450 was diluted or concentrated to either 25 mg/ml or 12.5 mg/ml in 50 
mM KPi pH 7.4.  If the protein was stored at -80oC, 10% glycerol was added and the 
protein was divided into aliquots of 30 µl. Hanging drop crystal trays were set up at 4oC 
with 1:1 aliquots of protein and mother liquor.  Stock solutions of 2 M MgCl2, 50% by 
weight PEG 3350, and 1 M MES pH 6 were filter sterilized.  The mother liquid usually 
included either 12.5 mg/ml or 25 mg/ml stock BMP with either 1 or 1.1 equivalents of 
NPG, 12-21% PEG 3350, 150-225 mM MgCl2, and 100 mM MES pH 6, and deionized 
water to make the total volume of the well 500 µl.  Crystals with high concentrations of 
PEG grew within 24 hours and lower concentrations of PEG usually grew within a couple 
of days as shown in Figure 3.4. Diffraction quality crystals were obtained by 
microseeding a drop of 16 mg/ml BMP in 50 mM potassium phosphate pH 7.4, 1 
equivalent of NPG, 150 mM MgCl2, 50 mM MES pH 6.0, 10% glycerol, and 13% PEG 
3350. 
 
Figure 3.4 - An example of a crystal of BMP with NPG bound that diffracted. 
 
Diffraction data was collected in collaboration with Dr. Gabriel Amodeo and 
Professor Liang Tong, Columbia University. The structure of cytochrome P450 BMP 
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with NPG, grown at pH 6.0, was determined at 2.0 Å resolution (Table 3.3). The final R 
factor for the refined structural model is 19.3% and the free R factor is 22.7%. The root-
mean-square (RMS) deviation from ideal values for bond lengths is 0.016 Å and for bond 
angles is 1.7°. The refined structural model contains residues 1-225, 229-458 of BMP, 
NPG, heme, and 299 solvent water molecules. This crystal form is in space group P21 21 
2, with unit cell parameters of a=188.7 Å, b=59.32 Å, and c=56.24 Å with angles α, β, γ 
=90o.  
Maximum resolution (Å) 2.0 
Space Group P21 21 2 
Unit cell parameters (Å, o) a=188.7, b=59.32, c=56.24 
α=β=γ =90 
Resolution range used for refinement 30.0 - 2.0 
Number of reflections 40835 
Completeness (%) 93.6 
R Factor (%) 19.3 
Free R Factor (%) 22.7 
rms deviation in bond lengths (Å) 0.016053 
rms deviation in bond angles (o) 1.70301 
Table 3.3 – Our crystal structure information on the space group and the resolution of the 
structure. 
Structure determination and refinement of X-ray diffraction data was collected at 
the X29A beamline of the National Synchrotron Light Source (NSLS).  Diffraction 
images were processed with the HKL package [21]. The structure was solved by 
molecular replacement with the program COMO[22] using the structure of BMP with 
NPG (1JPZ) as the search model.  The model was refined with the program CNS [23], 
and manually re-built using the program O [24].  
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 Mutagenesis Methods. In order to perform site-directed mutagenesis, the protein 
first had to be sequenced. BMP/BM-3 with a hexa-histidine tag in a pPROEX-1 vector 
was sequenced using four designed primers, which were purchased from Invitrogen 
(Carlsbad, CA). BMP/BM-3 could not be sequenced with commercial primers.  Only 
three primers were necessary for sequencing the protein, however a fourth primer was 
needed to sequence a gap between the regions of the first (BMPf) and middle (BMPM) 
primer. Table 3.4 shows what primers were used and what amino acids they sequenced. 
The full nucleotide sequence is in the appendix. All sequencing was done at Columbia 
University’s Protein Core Facility (New York, NY). Primer Name  Sequence  Amino Acid # Seq BMPf  GAGCTGTTGACAATTAATCATCCGGTCCG  His‐tag 1‐191 BMPM  CGACGACCCAGCTTATGATG  208‐435 BMPend  GGTACTTGGTATGATGCTAAAACAC  421‐458 C terminus BMPMID2  TACAAGTATGGTCCGTGCACTG  190‐427 
Table 3.4 Primer used to sequence BMP and BM-3 in a pPROEX-1 vector. The full 





         
R47Q  5'‐attcgaggcgcctggtcaggtaacgcgctacttatc‐3' 
R47Q_antisense  5'‐gataagtagcgcgttacctgaccaggcgcctgaat‐3' 
         
R47E  5'‐tttaaattcgaggcgcctggtgaggtaacgcgctacttatcaagt‐3' 
R47E_antisense  5'‐acttgataagtagcgcgttacctcaccaggcgcctcgaatttaaa‐3' 
Table 3.5 - Primers both forward and reverse (antisense) used to sequence R47K, R47Q, 
and R47E mutants of BM-3.  
 
Site-directed mutagenesis of R47E, R47Q, R47K was performed using designed 
primers from Invitrogen, shown in Table 3.5.  Both sense and antisense primers were 
designed with the QuikChange primer design program available on Stratagene’s website 
(http://www.stratagene.com/sdmdesigner/default.aspx). The mutagenesis was performed 
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using a QuikChange Lightning Site-Directed Mutagenesis Kit from Stratagene and the 
protocol was adapted from the handbook. The first step of mutagenesis was a PCR 
reaction of 50 µl, containing 50 ng of plasmid template, and 125 ng of both the sense and 
antisense primers. The PCR protocol is given in Table 3.6. Following PCR, the initial 
plasmid was digested with DnpI enzyme and incubated for 10 min at 37oC. The digested 
PCR mixture (2  µl) was transformed by heat shock into XL10 cells (Invitrogen) for 
plasmid production. Four colonies on the LB-agar ampicillin plate were grown in LB 
media (3 ml) and a plasmid prep was performed following the procedure by Qiagen using 
QIAprep Spin Miniprep Kit.  The plasmid was then sequenced to verify that the 
mutagenesis worked.  The successful mutated plasmids were transformed into BL21 DE3 
cells for protein expression. The mutants were purified and expressed the same way the 
wild type was purified and expressed in Chapter 2.  
5 ul of reaction buffer   1.56 DNA template  50 ng 1.485 ul of Primer #1  125 ng 1.343 ul of Primer #2 125 ng 1 ul of DNP mix     1.5 ul of sol reaction agent   37.1 ul ddH2O       
1 ul polymerase     
50.0 ul total volume    
Table 3.6 – PCR reaction mixture reagents (left) and PCR protocol adapted from 
Stragene’s QuikChange manual (right).  
 
Characterization of R47E. For the determination of dissociation constant (Kd); 25 
µl of protein (1 µM) was added to 50 mM potassium phosphate, pH 7.4 in a cuvette.  A 
titration of 0.1 nmoles/µl of NPG was added to the solution in 1 µl aliquots, the sample 
Step  # of times  Temp  Time   1 1 95C 2 min 2 18 95C 20 s 
  60C 10 s 
  68C 750 s 3 1 68C 5 min 
 Total  4.0 h 
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was then equilibrated for 1 minute before optical absorption data was collected. The data 




Kd + NPG[ ]
                 (3.1) 
where the absorbance at 394nm was subtracted from the absorbance at 418 nm in order to 
maximize the change in absorbance due to binding, ΔA394-418. Bmax is a fitting parameter 
and represents the absorbance at saturation.  For the determination of spin state change 
with temperature optical absorption spectra of enzyme-NPG mixtures at temperatures 
between -5 and 40 °C were taken, under the same conditions used in previous NPG [25]. 
Thirty equivalents of NPG (129 µM) were added to a solution of BM-3 (2.15 µM) in 500 
µl of 50 mM potassium phosphate pH 7.4 with 30% glycerol at room temperature.  The 
solution was then cooled to -5oC and equilibrated for 30 minutes before a measurement 
was taken and the temperature was increased for the next measurement.  
For determination of the catalytic constant (kcat), various concentrations of NPG 
(Figure 3.9) were added to 0.25 µM of BM-3 in 50 mM potassium phosphate pH 7.4 in a 
cuvette and incubated for 5 minutes.  The enzymatic reaction was started with the 
addition 200 µM NADPH and the reaction was monitored by the decrease in absorbance 
at 340 nm.   The rate was determined using the slope of the first 30 seconds of 
absorbance data (A/s), divided by ε340 for NADPH (6200 M-1cm-1) and the path length 
(b=1 cm) to obtain concentration/second (c/s), as shown in Equation 3.2.  The rate was 
then converted into units of minutes (concentration of NADPH min-1), Equation 3.3.  The 
plot of velocity, ν, (concentration of NADPH min-1) can be fit to Equation 3.4, where 
Vmax is the maximum velocity and Km, the Michaelis-Menten constant can be determined. 
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We plotted velocity divided the enzyme concentration against concentration of NADPH 





s                     (3.2) 
                (3.3) 
             (3.4) 
        (3.5) 
3.3 Results and Discussion 
3.3.1 Comparison of Crystal Structures: 1JPZ and Our Structure 
Both crystals were grown in 150 mM MgCl2 and 50 mM MES pH 6. The slight 
difference between 1JPZ and our structure’s conditions was the 1JPZ crystal was grown 
from 12.5 mg/ml of protein in 50 mM potassium phosphate pH 7.4, 12% PEG 3350, and 
1.1 equivalents of NPG and our crystal was grown from 16 mg/ml of protein in 50 mM 
potassium phosphate pH 7.4 with 10% glycerol, 13% PEG 3350, and 1 equivalent of 
NPG.  Even though the differences in crystal conditions between the two crystal 
structures were slight, the two crystals are in different space groups:  1JPZ is in P21 (P 1 
21 1) with dimensions 59.19, 148.36, 64.13 with angles 90, 98.82, 90 and our structure is 
in P 21 21 2 with dimensions 56.24, 59.32, 188.7 and angles 90, 90, 90.  Also, in the unit 
cell 1JPZ is a dimer and our structure is a monomer.  Even though 1JPZ and our structure 
are in different space groups, according to Table 3.7 other structures of BMP have been 





























Figure 3.5 - Alignment of 1JPZ and our crystal structure is shown and colored by Cα 
RMSD.  Blue is the lowest RMSD (0.0357), red is the highest (74.421), and white are 
residues not used in the alignment (>74.421). The overall RMSD for the structures were 
0.337 Å. The similarity of the Cα is not surprising since there were only slight differences 
in crystal conditions and 1JPZ was used as a starting model in constructing our structure. 
 
1JPZ and our structure Cα’s were aligned in PyMOL with an RMSD of 0.337 Å 
[26]. Figure 3.5 shows by color the differences in RMSD, with red being the most, blue 
being the least, and white are residues not used in alignment. Slight differences in the 
crystal structure can be explained by the fact that 1JPZ was used as a starting model for 
creating our structure and there are only small variations in the crystal conditions.  Most 
of the differences exist for charged solvent exposed residues and loop regions, which are 
common differences between crystal structures.  Even though the backbones of the 
crystal structures are very similar there was a large difference in the carboxylate group 
(C1) of NPG.  In 1JPZ, 1ZOA, and 1ZO9 C1 it is hydrogen bonded to Gln73 and Ala74 
and C3 to Tyr51, while in our structure C1 is only hydrogen bonded to Arg47 as shown 
in Figure 3.6. For palmitoleic acid (1FAG, 1SMJ, and 3EKD) and palmitic (2UWH) the 
carboxyl group is hydrogen bounded to Tyr51. In the crystal structure octane 
monoxygenase (mutated BMP) with NPG (3CBD), Arg47 is hydrogen bonding to one of 
the oxygen’s of C1. The new hydrogen bonding interaction shown in our crystal structure 
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where Arg47 is forming an ion pair with the carboxyl (C1) of NPG, represents an 
important conformation in the mechanism of binding and catalysis. As previous 
mutagenesis studies showed, all Kd’s and Km’s increased when Arg47 was mutated 
indicating its involvement in binding. Since our crystal structure does not show the ligand 
in chemically relevant binding mode, mutagenesis studies are needed to determine 
Arg47’s role in catalysis with NPG.   
 
Figure 3.6 - Comparison of hydrogen bonding networks between 1JPZ (blue) to our 
structure (red). In 1JPZ C1 is hydrogen bonding to the backbone of Gln73 and Ala74 and 
C3 is hydrogen bonding to Tyr51. However, in our structure, C1 is hydrogen bonding to 





















PDB Code Ligand Mutant/Other Space Group Reference 
Our structure NPG   P212121   
1JPZ NPG   P21 (P 1 21 1)  [11] 
1FAG Palmitoleic   C2 2 21  [2] 
1SMJ Palmitoleic A264E C2 2 21  [27] 
1ZO9 NPM   P21 (P 1 21 1)   
1ZOA NPG A328V P21 (P 1 21 1)  [28] 
2JLM DMSO [DMSO] high P212121  [29] 
2UWH Palmitic A82F P212121  [30] 
3BEN LEH inhibitor P21 (P 1 21 1)  [31] 
3CBD NPG   P212121   
3DGI DMSO  F87A/T268A P21 (P 1 21 1)   
3EKD Palmitoleic A264M P212121  [32] 
1BU7 -----   P212121  [33] 
1BVY ----- FMN Domain P212121  [33] 
1FAH ----- T268A P21 (P 1 21 1)  [34] 
1JME ----- F393H P21  [35] 
1P0V ----- F393A P21 (P 1 21 1)  [36] 
1P0W ----- F393W P21 (P 1 21 1)  [36] 
1P0X ----- F393Y P21 (P 1 21 1)  [36] 
1SMI ----- A264E P212121  [27] 
1YQO ----- T268A P21 (P 1 21 1)  [37] 
1YQP ----- T268N P21 (P 1 21 1)  [37] 
2BMH -----   P21 (P 1 21 1)  [38] 
2HPD -----   P21 (P 1 21 1)  [12] 
2IJ2 -----   P21  [39] 
2IJ3 ----- A264H P21  [39] 
2IJ4 ----- A264K P212121  [39] 
2J4S ----- [DMSO] low P212121  [29] 
2NNB ----- Q403K P21 (P 1 21 1)   
3EKB ----- A264C P212121  [32] 
3EKF ----- A264Q P212121  [32] 
3HF2 ----- I401P P21 (P 1 21 1)  [40] 
Table 3.7 - Summary of BMP crystal structures in the pdb showing if and what substrate 
is bound, any mutations, and the space group. This table shows that our crystal structure’s 
space group is similar to previously published structures. NPG is N-palmitoylglycine; 
NPM N-palmitoylmethionine; LEH is an inhibitor, N-(12-imidazolyldodecanoyl)-L-








Figure 3.7 - Titration of NPG into BM-3 wild-type (bottom) and R47E (top) at room 
temperature. The dark red spectra are at the start of the titration with zero NPG and the 
black spectra are at saturation conditions of NPG. The optical absoption spectra of wild-
type BM-3 has typical type 1 binding, an increase in absorabance at 394 nm upon the 
addition of NPG and a decrease at 418 nm indicating a change in spin state upon ligand 
binding. In the optical absorption spectra of R47E the same type I binding is not observed 
and the isospectic point (gray circle) is different (wt 406 nm and R47E 399 nm).  The 
inlays in the absorbance spectra are the fit of the change in absorbance between 394nm 
and 418nm plotted against the change in concentration of NPG to determine the Kd. The 
Kd of wild-type was 0.369 ± 0.052 µM compared to R47E’s Kd of 2.69 ± 0.122 µM. 
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3.1.2 Effect of the Mutation R47E 
In order to determine if Arg47 is important for the binding and catalysis of NPG, 
the Kd, Km, kcat, were determined and the spin state change with temperature was 
analyzed for the mutant R47E. First the Kd was determined for both wild type and R47E 
BM-3 as shown in Figure 3.7. The Kd for the full length BM-3 with NPG is 0.369 ± 0.052 
µM compared to the literature reported value for BMP with NPG of 0.262 µM [11].  For 
the R47E a Kd of 2.69 ± 0.122 µM was determined, which is seven times weaker. 
However, a direct comparison between the Kd cannot be made because type I binding is 
not observed for the mutant, which is shown by the difference in the absorption spectra in 
Figure 3.7. For the mutant, instead of the absorbance at 394 nm increasing and decreasing 
at 418 nm indicating the ligand is bound, there is a decrease at 418 and only a slight 
increase at 394 nm but also a large increase at 314 nm. This suggests that the ligand is not 
binding at the active site and is probably binding in a non-productive conformation, 
where it is unable to cause a spin state change. 
The wild type enzyme with NPG bound at 37oC has a high population of heme in 
the high spin state, where the Soret peak is at 394 nm.  The high spin state is expected to 
have the substrate bound in such a way that the water coordinated to the heme is 
displaced, thus allowing for the catalytic cycle to continue.  As the temperature is 
decreased, a smaller population is in the high spin state and the Soret peak moves to 418 
nm, which is also the peak for the resting state of the enzyme without ligand bound, 
indicating the substrate is in a non-productive binding mode. In order to determine if 
there is a temperature dependent spin state change for R47E, the same experiment was 
conducted with 30x excess NPG. For R47E with NPG at 37oC, there is only a small 
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population in the high spin state, as shown in Figure 3.8 and a majority is still in the low 
spin state, indicative of a distant substrate binding mode.  This is similar to the results 
seen in the titration curve (Figure 3.7), where type I binding was not observed indicating 
that NPG is bound in a non-productive binding mode.   
 
Figure 3.8 – Optical absorbance spectra of 2.5 µM P450 BM-3 R47E in 50 mM KPi pH 
7.4, 30% glycerol and 30x excess NPG (129 µM) at different temperatures. A slight 
change in spin state was observed, since 418nm (low spin) decreased and 394 nm (high 
spin) increased as temperature increased. 
 
We know from the Kd and spin state change experiments that a majority of NPG 
in R47E is not in the correct binding mode for catalysis, but there is a chance that upon 
reduction the substrate could move [41].  Therefore, we also measured the effect R47E 
had on the catalysis of NPG.  As shown in Figure 3.9 and Table 3.8, there was a 
significant decrease in catalysis with the mutant compared to the wild type.  The Km was 
tighter for the wild type, which is the same trend seen in the Kd. It appears that within 
error no catalysis occurred for the R47E mutant, which is in agreement with previous 
studies that showed there was no catalysis with AA and EPA (both C20), since NPG can 
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be considered approximately C19.  Therefore the interaction of R47 with the carboxylate 
of NPG is important to correctly position the substrate for catalysis. Table 3.9 shows our 
data with the previously published results for other substrates with the R47E mutant and 
by just observing kcat, R47E has more of an effect on NPG than the smaller substrates.  
 
Figure 3.9 – A fit of the rate of catalysis versus the concentration of NPG to determine 
Km and kcat for wild type (red) and R47E (blue) at room temperature, values reported in 
Table 3.8. The top figure shows the zoomed in fit for R47E. This figure shows that within 






 Wild type R47E Ratio - R47E/wt 
Kd 0.369 ± 0.052 µM 2.69 ± 0.122 µM 7.3 
kcat 1509 ± 139 min-1 21 ± 13 min-1 0.014 
Km 5.36 ± 2.75 µM 34.3 ± 90 µM 6.4 
kcat/Km 281.5 0.61 0.002 
Table 3.8 – Summary of our data of Kd, kcat, Km, and kcat/Km for NPG with wild type and 







Table 3.9 - R47E/WT ratios for Kd, kcat, Km, and kcat/Km for NPG with R47E as compared 
with previously published data. This table shows that kcat with respect to NPG (C19) is 
most strongly affected by the mutation of R47E [4, 6]. 
3.4 Conclusions & Future Directions 
A crystal structure of BMP bound to NPG at 2.0 Å resolution was solved.  Our 
crystal structure was determined to be in a different space group than 1JPZ, but other 
crystals of BMP have been solved in this space group.  Our crystal structure shows 
support for the argument that Arg47 is involved in initial binding of the substrate.  In 
addition, the ligand is flexible in the active site since the only difference between our 
structure and the previous published structure is the conformation of the ligand. SSNMR 
studies on the ligand dynamics are discussed in Chapter 5.  In the future it will be 
interesting to look at the dynamics of Arg47 by SSNMR and its interaction with the 
ligand, which may provide more insight on the role of this amino acid. 
Our mutagenesis studies showed that Arg47 is essential for larger substrates since 
it may aid in initial binding and/or positioning the substrate correctly for catalysis. For 
NPG bound to R47E, the substrate was not binding or binding in an unproductive binding 
mode, as shown by our optical absorption data, such that catalysis could not occur. This 
R47E/WT C12 C14 C16 NPG  
Kd 6.6   7.30 
kcat 1.12 0.13 0.15 0.014 
Km 14.70 2.57 2.86 6.4 
kcat/Km 0.076 0.049 0.052 0.002 
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is supported by previous mutation studies where R47E could not catalyze large substrates 
such as AA and EPA (C20).  However, it is still not explained why R47A and R47G were 
still able to perform catalysis on AA. In order to rule out the possibility that it is not just 
charge repulsion between the larger ligands and glutamic acid, studies of NPG with 
mutants R47Q and R47K will be performed.  Glutamine has similar steric bulk to 
arginine, but a neutral charge and lysine has a positive charge like arginine.  R47E was 
able to perform catalysis on smaller substrates such as laurate, myristate, and palmitate, 
which can be explained by hydrophobic interactions also playing a role in guiding the 
ligand into the binding pocket. Even though catalysis was able to occur it was at a 
decreased rate and Km also increased for all substrates, which supports that Arg47 is 
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Chapter 4  
 





Cytochrome P450 is a well-studied enzyme and of great interest to the 
pharmaceutical industry since it metabolizes drugs. Knowledge of the structure of the 
active site is important in order to optimize binding of substrates. However, the current 
crystal structure of a substrate bound to BMP, the model enzyme for mammalian P450s, 
shows the substrate positioned too far away from the heme to be a catalytically active 
binding mode [1].  The distant substrate is not unique to cytochrome P450 BM-3; it is 
also a feature of mammalian P450s [3-6]. Previous members of the McDermott group 
have supporting evidence that there is temperature dependence on the conformation of 
the ligand shown by optical absorption, SSNMR experiments, and molecular dynamics 
simulations [7-10]. All of these experiments indicate that the substrate moves, however 
there is no structural evidence of the new binding site.  Therefore, a room temperature 
crystal structure is necessary to determine the correct position of the substrate at 
biological temperature where the enzyme is active.   
Previously all structures were collected at room temperature.  However, better 
synchrotrons that deliver high power X-ray doses have been developed over the years to 
increase the resolution of diffraction data. In order to minimize radiation damage when 
using high X-ray doses, crystals are cryo-cooled.  However, it is unknown whether 
structural changes occur during this cooling process and if the room temperature 
conformation is trapped. A recent study by Dunlop et al. showed the difference of the 
protein PAK pilin determined at room temperature (1.63 Å) vs. cryogenic temperature 
(0.73 Å).  A comparison of the two structures showed different disulfide bond 
conformations and different conformations of solvent exposed side chains [11]. 
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Calculations of flash cooling by Halle showed different parts of the crystal freeze at 
different rates, therefore the crystal is not in thermodynamic equilibrium, and delayed 
quenching of the room temperature conformation for important regions of the protein 
(sites for recognition, binding, or catalysis) was observed [12]. Therefore, determining a 
room temperature crystal structure is important to make sure the correct active site is 
captured.  
4.2 Materials and Methods 
 Natural abundance cytochrome P450 BMP was expressed in E.coli B21 DE3 cells 
and purified as stated in Chapter 2. After purification, cytochrome P450 was diluted or 
concentrated to either 25mg/ml or 12.5 mg/ml in 50 mM KPi pH 7.4.  If the protein was 
stored at -80oC, 10% glycerol was added and the protein was divided into aliquots of 30 
µl. We later found that we got better crystals if we avoided freezing the protein and the 
protein was stored at 4oC.  Crystal trays were set up in collaboration with Gabriel 
Amodeo in the lab of Professor Liang Tong (Columbia University, New York). Hanging 
drop crystal trays were set up at 4oC with 1:1 aliquots of protein and mother liquid.  Stock 
solutions of 2 M MgCl2, 50% by weight PEG 3350, and 1 M MES pH 6 were filter 
sterilized.  The mother liquor usually included either 12.5 mg/ml or 25 mg/ml BMP, 
either 1 or 1.1 equivalents of NPG, 12-21% PEG 3350, 150-225 mM MgCl2, and 100 
mM MES pH 6, and deionized water to make the total volume of the well 500 µl.  
Crystals with high concentrations of PEG grew within 24 hours and lower concentrations 
of PEG usually grew within a couple of days as shown in Figure 4.1. Diffraction quality 
crystals were obtained by microseeding a drop of 16 mg/ml BMP in 50 mM potassium 
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phosphate pH 7.4, 1 equivalent of NPG, 150 mM MgCl2, 50 mM MES pH 6.0, 10% 
glycerol, and 13% PEG 3350. Crystals were diffracted on a home source. 
 
Figure 4.1 Crystal of BMP with NPG bound, showing that we grew diffraction quality 
crystals at 4oC. However, in the X-ray beam at room temperature the crystal quickly 
deteriorated making data collection impossible. 
 
4.3 Results and Discussion 
Since we were able to grow diffraction quality crystals and obtain a new X-ray 
crystal structure, as presented in Chapter 3, we attempted to collect data on a couple of 
crystals at room temperature.  However, at room temperature the crystals were destroyed 
after the first shot of the X-ray beam.  A paper by Barker et al. showed radical scavengers 
decrease crystal damage [13]. Therefore, we added radical scavengers to our crystals to 
decrease the amount of radical oxygen that could be destroying the crystal.   We tried 1 
M ascorbate at pH 2 and pH 6, less than 1 M 1,4-benzoquinone, and 1 M sodium nitrate.  
The crystals were soluble in ascorbate at pH 6 and sodium nitrate.  The crystal quality by 
eye looked worse with 1,4-benzoquinone and with ascorbate at pH 2 no improvement in 
diffraction was seen.  However, we found out later that we soaked the crystals in 
ascorbate longer than was suggested by the author, 20 minutes versus 3 days.  
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4.4 Conclusions and Future Directions 
Our ultimate goal was to get a room temperature crystal structure, to show the 
ligand conformation at a temperature where the enzyme is active. However, in order to 
solve a room temperature structure, other methods may need to be used such as Laue 
diffraction [14] or solid-state NMR. Laue diffraction refers to method in which the crystal 
is stationary and a wide bandwidth X-ray beam is used.  All reflections are recorded 
simultaneously, reducing the exposure time of a single crystal.  Solid-state NMR, which 
will be discussed in Chapter 5, is also a good technique to address our hypothesis because 
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5.1 NMR and Ligand Binding 
Nuclear Magnetic Resonance (NMR) is a useful tool to study ligand-protein 
interactions in biological macromolecules. NMR experiments can target the ligand and/or 
protein to examine changes in chemical shift upon binding. Protein chemical shift 
perturbations caused by ligation are mostly localized to the binding pocket. An important 
technique in the pharmaceutical industry is Structure Activity Relationships (SAR) by 
NMR [1]. In the most common implementation of the SAR experiment in solution NMR, 
1H-15N heteronuclear single quantum correlations (HSQC) are recorded for 15N enriched 
samples as a function of ligand concentration, mapping out site-specific 1H-15N chemical 
shift perturbations. This method can quickly detect high affinity substrates for the target 
protein.  However, this technique is limited to small soluble proteins, because backbone 
resonances need to be resolved and assigned. NMR methods to study larger protein-
ligand interactions include: separating the solvent exposed amides using transverse 
relaxation optimized spectroscopy (SEA-TROSY) [2], incorporation of deuterium [3] to 
narrow linewidths, and selective labeling schemes that target specific amino acids [4, 5].  
In solid-state NMR (SSNMR), standard methods involve ligating 13C labeled substrate 
with 15N labeled protein (or vice-versa) to measure precise heteronuclear distances to 
determine binding geometry and affinity [6].  
  X-ray crystallography and solution NMR are currently the primary methods for 
solving protein structure.  Currently there are 57,898 crystal structures of proteins solved 
by X-ray diffraction in the pdb and 7,657 protein structures solved by NMR [7]. Even 
though these statistics are quite large, there remains a significant amount of unknown 
protein structures such as membrane proteins, fibrils, and aggregates exhibiting poor 
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crystallinity and negligible solubility. SSNMR is able to fill this void as techniques, 
methodology, and hardware continues to advance. Currently there are about twenty 
published protein structures solved by SSNMR, with the largest monomer being matrix 
metalloproteinase 12, 17.6 kDa [8]. Developments in 2D and 3D experiments for 
sequential assignment along with structural constraints, such as distance, torsional angles, 
pseudocontact shifts, and CSA tensors have allowed SSNMR to achieve similar 
resolution to X-ray crystallography [9].  
Solid-state NMR is uniquely suited to collect dynamics and structural information 
on NPG bound to BM-3 over a range of temperatures to determine if there is a 
temperature dependence on the ligand’s conformation. For our SSNMR studies, we use 
only the heme domain of cytochrome P450 BM3 (BMP) because it is 55 kDa compared 
to the full length (119 kDa). However, 55 kDa remains a challenging target for current 
SSNMR methods and equipment. Therefore a combination of fully labeled and selective 
labeled samples is desirable for assignment and structural studies. Part I (Section 5.4) of 
this chapter describes the difference in chemical shift due to binding of NPG and changes 
in temperature using 2D 13C-13C correlations.  In part II (Section 5.5), alanine marker 
peaks are assigned and possible protein-ligand cross peaks are observed. In part III 
(Section 5.6), TEDOR is determined to be the best method for observing protein-ligand 







5.2 NMR Theory  
5.2.1 Magic Angle Spinning Solid-State NMR 
The Hamiltonian describing a nuclear spin in a magnetic field is below 
Htotal=HZ+HRF+HDIP+HCS+HQ+HA+HJ   (5.1) 
where Hz is the Zeeman term, which describes the interaction between the nuclear spin 
and the static magnetic field (Bo); HRF is the interaction of the nuclear spin with the the 
applied radio frequency pulses of an NMR experiment (B1); HDIP is the dipolar 
interaction of a nuclear spin with another nuclear spin through space, both homonuclear 
and heteronuclear; HCS is the chemical shift, which is the interaction of the nucleus with 
its local chemical environment (magnetic shielding, containing both isotropic and 
anisotropic terms); HQ is the quadrupolar Hamiltonian, applicable to nuclei where spin I 
is greater than or equal to 1 and the nucleus’ electronic quadrupolar moment interacts 
with the local electric field gradient; HA is the hyperfine interaction for paramagnetic 
systems where the nuclear spin interacts with an unpaired electron; HJ is the J-coupling 
interaction most often truncated to the scalar through-bond couplings, with a small 
anisotropic term. 
In solution NMR, molecular tumbling averages second rank tensors, such as HCS 
and HDIP to zero.  However, in the solid-state spectra of powder samples (defined as a 
collection of molecules or cyrstallites with random orientations) these anisotropic terms 
are unaveraged, leading to large inhomogeneous linewidths. In order to reduce the 
linewidth to achieve high resolution data, proton decoupling [10] and magic angle 
spinning (MAS) [11, 12] is applied. MAS is implemented by mechanical spinning of the 
sample about the node of a second-order Legendre polynomial (3cos2θ-1=0, θ=54.70) 
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relative to the magnetic field, spatially averaging second rank terms in the Hamiltonian 
depending upon the relative magnitude of the MAS frequency and the tensor magnitude. 
However, sample inhomogeneity, probe shimming, residual dipolar couplings, and other 
factors yield linewidths in SSNMR that are still larger than liquid state.   
MAS is necessary to obtain high resolution data of proteins, however it averages 
useful tensor information such as chemical shift anisotropy and dipolar couplings.  In 
some cases, it is beneficial to know this information and there are pulse sequences that 
either preserve or reintroduce these terms. Homonuclear dipolar coupling, such as 13C-
13C, can be reintroduced to obtain distance information between the two nuclei by 
rotational resonance [13] and various single and double quantum experiments [14]. 
Heteronuclear 1H-13C dipolar coupling information can be useful in determining order 
parameters, which can provide information about dynamics [15, 16].  Also, heteronuclear 
dipolar coupling experiments, such as REDOR (rotational echo double resonance) [17] 
and TEDOR (transferred echo double resonance) [18, 19] are also extremely useful for 
determining distance information.  REDOR reintroduces heteronuclear dipolar couplings 
by applying rotor-synchronized π pulses; this is then compared to the same experiment 
without the π pulses to minimize covariance between dipolar dephasing and transverse 
relaxation (T2) to obtain very precise distance information.  REDOR is ideal for sparsely 
labeled systems or systems with only one heteronuclear species, such as 19F, however for 
large highly-enriched systems, such as proteins, background caused by a large number of 
heteronuclei prevent accurate measurement of the dipolar coupling. TEDOR does not 
have this weakness because each nucleus in the reintroduced dipolar interaction is 
frequency labeled, thus providing site resolution provided there is sufficient spectral 
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resolution. However, TEDOR trajectories, like REDOR, is modulated by homonuclear J 
couplings, and therefore advanced 3D TEDOR pulse sequences are used to avoid this 
problem [20, 21].   
5.2.2 NMR of Paramagnetic Systems 
Cytochrome P450 and numerous other important biological proteins contain metal 
centers that are paramagnetic. However, paramagnetic proteins are challenging to study 
due to paramagnetic relaxation enhancement (PRE) and paramagnetic chemical shift 
changes. SSNMR studies of paramagnetic systems began in the 1980s on small 
molecules [22-24]. Only recently has the field of solid-state NMR begun to establish 
methods for paramagnetic systems in proteins compared to solution NMR where 
paramagnetic studies have become routine [25]. The use of very fast magic angle 
spinning (VFMAS) for paramagnetic systems has increased sensitivity because VFMAS 
better attenuates H-H and H-C dipolar couplings and interactions with the paramagnetic 
center compared to moderate MAS frequencies, making proton decoupling not as critical, 
which is fortunate considering 1H decoupling is often less efficient for paramagnetic 
molecules [22]. For this study, it is important to be aware of the effects of paramagnetic 
systems, therefore, below is a brief mathematical description of relaxation and changes in 
chemical shift for paramagnetic systems. 
Paramagnetic functionalities (metal centers, spin labels, etc.) affect relaxation of 
the surrounding molecules; the processes (longitudinal and transverse) after a pulse is 
applied that returns the excited nucleus to equilibrium.  An electron or nucleus, having an 
odd number of proton or neutrons, has a magnetic moment.  The magnitude of the 
magnetic moment determines how strongly it interacts with a magnetic field.  Unpaired 
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electrons have 660 times larger magnetic moments than protons, seen in Equations 5.2-4, 
and can be contributed to the fact that electrons have a smaller mass as seen in Equations 
5.5 and 5.6. 
€ 
µs = ge µB S(S +1)       (5.2) 
€ 



















      (5.6) 
where µs is the electron magnetic moment, ge is the electron g factor, µB is the Bohr 
magnetron, µI is the magnetic moment of spin I, gI is the g factor for the nucleus (gP is for 
proton), µN is the nuclear magnetic moment,   
€ 
 is Planck’s constant, e is the elemental 
charge, me,p is mass of a electron/proton, and I represents the spin quantum number of the 
particle in question. Equation 5.7 is a general term for relaxation between two spins. If 
we substitute γs for γe (Equation 5.8) where µsis defined in Equation 5.2, we get a term for 
relaxation between an electron and another spin, Equations 5.9 and 5.10.  Equations 5.9 
and 5.10 show that due to the electron’s large nuclear magnetic moment, nuclei near the 






























































' (ω,tc )      (5.10) 
 
where R1 is longitudinal relaxation, R2 is transverse relaxation, µo is the magnetic 
moment in a vacuum, γI,S is the gyromagnetic ratio of the spins, r is the distance between 
the spins, ƒ(ω,τc) and ƒ’(ω,τc) are terms for the correlation time.  
The magnitude of relaxation is dependent on the distance from the paramagnetic 
center. For nuclei close to the paramagnetic center relaxation is faster than the timescale 
of the NMR experiment; so more than one orientation for the nuclei is observed which 
leads to broad line widths and possibly unobservable peaks. Therefore a radius around the 
paramagnetic center is called the blind zone. The size of the radius is dependent on the 
identity of the paramagnetic center and detected nucleus. SSNMR has an advantage over 
solution NMR since it directly detects heteronuclei. The relaxation of a nucleus is 
proportional to the square of its gyromagnetic ratio and distance from the paramagnetic 
center.  Therefore a proton would relax 16 times faster than a hypothetical equivalent 
carbon through this mechanism, as shown in Equation 5.9 and 5.10, thus decreasing 
carbon’s blind zone. In addition, the faster relaxation time can be advantageous because 
the time between pulses can be shortened, decreasing experimental time.  Therefore 
paramagnetic molecules, such as nitroxide radicals [26] and copper EDTA, are often 
added to systems to increase the relaxation of molecules with long t1.  
NMR of paramagnetic systems can also be very advantageous due to an additional 
term in the Hamiltonian (HA), Equation 5.11, which is used as another restraint for 
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structure determination. Recently paramagnetic compounds have been introduced into 
diamagnetic systems to gain additional structural information [27].  
€ 




3kT      (5.12) 
Sz is the electron spin operator, I the nuclear spin operator, Â is the hyperfine coupling 
tensor, k is Boltzmann’s constant (1.38x10-23 J·K-1), T is temperature, and Bo is the 
magnetic field.  
Both Fermi contact and pseudo contact coupling have an effect on the chemical 
shift. Fermi contact is caused by delocalized electron density on the nuclei from the 
unpaired electron. The Hamiltonian to best describe fermi contact shift is shown below 
where A is defined as the hyperfine coupling constant. 
€ 
HA = AI ⋅ Sz       (5.13) 
The expression for isotropic chemical shift for paramagnetic molecules is obtained by 
dividing Equation 5.13 by the Zeeman energy (  
€ 
γ I Bo).  Equation 5.14 predicts that the 








T     (5.14) 
where ge can be replaced by a g tensor for anisotropic systems, and C is the Curie factor.   
The pseudo contact or dipolar coupling is caused by the electron spin magnetic 
moment coupling to the nuclear spin magnetic moment through space. As stated above, 
due to the differences in magnetic moment, the coupling between an electron and a 
nucleus is 660 times stronger, so the observable distance of dipolar coupling is larger. 
The pseudo contact shift is best defined as the interaction between two magnetic dipoles, 
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subject to motional averaging of the molecule, thermal averaging of the electron states, 










3  µ e
 
R ( )  µ N
 
R ( )
R5     (5.15)
 
where   
€ 
 
R is the vector between the metal and the nucleus,   
€ 
 
µ N is the nuclear magnetic 
moment and   
€ 
 
µ e  is the electron magnetic moment. Since both vectors will be parallel to 
the external magnetic field, this expression can be simplified to 
  
€ 
H = − µ04π
µSµI
r3 (3cos
2θ −1) = − µ04π
γ I geµB Sz
r3 (3cos
2θ −1)  (5.16) 
where θ is the angle between the vector and the direction of the external magnetic field. 
The expression for pseudo contact shift is obtained by integration over all molecular 
orientations and dividing by the Zeeman energy (  
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2 − g⊥2 )(3cos2−1)  (5.17) 
where g is dependent on direction. This equation can be also represented similarly to 








T     (5.18) 
 The above equations state that for our experiments we have to be aware of faster 
relaxation close to the paramagnetic center, which may prevent us from seeing certain 
peaks (Equation 5.9 and 5.10). In addition, as stated in Equation 5.14 and 5.18, the 
chemical shift of residues near the paramagnetic center will shift ftom their predicted 




5.3 Materials and Methods 
Samples of cytochrome P450 BMP were prepared by the procedure as described 
in Chapter 2 except cells were transferred into isotopically enriched media before 
induction by IPTG. Fresh colonies on LB agar plates were used to inoculate a preculture 
of 250 ml of LB media with 5 ml of 1 mg/ml hemin in 0.1 M NaOH and 250 ml of 100 
mg/ml ampicillin. The preculture was grown at 37oC with shaking at 200 rpm until the 
optical density at 595 nm was 0.8. Five ml of preculture was used to inoculate 2 x 1 liter 
of LB medium with 20 ml of 1 mg/ml hemin in 0.1 M NaOH and 1 ml of 100 mg/ml 
ampicillin. For labeled proteins, when the 1 liter LB cultures reached an absorbance of 
0.3 OD at 595 nm, they were gently harvested at 5,000xg for 20 minutes at 4oC under 
sterile conditions. The cells were resuspended in 0.5 liter of defined media.  The recipe 
for defined media for 1 liter: 100 ml of 10x M9 salts without ammonium chloride, 1 ml of 
MgSO4; 0.5 ml of 0.1 M CaCl2; 10 ml of Solution C; 1 ml of vitamin stock; 5 ml of 0.1% 
thiamin; 20 ml of 1 mg/ml hemin in 0.1 M NaOH, and 1 ml 100 mg/ml ampicillin. 
Description of 10x M9, Solution C and vitamin stock are found in the Appendix. In 
addition, for selective labeling, defined media (1 liter) contained 1 g of unlabeled amino 
acids except the desired labeled amino acids, glutamine, and asparagine; 0.3 g of labeled 
amino acids; 2.5 ml of 1.87 M NH4Cl pH 7.2; 1 ml glycerol; and 8 µl of 0.1 M CuCl2. In 
the case of 15N labeled protein: 24 ml glycerol; 3 g NH4Cl labeled; 2 g Na2SO4; 0.15 g of 
labeled amino acids; and 4 µl 0.1 M CuCl2. For 13C and 15N labeled protein followed the 
same protocol 15N, except instead of glycerol, 4 grams of 13C labeled glucose was added. 
Cells were grown in defined media for 45 minutes at 37oC before adding 238 mg/l of 
IPTG.  The cells were harvested (5,000xg for 20 minutes) after 14 hours of incubation at 
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37oC and resuspended in 50 mM Tris-HCl pH 7.4 with 10% glycerol before freezing at -
80oC.  The protein was purified as described in Chapter 2. Protein purity was determined 
by SDS-PAGE gel, mass spectrometry, and the ratio of absorbance at 420/280 to be 
approximately 1.7.  
Pure enzyme was concentrated to a volume of 40 µl using a Microcon 20 kDa 
MWCO centrifugal device. The enzyme was precipitated by adding it to 140 µl of 40% 
PEG 8000 in 25 mM MgSO4 and 50 mM MOPS pH 7.4 in a pipette tip. Most of the 
enzyme precipitated instantaneously, however the sample was left overnight at 4oC. The 
sample was then spun down and packed into a rotor with a microcentrifuge. The amount 
of protein in each rotor was approximately 10 – 15 mg. The samples that I used in this 
thesis include: 1. selective labeled IG (Ile 13CO and Gly 13Cα and 15N); 2. selective 
labeled Ile 13CO  and uniform 15N BMP; 3. uniform labeled 15N 13C BMP; 4. 13C16-NPG; 
5. 13C16-NPG  and natural abundance BMP; 6. 13C16-NPG and uniformly labeled BMP; 7. 
13C16-NPG fully labeled AG with uniform 15N BMP. 
NMR spectra were recorded using Varian/Chemagnetics Infinity Plus 600 MHz 
spectrometer, operating at Larmor frequencies of 599.08 MHz for proton, 150.6 MHz for 
carbon, and 60.7 MHz for nitrogen.  The only exception was the selective labeled Ile-Gly 
sample that was collected on a 400 MHz spectrometer, operating at Larmor frequencies 
of 396.8 MHz for proton, 99.7 MHz for carbon, and 40.2 MHz for nitrogen. The selective 
labeled Ile-Gly uniform 15N and 13C16-NPG selective labeled Ala-Gly uniform 15N were 
collected on a T3 HFXY MAS probe in HCN mode with 13.333 kHz spinning. All other 
spectra were acquired with a 4mm triple resonance T3 MAS probe in HC or HCN mode 
with a spinning speed of 13.333 kHz.  Temperatures for the NMR samples were corrected 
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due to sample heating caused by MAS spinning at 13.333 kHz, which was calibrated 
using PbNO3 solid sample and an additional 5oC due to proton decoupling.  Proton 
decoupling was approximately 80-85 kHz in each experiment. The TEDOR pulse 
sequence was based of Jaroniec’s zero quantum filtered TEDOR [21]. The SSNMR data 
was collected in collaboration with Dr. Benjamin J. Wylie, Columbia University. 
5.4 Conformational Change of NPG Bound to BMP  
5.4.1 Introduction 
Previous researchers in the McDermott lab have shown that the conformation of the 
terminal methyl group at the tail of NPG (ω-C18) is temperature dependent, which was 
described in Section 1.8.2.  However, hydroxylation does not occur at the ω carbon, but 
rather at ω-1, ω-2, and ω-3.  In addition, important interactions happen at the other end of 
the molecule, where the carbonyls are essential for substrate recognition and binding as 
described in Chapter 3.  Therefore, experiments conducted on partially labeled ligand 
13C3-18 NPG (13C16 NPG), shown in Figure 5.1, provided insight on the substrate as a 
whole. 13C-13C correlation experiments showed changes in the chemical shift of the 
ligand and protein upon binding of NPG, in addition to providing evidence for the 





Figure 5.1 – Structure of 13C16 NPG, the ligand used in our SSNMR studies, the carbons 
numbered in red are 13C isotopically enriched. This ligand was synthesized from 13C 
palmitic acid and unlabeled glycine. 
 
5.4.2.1 Assignment of NPG 
Free 13C16 NPG was assigned using 13C-13C 2D SSNMR experiments. The carbon 
chemical shift assignments were based on trends in solution NMR [28], solution NMR 
data, 2D SSNMR cross peaks, in addition to signal build up at longer mixing times.  
Carbons 1-4 and 14-18 were assigned and their chemical shifts are shown in Figure 5.2 
and reported in Table 5.1. Carbons 5-13 are indistinguishable from each other and are 
labeled as carbon bulk (B). C1 & C2 were not labeled, however there was enough signal 
averaging to produce a peak on the diagonal. Assignment of NPG in the protein was more 
difficult due to natural abundance protein background and the change in chemical shift 
associated with binding, Figure 5.3 and reported in Table 5.1.  Carbons 14-18 were 
assigned easily, and C4 and C5 were separated from the natural abundance protein 
background by their cross peaks with C3. C1 and C2 were unable to be assigned because 
they were indistinguishable from the protein background on the diagonal.  Carbons 14-
18’s chemical shift changed slightly when bound and there seems to be two 
conformations for C17-C18 noted by the * in Figure 5.3.  Two possible explanations 
exist: either one is bound and the other is unbound or both are bound but in two different 



























probably a result of a change in the hydrogen bonding network. The upfield shift is a 
result of a weaker hydrogen bond in the protein compared to an intermolecular hydrogen 
bond in the solid-state. The crystal structure of 1JPZ [29] shows C3 of NPG hydrogen 
bonding to Tyr 51, Figure 5.7. 
A comparison of chemical shifts of free to bound ligand was also done by solution 
NMR, shown in Table 5.1 and Figure 5.4.  In solution, all carbons shifted, however C3 
and C18 shifted the most upon binding. The free ligand spectrum was recorded in 
methanol/TMS and the ligand bound was measured in D2O and referenced to 
glycerol/DSS, therefore 2.57 ppm was added to the free ligand’s chemical shifts [30]. The 
different solvents and temperature may account for the differences is the chemical shift 
between solution and SS bound for C3, C17, and C18. However, the same trend is 











Table 5.1 - Solution and solid-state chemical shifts for 13C16 NPG free and bound to 
BMP. For C17 and C18 two numbers are listed for SS NMR bound, the second number 
corresponds to C17* and C18*.  The largest change in chemical shift for SSNMR bound 
versus unbound was C3-5 and C17*-18*. For solution the largest changes were for C3 
and C18.  
 
 
 Solid-state NMR Solution NMR 
 
Free 
(28oC) Bound (19oC) Free (RT) 
Bound 
(RT) 
C18 17.02 17.01/17.17 15.92 16.42 
C17 25.79 25.47/26.91 25.43 25.09 
C16 36.31 36.3 ND 34.5 
C5 30.97 28.13 28.73 28.28 
C4 37.68 38.7 38.53 38.62 
C3 176.6 175.7 178.42 177.70 
C2 42.37  43.22 41.92 




Figure 5.2 – SSNMR 13C assignments of NPG at 600 MHz, 13.333 kHz, 28oC, and 50 ms 
mixing. C16-18 and C3-C5 could be separated from the bulk (B) chain carbons (C6-
C15). C1 and C2 were not isotopically enriched but could be assigned from the peaks on 
the diagonal, shown in the top spectrum. The bottom spectra are zoomed in regions 




Figure 5.3 – Comparison of ligand bound (blue) and unbound (green same as Figure 5.2). 
The figure of NPG is in the conformation bound to BMP in the crystal structure - 1JPZ 
[29]. Ligand bound spectrum was recorded on a 600 MHz magnet, 13.333 kHz at 19oC 
with 50 ms of mixing. The spectrum shows assignment of the ligand bound to BMP. The 
overlay of the two spectra show only a slight difference between bound and unbound, 
except in the carbonyl region shown to the left. The chemical shift change of the carbonyl 
(C3) is a result of a different hydrogen bonding network when bound to the protein. Also 
for C17 and C18, there are two peaks (indicated by C17* and C18*), which implies that 






Figure 5.4 – Solution NMR spectra of NPG bound (red) and NPG free (aqua). The NMR 
spectra show the largest changes in chemical shift were for C18 (~16.4 ppm) and C3 
(~178 ppm). 
 
5.4.2.2 Temperature Dependence of Ligand Chemical Shift 
Our hypothesis that the conformation of the ligand changes with temperature was 
tested by observing changes in NPG’s chemical shift as a function of temperature.  Since 
BMP is paramagnetic, according to Curie’s law (Equation 5.18) the change in chemical 
shift should be linear when plotted against inverse temperature.  However, if the plot is 
non-linear then the change in chemical shift is a result of a conformational change. 13C-
13C correlation data was collected on the 13C16 NPG at four different temperatures and 
showed that more than the terminal carbon (C18), shown by Jovanovic and Harris [31], 
has temperature dependence.  For C3-5, along with C17* and C18* as shown in Figure 
5.5 and 5.6, the change in chemical shift is non-linear with inverse temperature.  Since 
C3 is further away from the heme (17 Å), changes in chemical shift mostly likely are 
conformational changes rather than a result of paramagnetic shifts. Differences in crystal 
structures and simulation measurements [5, 32] also showed that C17*, C18*, and C3-C5 
are mobile carbons.  The other carbons could also be moving however we are unable to 
distinguish the bulk carbons from each other to observe their change in chemical shift.  
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Another difference with temperature is the intensity of C3. The signal to noise 
ratio of C3-4/C17-C18 at low temperature shows that the carbonyl is more mobile and the 
cross section shows there may be three different conformations of C3 and C4, as shown 
in Figure 5.6. This is in agreement with different crystal structures showing different 
conformations for C3, as depicted in the schematic of NPG in Figure 5.6.  At higher 
temperature, either one conformation is preferred or there is fast dynamics between the 
multiple states.  More signal to noise is needed, however it is likely that we are seeing a 
different conformation for the ligand at room temperature than at low temperature.  In 
Figure 5.7, the crystal structure shows C3 hydrogen bonding to Tyr51, which is not seen 
in the predicted room temperature structure [5].  
 
Figure 5.5 –Temperature dependence of the tail of NPG (C16-C18). Upper left: shows 
the structure of NPG is the crystal structure (1JPZ [29]-blue) versus the possible change 
in conformation at higher temperature (IF7 [5]-red) proposed by MD. Bottom left: The 
change in chemical shift versus inverse temperature, showing that the changes for C17* 
and C18* are non-linear indicative of a change in conformation. (The change in chemical 
shift was normalized to the free ligand.) Right: A comparison of the 13C-13C correlation 




Figure 5.6 - Dynamics of NPG’s carbonyl (C3) as a function of temperature. Top left: 
Shows differences in the conformation of C3 in different crystal structures, showing that 
it has multiple conformations: red predicted room temperature [5], blue is 1JPZ [29], 
green is our crystal structure (Chapter 3) and purple is 3CBD [7]. Top right: Non-linear 
change in chemical shift of C3-5 as a function of inverse temperature, indicating a 
conformational change. (The change in chemical shift was normalized to the free ligand.)  
Bottom: Temperature comparison of the CO chemical shift of NPG at 28oC(red), 19oC 
(orange), -3oC (green), -25oC (blue), similar to the crystal structures shown in the top left, 
C3 has multiple conformations at low temperature. However, as you increase the 
temperature there is either fast dynamics between these states or one preferred 





Figure 5.7 – Hydrogen bonding network of C3 at room temperature (red) and low 
temperature (blue). At low temperature C3 is hydrogen bonding to Tyr51, however the 
predict room temperature structure shows this hydrogen bond is broken and C3 may be 
weakly interacting with Leu188. The change in hydrogen bonding is also seen by the 
change in chemical shift of the C3. 1JPZ [29] and IF7 [5] were aligned using Pymol [33] 
with an RMS of 0.220 for 3439 atoms. 
 
5.2.2.3 Protein Chemical Shift Perturbation 
 Solid-state NMR experiments were conducted on uniformly labeled BMP with 
and without NPG in order to see if there were any chemical shift changes due to binding. 
Figure 5.8 shows the changes in amino acid position upon binding by comparing 1BVY 
[34], which is the open conformation without ligand to 1JPZ [29], is the closed 
conformation with NPG. Upon binding, the F and G helix move along with the loop 
between them, there is a 5o kink in the I-helix, Phe42 closes the binding pocket, and 
Phe87 moves out of the way to make room for the substrate [35]. The 13C-13C spectra of 
BMP bound and unbound is crowded since BMP is a 450 amino acid protein.  Overall, 
there does not seem to be a drastic change upon binding, however one isoleucine’s 
chemical shift changes upon binding, as shown in Figure 5.9.  There is one isoleucine in 
the binding pocket, Ile263, which is apart of the I helix that upon binding forms hydrogen 
bonds with Glu267. Ile258 and Ile259 are also apart of the I helix but further away from 
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the ligand. Selective labeling schemes will be needed in order to observe any other 
changes upon binding. Jovanovic observed that Ala82 and Phe87 chemical shift changed 
upon binding [36], but these resonances were unresolved from the rest of the protein. 
 
 
Figure 5.8 – Important amino acids in the binding pocket of P450 BM-3 are identified in 
the comparison between IJPZ (blue) where NPG (green) is bound and 1BVY without 
substrate. There is a closure of the substrate access channel upon ligand binding shown 
by the movement of Phe42. Ile263 through Glu267 are amino acids in the I-helix that are 





Figure 5.9 – Chemical shift perturbations upon ligand binding, comparing 13C-13C 
correlation spectra for 13C enriched BMP without ligand (blue) at -25oC and with ligand 
(orange) at -33oC. The major difference between these two spectra is the appearance of 
an isoleucine, indicated by the circles. A possible assignment for these resonances is 
Ile263, which is in the binding pocket and part of the I-helix known to change from a 13o 
to a 5o kink upon ligand binding. 
5.4.3 Conclusions & Future Directions 
The assignment of 13C16 NPG by solid-state and solution NMR of both free and 
bound to cytochrome P450 BMP allowed us to observe changes in chemical shift of NPG 
upon binding and as a function of temeprature. Upon binding at the solvent exposed end 
of the ligand, carbonyl C3 is in a weaker hydrogen bonding network than free ligand.  We 
also observed that C3 has multiple conformations and at high temperatures it has fast 
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dynamics between them or is locked into place.  We proposed that the different 
conformations of C3 is a result of its interaction with Tyr51 and at room temperature 
shown in the predicted MD structure, C3 is no longer hydrogen bonding to Tyr51.  At the 
other end of the molecule, for C17* and C18* there were non-linear changes in chemical 
shift versus inverse temperature, confirming the change in conformation of the ligand as a 
function of temperature that Harris and Jovanovic also observed. Future directions would 
include fully labeling the ligand, to look at the conformation change of C1, which is the 
carbonyl interacting with Arg47 that is discussed in Chapter 3. In addition, in comparing 
the 2D 13C-13C correlation spectra of BM-3 with and without NPG, we saw evidence for a 
shifted isoleucine in the bound structure, which is speculated to be Ile263. Future 
experiments would include assignment of this peak along with selective labeling schemes 
to assign other amino acids in the binding pocket. 
5.5 Marker Peaks and Protein-Ligand Cross Peaks 
5.5.1 Introduction 
Even though SSNMR structures have been solved, it has mostly been for much 
smaller proteins. Instead of obtaining the whole structure of the BMP, we are looking for 
protein marker peaks that interact with the substrate for the high temperature and low 
temperature conformation.  Alanine was chosen as a selective label because alanine is a 
good reporter for both ligand binding and for protein ligand interactions.  Ala82 is close 
to the ω-end of the ligand in the low temperature form and Ala328 is close the ω-end in 
the room temperature form, shown in Figure 5.10.  There are two Ala-Gly pairs, one 
being A82-Gly83 and the other Ala264-Gly265, which is part of the I-helix and is known 
to move upon ligand binding, therefore glycine was also incorporated into the labeling 
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scheme.  Jovanovic observed Ala82’s chemical shift changes from bound to unbound. In 
addition she detected a cross peak from Ala82-ω 13C NPG [36]. However, these peaks 
were weak and we repeated these results using partially labeled NPG, where 16 carbons 
are 13C enriched instead of one.  Other alanines close to the whole ligand were 
determined using Ivan Sergeyev’s program Accept-NMR [37] and are shown in Figure 
5.10.  Besides the alanines mentioned above, Ala74 and Ala330 are also close to the 
ligand and can be used as important markers for ligand binding and structure.  
 
 
Figure 5.10 – NPG-alanine distances for the low temperature form (green) and the room 
temperature form (cyan). Ala82 is a good marker peak for the low temperature 
conformation and Ala328 for the room temperature conformation due to their proximity 
to C18.  However, since the ligand is 13C16-NPG, we may also be able to detect protein-
ligand cross peaks from other alanines to the ligand, such as Ala74, Ala330, and Ala264. 
5.5.2 Results and Discussion    
SSNMR experiments were first conducted on a uniformly labeled BMP without 
NPG in hopes of assigning amino acid residues.  Spectral crowding made assignment of 
the protein difficult and in most cases impossible, except in the alanine region. A 
selective labeled alanine sample helped in separating alanine peaks from other amino acid 
residues. Assignment of the alanine residues were based on chemical shift prediction 
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programs such as SPARTA [38] and SHIFTX [39].  The alanines in β sheets (Ala44, 
Ala330, Ala335, Ala448) and random coils (Ala191, Ala225, Ala328, Ala399) were 
separated from the rest of the 35 alanines except Ala191 could not be assigned. A 
comparison of fully labeled protein without any ligand at 10oC and -25oC showed that 
some of the resolved alanines’ chemical shift changed with temperature, as seen in Figure 
5.11.  At low temperature the protein became more globular and the same spectral 
resolution could not be achieved.   Significant changes in chemical shift with temperature 
were Ala44, which is at the mouth of the substrate access channel, and Ala330, which is 
apart of the ligand binding pocket. Both Ala44 (28 Å) and Ala330 (12 Å) are too far 
away for the shifts to be paramagnetic contact shifts. There were also chemical shift 
changes observed besides alanine residues, however we were unable to assign these 
residues.  
Experiments with fully labeled protein and 13C16-NPG showed some well resolved 
amino acid peaks, however, the ligand peaks were inseparable from protein peaks, Figure 
5.9. If we compare protein bound to unbound protein in the alanine region at low 
temperature, we only see slight differences; especially since our low temperature 
unbound sample had low resolution, Figure 5.11. A comparison cannot be made at the 
higher temperature because experiments on the fully labeled protein with ligand at a 
higher temperature were unable to be performed due to an instrument malfunction that 
caused the sample to partially unfold. Indication that the protein partially unfolded was 
seen by the disappearance of the threonine Cα-Cβ cross peaks and confirmed by optical 
absorption spectroscopy. The results of these experiments showed that selective labeling 





Figure 5.11– Possible assignments of alanines in uniformly labeled BMP. Left: BMP 
without ligand (red, 10oC and blue, -25oC) shows there are slight temperature dependent 
shifts for Ala44 and Ala330.  Both these amino acids are in the binding pocket and 
indicate there may be changes in protein conformation as a function of temperature. 
Right: A comparison between uniformly labeled BMP with ligand (orange, -33oC) and 
without ligand (blue, -25oC), showing there are only slight differences upon binding.  In 
addition selective labeled Ala-Gly with ligand (green, -33oC), distinguishes the alanine 
peaks from the rest of the amino acids.  
 
 A selective labeled, uniform alanine and glycine with uniform 15N BMP and 
13C16-NPG, sample was also prepared to identify protein ligand cross peaks using the 
alanine marker peaks (Figure 5.10 (green)).  SSNMR 13C-13C correlation experiments at a 
mixing time of 50 ms and 500 ms at -33oC showed that there are possible protein-ligand 
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contacts with Ala82 and C17; Ala330 Cβ with C6-9; Ala330 Cα with C8-9 and Ala74 
with C5, as shown in Figure 5.11.  In order to accurately determine these assignments 
more signal averaging is needed, however possible assignments are shown in Figure 5.12.  
The closest contacts between ligand and protein at low temperature are with Ala82 Cβ 
and C18, however this cross peak is too close to the diagonal to be distinguishable from 
protein background. Advanced NMR techniques that use zero quantum filters could be 
used to detect peaks closer to diagonal. Using the chemical shifts that Harris and 
Jovanovic reported for Ala82 the chemical shift of Cα is 51.5 ± 0.2 ppm or ~55.3 ppm, 
we cannot see a Ala82 Cα to C18 NPG cross peak due to crowding by Cα to Cβ alanine 
cross peaks.  However, we can see a possible cross peak between Ala82 Cα and C17.  The 
possible protein-ligand cross peaks which were assigned will guide future experiments on 
this system.  
5.5.3 Conclusions & Future Directions 
We assigned key alanine peaks and showed that there may be changes in the 
binding pocket with temperature without ligand bound. We were able to use these alanine 
peaks to assign possible protein ligand cross peaks and determined that the labeling of 
alanine may be helpful in future experiments. Further assignment of the protein will be 
helpful in determining other key residues in the binding pocket.  Accept-NMR [37], 
predicts that there are other amino acids close to the ligand, as shown in Table 5.2. Future 
3D experiments along with 1,3 glycerol labeling would aid in assigning more residues in 







Alanine Atom NPG 
74 CB C1, C5, C5, C7 
82 CB C17, C18 
82 CA C18 
264 CB C15, C17 
264 CA C15, C17 
328 CB C9-C13 
328 CA C9-C12 
328 C C9, C11 
330 CB C6-C9 
330 CA C8, C9 
330 C C8, C9 
Figure 5.12 – Possible protein-ligand cross peaks. Top: 13C-13C correlation spectra of 13C 
labeled alanine and glycine with 13C16 NPG at 50 ms (green) and 500 ms (red) mixing at -
33oC.  Possible protein-ligand cross peaks are shown in red: Ala82-C17, Ala330-C?, and 
Ala74-C5. It is important to note that some scrambling of the 13C labels occurred such 
that serine was also labeled. The table and bottom figure show possible Ala-NPG cross 







   
Residue # of contacts Min Distance Avg Distance 
Pro25 2 4.62 4.69 
Val26 4 4.00 4.27 
Leu29 2 3.98 4.04 
Tyr51 3 4.54 4.58 
Ser72 4 3.64 4.25 
Gln73 4 3.78 4.17 
Ala74 5 4.30 4.57 
Leu75 4 4.52 4.81 
Val78 8 3.74 4.59 
Ala82 3 3.44 4.39 
Phe87 33 3.77 4.41 
Thr88 1 4.80 4.80 
Leu181 1 4.81 4.81 
Leu188 7 4.06 4.46 
Thr260 8 3.78 4.32 
Ile263 8 4.19 4.58 
Ala264 4 4.14 4.51 
Ala328 11 3.96 4.62 
Pro329 10 3.70 4.60 
Ala330 8 3.93 4.52 
Met354 5 4.26 4.67 
Leu437 20 4.11 4.60 
Thr438 4 3.80 4.31 
Table 5.2 - Amino Acid contacts of BMP (1JPZ) [29] to NPG determined by Accept-
NMR [37].  This table provides insight on future labeling schemes. 
 
5.6 Evaluation of Peaks Close to the Paramagnetic Center 
5.6.1 Introduction 
BM-3 is a paramagnetic protein and therefore, residues close to the heme may be 
very broad and unobservable.  In order to test whether we could observe a cross peak 
between ligand and protein in the room temperature form, we selectively labeled a rigid 
isoleucine and glycine pair (Ile401-Gly402) close to the paramagnetic center, 
approximately 5 Å. There are two Ile-Gly pairs, the other pair, Ile153-Gly154 is 12.4 Å 
away from the heme, and should not be influenced by the same paramagnetic effects. 
These control experiments demonstrated that TEDOR experiments are a promising 




5.6.2 Results and Discussion 
In order to determine if we can observe residues near the paramagnetic center, we 
conducted 13C-13C DARR experiments on a selectively labeled 13CO Gly-15N 
Cα Ile BMP sample, shown in Figure 5.13.  In BMP, there are two Ile-Gly pairs, one 
Ile153-Gly154 approximately 12.4 Å and the other Ile401-Gly402, which is directly 
attached to the cysteine coordinating the heme that is 5 Å away.  We were unable to 
detect the Ile401-Gly402 pair closest to the paramagnetic center but we were able to 
assign the other Ile153-Gly154 pair (Figure 5.13) in the protein by showing the peak’s 
chemical shift did not change with temperature, as described in Equation 5.14.  The peak 
labeled “?” was not assigned because it was just above the noise and we observed some 
scrambling of the glycine to serine or threonine.   
In addition, we made a sample that was 13CO isoleucine and uniform 15N in order 
to prevent scrambling of the glycine.  There are 24 isoleucines in BMP, which resulted in 
spectral overlap in our 2D 15N-13C experiments.  Even though we were unable accurately 
assign any peaks, possible assignments are shown in Figure 5.14 by using chemical shift 
predictions from SPARTA [38] and SHIFTX[39]. As shown in Figure 5.14 TEDOR is 
better than double cross polarization (DCP), especially for proline peaks. In addition, in 
the TEDOR spectra there were more peaks in the expected Ile-Gly region, and possibly 
one being our IIle401-Gly402 pair of interest.  TEDOR is able to detect prolines because 
cross polarization between H-N is not in the pulse sequence, which is the case in DCP. 
Previous researchers also showed that TEDOR is better for paramagnetic systems 
because TEDOR can provide a more uniform transfer of magnetization than DCP [40, 
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41]. Therefore, other labeling schemes with TEDOR would be promising in detecting 
protein ligand cross peaks. 
 
 
Figure 5.13 – Assignment of Ile153-Gly154. Upper left: The Ile-Gly pair of interest is 
approximately 5 Å compared to the other Ile-Gly pair, which is 12.4 Å away. Lower left: 
Location of Ile-Gly pairs in the structure of BMP.  Ile401 is next to Cys400, which is 
bound to the heme. Right: Possible Ile153-Gly154 cross peaks of 13C-13C DARR 400 
MHz at 0oC (red) and -30oC (blue) with 20 ms mixing. The “?” is within the noise and is 




Figure 5.14 – Comparison of TEDOR versus DCP.  Ile-Gly 15N BMP TEDOR 
experiments n=4 at 0oC (red), -15oC (blue) and DCP at 0oC (Green). TEDOR was able to 
detect more peaks than DCP, making TEDOR a promising method for detecting protein-
ligand cross peaks. 
 
5.6.3 Conclusion 
Our control Ile-Gly sample showed that it may be difficult to detect a peak close 
to the paramagnetic center, however TEDOR experiments may help in increasing our 
chances.  The next step of the project would be to perform TEDOR measurements on our 
selective labeled 13C16 NPG with 13C Ala-Gly and uniform 15N, using our assigned NPG 
and alanine marker peaks. TEDOR experiments will not only provide protein-ligand 
cross peaks, but also provide distance information, which will enable us to determine the 





5.7 Conclusions & Future Directions 
 Our SSNMR experiments laid the foundation for future structural experiments for 
determining the ligand’s conformation at room temperature.  Assignment of the ligand 
both bound and unbound and identification of important alanine marker peaks enabled us 
to determine protein-ligand cross peaks. These experiments showed that alanine peaks are 
well resolved and may aid in identification of the proximal and distal ligand 
conformation.  We also learned that in addition to the terminal end of NPG, the solvent 
exposed region of the ligand has significant motion that may play a role in substrate 
docking and positioning for catalysis. Future SSNMR experiments where C1 and C3 are 
labeled will provide more information on these dynamics.  From our control experiments 
on residues close the paramagnetic center, we learned that some peaks may be 
unobservable but a selective labeled sample with TEDOR experiments would give us the 
best chance at detecting and assigning residues close to the paramagnetic center and 
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Probing the Role of the Thioether Linkages 
in Cytochromes c Using Thermodynamic 
Analyses of Cytochrome c-to-b Conversions 
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6.1 Introduction to Cytochromes c 
6.1.1 Overview 
Cytochromes are heme proteins found in all living things that are essential for 
cellular function.  Important functions of cytochromes include aerobic respiration, 
photosynthesis, steroid synthesis, and drug metabolism. Cytochromes are classified by 
the chemical identity of their heme cofactor with cytochromes a, b, c, d, and o known.  
Cytochromes b and c are the most prevalent and their heme chemical structures are 
similar as shown in Figure 6.1.  The major structural difference between b-type and c-
type cytochromes is that the heme cofactor is covalently linked to cysteine protein 
residues in c-type cytochromes by a pair of thioether bonds.  Cytochromes c contain a 
conserved Cys-X-X-Cys-His structural motif which includes the two cysteines that form 
the thioether bonds and the histidine that acts as an axial ligand to the iron.  Since c-type 
and b-type cytochromes are the most abundant and c-type cytochromes are 
biosynthesized from apo-protein and b-type heme; the fundamental question arises as to 
why Nature has made the covalent attachment in c-type cytochromes. 
 
Figure 6.1 - Structure of heme b and c. Heme c is synthesized from heme b and apo-



























Figure 6.2 - Structures of cytochromes discussed in this thesis chapter. Cytochromes b562, 
b5 and P450 all have b-type hemes. Cytochromes c549, c553, c552, and cytochrome c from 
horse heart all have c-type hemes and cytochrome c oxidase has a-type heme.  Axial 
ligand coordination is in cyan for histidine, magenta for methionine, and orange for 
cysteine. Cytochrome b5 has similar fold to the cytochromes c shown above yet it does 
not have a covalent bond. In addition, cytochrome b562 has similar coordination (His-Met) 




6.1.2 Importance of Cytochromes    
A majority of cytochromes are involved in electron transfer and 
oxidation/reduction chemistry.  They are found in most prokaryotic and in all eukaryotic 
organisms and are involved in photosynthesis, cellular respiration, and catalysis.  In 
cyanobacteria and in green plants, cytochromes transfer electrons in photosystem I and 
are involved in oxygen evolution in photosystem II [1]. For cellular respiration in 
bacteria, electron transfer occurs between dehyrogenases and reductases, and between the 
bc1 complex and an oxidase or a photoreaction center. In eukaryotes during cellular 
respiration, cytochrome c transfers electrons from cytochrome bc1 to cytochrome c 
oxidase. Cytochromes are also involved in catalysis, such as cytochrome c oxidase and 
cytochrome P450, which was also described in this thesis.  Cytochrome c oxidase located 
in the mitochondrial membrane is the terminal oxidase in the respiratory chain.  After 
receiving four electrons from cytochrome c, it is able to reduce dioxygen to water as well 
as pump four protons across the membrane, causing an electrochemical gradient for ATP 
synthesis to occur [2-4]. Cytochrome c has also been found to be involved in apoptosis, 
programmed cell death. Upon an apoptotic stimulus cytochrome c is released into the 
cytosol, triggering apoptosis by activating a cysteine protease, caspase [5, 6]. Since 
cytochromes are heavily involved in life processes it is important to understand how they 
function. 
6.1.3 Classification  
 MacMunn discovered and described cytochromes as respiratory pigments in 1884 
[7]. In 1920, cytochromes (meaning cellular pigment), were rediscovered and named by 
Keilin [8]. Cytochromes are named first by the identity of their heme cofactor and then 
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by the wavelength of their reduced α absorbance band. For example, cytochrome c553 has 
a c-type heme and its reduced α absorbance band is at 553 nm. The name cytochrome 
originally referred to only heme proteins that were involved in mitochondrial respiration. 
Now, the name has expanded to refer to a heme protein that carries out electron transfer 
or catalyzes a reduction or oxidation of a substrate [9].  
Cytochromes are classified by the chemical identity of their heme cofactor, with 
cytochromes a, b, c, d, and o known. (Cytochrome f is a subset of cytochrome c.) Only 
cytochromes c have the heme cofactor covalently bound to its protein scaffold and is 
characterized by a Cys-X-X-Cys-His motif.  The cysteines are covalently bound to the 
heme through thioether bonds and the histidine is an axial ligand. Other sequences have 
also been observed, including Cys-X-X-X-Cys-His, Cys-X-X-X-X-Cys-His, and Cys-X-
X-Cys-Lys (where lysine is coordinated to the heme).  In addition, single thioether bonds 
have been observed, where the motif is Ala/Phe-X-X-Cys-His [10]. Covalent attachment 
in mammalian myeloperoxidase is not through thioether bonds, but rather two ester bonds 
and one sulphonium ion between a heme vinyl group and a methionine sulphur atom. The 
reason for this attachment in myeloperoxidase is unknown but may be a result of 
autocatalytic events after protein folding [11]. 
All cytochromes have the same iron porphyrin core, protoporphryin IX, but what 
distinguishes them and determines their function are differences in the active site, such as 
iron’s axial ligands and the surrounding protein scaffold. The majority of cytochromes 
are six coordinate with His-His (cytochrome b5) or His-Met axial ligands (cytochrome 
b562).  Cytochrome c’ is one exception with a five coordinate mono-His coordination. 
Histidine is the most common axial ligand followed by methionine.  Tyrosine can 
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coordinate heme both through its Oη (hydroxyl group) in cytochrome cd1 nitrite 
reductase or by its backbone nitrogen in cytochrome f. In addition, cysteine forms heme 
thiolates in cytochrome P450 (b-type heme) and nitric oxide synthases.  
Ambler categorized cytochromes into four classes [12-14]. In class I cytochromes, 
the heme is attached close to the N terminus and the protein has a ‘cytochrome fold’.  
Class I contains low spin soluble cytochrome c of mitochondria and bacteria that have 
His-Met ligation, such as cytochrome c553. In class II cytochromes, the heme attachment 
is close to the C terminus and their overall fold is a four alpha helix bundle.  Class II 
contains high spin iron cytochrome c’, but also includes other cytochromes with similar 
folds, such as cytochrome b562.  Class III contains multiheme cytochromes and Class IV 
includes proteins at have other types of hemes and heme c. 
6.1.4 Biosynthesis of Heme c   
Apo-cytochrome c at neutral pH resembles a random coil, unlike hemoglobin, 
myoglobin, cytochrome c peroxidase, horseradish peroxidase, and b-type cytochromes 
that exhibit a partially-folded structure in their apo form [15]. Cytochrome c is 
synthesized from apo-cytochrome c and heme b by different mechanisms depending on 
the organism. There are three different biogenesis systems that catalyze heme c synthesis, 
called systems I, II, and III [16, 17]. The most common and complex, system I, is found 
in Gram negative bacteria and plant mitochondria, and involves eight cytochrome c 
maturation (Ccm) proteins.  System II is present in thylakoids, Gram positive, and Gram 
negative bacteria and involves two cytochrome c synthetase (Ccs) proteins.  In system III 
found in humans and other eukaryotes, cytochrome c is synthesized in the cytoplasm as 
apo-protein [18] and an enzyme, cytochrome c heme lyase (CCHL), covalently attaches 
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heme b to the protein by a thioether bond [19-21].  These systems are rather complex; 
therefore it further stresses the question as to why Nature would go through all this 
trouble to make c-type cytochromes. 
The exact mechanism of heme attachment is not known. The vinyl group of the 
heme is not very reactive and when the thiols are in the correct position it would be an 
anti-Markovnikov addition, which is not favorable. However, if the vinyl groups are 
protonated the reaction will follow Markovnikov’s rule [22]. In vitro studies showed that 
the uncatalyzed covalent attachment is favored by the ferrous state of the heme, low pH, 
and prevention of disulfide bond formation between the two cysteines [23]. Cytochrome 
c552 from Hydrogenobacter thermophilus was shown to form thioether bonds in vivo 
without the presence of a biogenesis system in Escherichia coli (E. coli) [24]. The NMR 
spectrum of ferrous cyt c552 implicated correct attachment of the thioether bonds [22]. 
This correct positioning of the heme in cyt c552 from H. thermophilus can be attributed to 
the existing tertiary structure in the apo-protein, thus enabling the heme to correctly bind 
by positioning the vinyl groups close to the thiols.  This is in contrast with other apo-
cytochromes c, which are unstructured in the apo form. The correct positioning and 
spontaneous attachment of heme b was not observed in cytochrome c552 from Thermos 
thermophilus, where other products of the covalent attachment were observed [25]. 
6.1.5 Reason for Covalent Attachment 
The reason as to why Nature has made a covalent attachment in c-type 
cytochromes is unknown but there are many hypotheses. In 1983, Wood observed a lack 
of b-type cytochromes in the periplasm and proposed that the need for covalent 
attachment was to prevent heme in cytochromes c from dissociating in the periplasm 
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[26]. Thus mitochondrial cytochromes c and c1 were evolutionary descendants of 
periplasmic cytochromes and noncovalently attached heme proteins existed where loss of 
heme could be replaced. However, the discovery of b-type cytochromes in the periplasm 
challenged Wood's hypothesis [27]. In addition, evolutionary ancestry was challenged by 
yeast and other eukaryotics’ use heme lysases to make c-type cytochromes and bacteria 
use different multicomponent systems, which even differ between Gram positive and 
Gram negative bacteria.  Due to the complexity of cytochrome c synthesis, it is not likely 
that cytochromes stemmed from a single ancestor. 
Based on structural studies of multiheme c-type cytochromes, Ferguson proposed 
that the covalent attachment allows for the dense packing of hemes in multiheme proteins 
and there is a minimum protein to heme ratio for noncovalently linked hemes [27]. Heme 
to amino acid ratios for noncovalently bound heme is minimally 1:150, with the 
exceptions of cytochrome b5 and b562, whose ratios are 1:90 and 1:106, respectively.  For 
c-type cytochromes the ratio is lower, between 1:70 and 1:120. Thus the covalent binding 
of the heme seems to be more important for smaller proteins and for multihemes. Also, 
based on heme:amino acid ratios, clustering of hemes would not occur without the 
covalent linkage [9], which is necessary for fast catalysis and electron transfer.  
Another proposed reason why c-type heme are covalently attached is that the 
heme needs to be solvent exposed in order for electron transfer to occur, unlike some b-
type hemes where the heme is sandwiched between alpha helices.  However, there is no 
correlation between solvent exposure and c-type cytochromes; not all hemes in c-type 
cytochromes are solvent exposed and in some globin b-type hemes the heme propionates 
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are solvent exposed [27]. For example, in cyt b5, as shown in Figure 6.2, the heme is 
solvent exposed. 
Axial ligands may also play a role in the reason for covalent attachment. Benson 
has shown that the role of the covalent attachment is to increase heme’s affinity for weak 
ligands, such as methionine, thus allowing the ligands to bind to the heme iron in both 
oxidation states [28]. In addition, if the change in oxidation state involves a 
conformational change it may be necessary to have the heme covalently linked.  For 
example, the c-type cytochrome domain of cd1 nitrite reductase can switch from His-His 
to His-Met coordination upon oxidation state change [29]. However, the reason of 
covalent attachment cannot be solely related to coordination of methionine because of the 
existence of b-type cytochromes with methionine ligands such as cyt b562.  However, apo- 
cyt b562 unlike apo-cyt c has a preorganized protein fold allowing it to coordinate heme 
through His-Met ligation. Apo-cyt b562 has three out of its four helices well ordered, one 
of which is the helix with the methionine ligand.  Mutations of cytochrome b5, from His-
His ligated to His-Met have proven to be unsuccessful because His-Met ligation was not 
observed [30, 31]. Apo-cytochrome b5 shows the heme binding pocket to be partially 
unfolded even though other parts of the protein are folded [32]. Thus the unsuccessful 
attempts to coordinate His-Met heme are linked to the fact that too much energy is 
required to refold the protein and therefore heme binding is not observed.  Therefore, a 
preorganized protein structure may be needed for His-Met ligation of the heme, when the 
heme is not covalently attached.  
Ferguson converted the His-Met ligated cytochrome c552 from Hydrogenobacter 
thermophilus into a b-type cytochrome by mutation of the cysteines in the structural 
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motif to alanines [33, 34].  From this study, Ferguson concluded there was little 
difference in the characteristics between the mutated and wild-type, except that the wild-
type was slightly more stable to chemical and thermal denaturation.  Studies were also 
done with only a single mutation, so only one covalent bond could form and a smaller 
effect was seen compared to the double mutation [33, 34]. Since this protein has very 
high stability and is the only protein that has been shown to form covalent attachment to 
heme spontaneously both in vivo [24] and in vitro [23], experimental results on this 
protein cannot be applied generally to c-type cytochromes.   
6.1.6 b-to-c Conversions 
It is proposed that cytochrome b562 could be the evolutionary intermediate 
between b and c cytochromes.  Cytochrome b562 is in class II and unlike the other 
members of its class, all of which contain a four alpha helix bundle architecture, its heme 
is not covalently attached [26]. Therefore, cytochrome b562 in addition to cytochrome b5, 
has been used to evaluate the role of the covalent attachment by a b-to-c conversion [26-
28]. A glutamine to cysteine mutant of cytochrome b5 was made within 4 Å of the heme 
propionate group. Especially under reducing conditions, the mutation resulted in the 
formation of a covalent bond between the protein and the heme.  The heme of the mutant 
was not removed by acid denaturation, proving the heme was covalently attached.  Under 
oxidizing conditions, the mutant also formed covalent bonds, but this resulted in two 
different conformations in addition to some non-covalently coordinated heme species 
[27]. Mutations of cytochrome b562 were also done, which included single and double 
mutants to gain the conserved motif Cys-X-X-Cys-His [26, 28]. All mutants formed 
covalent attachments in E. coli.  The mechanism of covalent bond formation in these 
  
154 
mutants is unknown but it has been suggested that if placed in close proximity they will 
form spontaneously or there is an enzyme in the E.coli strain that forms the covalent 
bond.  The b-to-c conversions showed that the single covalent bond significantly 
increased stabilization towards thermal and chemical denaturation and even more with 
two covalent bonds. 
6.1.7 Cytochrome c553 from Bacillus pasteurii 
The goal of this portion of my thesis research was to evaluate the role of the 
thioether linkages in c-type cytochromes by performing thermodynamic analyses and 
structural studies of a c-to-b conversion in a mutated cytochrome c, in which the thioether 
bonds cannot form. The method that we used to thermodynamically characterize the 
mutant was also done on a de novo designed four-helix bundle [35]. The oxidized and 
reduced heme affinities were measured by optical absorption spectroscopy, along with 
redox potentiometric titrations, to analyze the thermodynamics of the system. Previous 
studies to evaluate the role of the thioether linkages were either performed on a unique 
protein that can spontaneously form covalent bonds, cytochrome c552, or peptide 
fragments; therefore, I have selected cytochrome c553 (Figure 6.2) a mono-heme with His-
Met coordination from Bacillus pasteurii to study.  This protein was chosen because it is 
water soluble, monomeric, contains only one c-type heme, doesn't contain any other 
histidine or methionine residues, and an atomic resolution crystal structure (0.97Å 
resolution) has been solved of this protein [36]. In addition, cytochrome c553 was chosen 
because it has the lowest known reduction potential of a mono-heme His-Met c-type 
cytochrome (+47 mV) and solution NMR showed that upon reduction there is no large 
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change in its structure [37]. These criteria optimized the possibility of successful 
completion of the thermodynamic analyses and structural studies. 
Cytochrome c553 (cyt c553) from Bacillus pasteurii was the first X-ray structure 
solved of an isolated c-type cytochrome from Gram positive bacteria [38]. Bacillus 
species are Gram positive microorganisms that need membrane bound electron transfer 
proteins because they lack the outer membrane present in Gram negative bacteria. Since 
these cytochromes are membrane bound, they become difficult to study due to their 
insolubility and the associated difficulty in purifying them [39]. This has resulted in a 
lack of information known about them. Cyt c553 is 9.6 kDa, with 92 amino acids (AA); its 
membrane linker of 21 AA was cleaved to make the protein soluble (71 AA) and easy to 
study.   
Cytochrome c553 shares some similar helices with cytochromes observed in 
eukaryotes and Gram-negative bacteria [36]. The structure of cyt c553 involves a single 
peptide chain folded around the heme, with three α helices, and a short 310 helix. The N-
terminal helix (residues 24-36) contains Cys32 and Cys35 that are covalently bound to 
the heme and His36, which is axial coordinated to the heme. The electrostatic potential 
map of the surface shows that there is a highly asymmetric charge distribution. The 
surface around the heme has no net charges, and is considered to be involved in 
molecular recognition during electron transfer [36]. However, the exact function of cyt 
c553 is unknown, but it has been proposed to be involved in respiratory metabolism. 
For our experiments, cytochrome c553 has been mutated from a c-type cytochrome 
to a b-type (cytochrome c553-b) by replacing the cysteine residues in the structural motif 
with alanines (C32A/C35A).  In order to test the generality of our results, cytochrome c 
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from horse heart, in which the heme was chemically removed, was also analyzed. Horse 
heart cytochrome c is a well-studied cytochrome with similar His-Met axial coordination, 
but a larger reduction potential of +247 mV.  Experiments were also conducted on 
another similarly mutated cytochrome, cytochrome c549, to examine the role of the axial 
ligands on the covalent attachment, since cytochrome c549 has His-His axial ligand 
coordination.  Margaret Elvekrog carried out experiments on this protein.  
6.2 Materials and Methods 
All this work was performed in the research lab of Prof. Brian Gibney. 
Materials.  Hemin (ferriprotoporphyrin IX chloride) was purchased from Alfa 
Aesar (Ward Hill, MA).  Cytochrome c from horse heart (98%) was purchased from 
Sigma-Aldrich (Milwaukee, WI).  The gene coding for cytochrome c549-b was 
synthesized by PCR while the one for cytochrome c553-b was purchased from Genscript 
(Piscataway, NJ). All primers were purchased from Invitrogen (Carlsbad, CA).  All 
restriction enzymes were purchased from New England Biolabs (Ipswich, MA), except 
Pfu Turbo, which was purchased from Stratagene (La Jolla, CA).  The m-pET-32b(+) 
plasmid was a gift from Josh Wand (University of Pennsylvania).  Promega Wizard SV 
Gel, and PCR Cleanup System, and Promega Wizard Plus SV Minipreps DNA 
Purification System were purchased from Fisher Scientific (Fairlawn, NJ). XL1-Blue 
supercompetent cells were obtained from Stratagene (La Jolla, CA) and 
BL21(DE3)pLysS expression cells were from Promega (Madison, WI).  All other 
chemicals were molecular biology grade and purchased from Fisher Scientific, VWR, or 
Sigma-Aldrich unless otherwise noted. 
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Cloning of cytochrome c553-b. The gene coding for cytochrome c553-b in a pUC57 








The gene was amplified by PCR with primers that contained BamHI and EcoRI 
restriction sites.  The forward primer was 5'-AGGATCCGTGGATGCTGAAGC –3' and 
the reverse primer was 5'-CGAATTCTTATTATTATTTTTTCTCG–3'.  The PCR 
product was cleaned-up with a Promega Wizard SV Mini-prep DNA Purification System 
and restriction digested overnight with BamHI and EcoRI.  The restriction digest product 
was mini-prepped and then ligated into a m-pET-32b(+) plasmid with T4 ligase for 4 
hours at 16ºC followed by 70ºC for 10 minutes. The m-pet32b(+) plasmid contains a T7 
promoter region, a thioredoxin fusion partner with a His6 tag, and a thrombin cleavage 
site.  The plasmid was then transformed by electroporation into E. coli XL1-Blue 
supercompetent cloning cells.  Cells were grown on LB agar media containing 100 mg/l 
ampicillin.  After colony isolation, overnight cultures in LB and ampicillin, and plasmid 
preparation (Promega), the gene was sequenced at Columbia University’s DNA facility. 
Construction of the cytochrome c549-b gene. The gene coding for cytochrome c549-
b was synthesized from fourteen oligonucleotides by PCR.  Sets of four continuous gene 
fragments were fused with DNA pol I Klenow fragment in the presence of dNTPs (1 µl), 
NEB 2 buffer (2 µl), and water (12 µl); 37ºC for six hours, 75ºC for 10 minutes.  
Fragments with overlapping ends were fused and amplified in four successive rounds of 
PCR (Tannealing = 50ºC, Telongation = 68ºC, Telongation = 1 min, 24 cycles) using the first and 
last primers to amplify each segment.  The product from each reaction was purified using 
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a Promega Wizard SV Gel and PCR Cleanup System.  The gene was digested overnight 
at 37ºC with EcoRI and BamHI.  The digested gene was cleaned-up and ligated into a 
digested plasmid m-pET-32b(+).  All subsequent steps were performed as with 
cytochrome c553-b. 
Transformation and expression of cytochrome c549-b and cytochrome c553-b.  
Plasmids were transformed into E. coli BL21(DE3)pLysS by electroporation.  Cultures of 
LB (1 liter) media containing 25 mg chloramphenicol and 50 mg ampicillin were 
inoculated with 10 ml starter cultures and grown at 37ºC while shaking at 200 rpm to an 
OD600 of approximately 0.8.  Addition of 1 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) induced an overexpression of cytochrome c549-b or cytochrome c553-b.  Cells were 
harvested by centrifugation 3 hours after induction and resuspended in 25 mM Tris-HCl, 
500mM NaCl, 25 mM imidazole, pH 8.2, to a final volume of 30-40 ml and stored at –
20ºC. 
Purification of cytochrome c553-b and cytochrome c549-b.  Frozen cells were 
thawed on ice and then lysed by three passes through a French press at 15,000-18,000 psi.  
After centrifugation, a FPLC was loaded with 10 ml fractions of the supernatant through 
a 5 ml HisTrap Chelating HP column (Amersham Biosciences, Uppsala, Sweden).  After 
washing the immobilized His6-tagged protein with ten column volumes of binding buffer 
(25 mM Tris-HCl, 500 mM NaCl, 25 mM imidazole, pH 8.2) the fusion protein was 
eluted with excess imidazole buffer (25 mM Tris-HCl, 500 mM NaCl, 500 mM 
imidazole, pH 8.2); purity is shown in Figure 6.3a.  The protein-containing fractions were 
pooled and placed in 3500 MWCO dialysis tubing with 5 NIH units of thrombin and 1.25 
ml of 100 mM CaCl2.  The protein was dialyzed overnight against 5 liters of thrombin 
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cleavage buffer (25 mM Tris-HCl, 500 mM NaCl, 2.5 mM CaCl2, pH 8.2).   Cleavage of 
the protein from the thioredoxin-His6 tag was checked by analytical reversed phase C18 
HPLC, shown in Figure 6.3b.  After cleavage, the protein was loaded onto a second 
nickel affinity column.  The protein was eluted with binding buffer (Figure 6.3c).  The 
protein was concentrated by a 5000 MWCO centrifugal concentrator and then purified by 
preparative reversed phase C18 HPLC, Figure 6.3d.  Fractions were collected, 
lyophilized, and stored at -20ºC.  Protein mass was checked by MALDI-TOF mass 
spectrometry. The experimental mass was 7182.88 amu, which compares to a calculated 
value of 7190.38 amu. This expression and purification procedure provides about 40 mg 
of pure protein per liter of culture.   
 
Figure 6.3 - HPLC traces showing the steps in purification: (a) nickel affinity column 
purified thioredoxin-cyt c553, (b) cleavage of cyt c553 (21 min) from thioredoxin (38 min), 
(c) second nickel affinity column purified cyt c553, (d) prep HPLC purification. 
 
Purification of apo-cytochrome c from horse heart.  Removal of heme from 
cytochrome c (horse heart) was performed as described previously [40].  Further 
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purification was achieved by preparative HPLC.  Fractions were lyophilized and stored at 
-20oC.   
Optical absorption spectroscopy:  Optical absorption spectra were recorded on 
Varian Cary 300 and 100 spectrophotometers using quartz cells of 1.0 and 10 cm path 
lengths.  Protein concentrations were determined spectrophotometrically using  ε280 of 
6900, 10821 [40], and 5600 M-1 cm-1 for cyt c553-b, cyt c-b from horse heart and cyt c553-b, 
respectively. These extinction coefficients for cyt c553-b and cyt c549-b were estimated by 
each protein’s sequence using Protein Calculator [41]. In initial ferric binding studies, 0.5 
equivalent of a freshly prepared solution of 1.5 mM heme b in 0.1 M KOH were added to 
5 µM protein solutions 20 mM KPi, 100 mM KCl, pH 8.0 for cyt c-b from horse heart, 
cyt c549-b and 20 mM sodium borate, 100 mM KCl, pH 9.5 for cyt c553-b.  In initial 
ferrous binding studies, the reductant sodium dithionite was added to the same samples 
before taking optical absorption spectra.  
Solution Molecular Weight Determination: Sedimentation equilibrium analytical 
ultracentrifugation analysis was performed on a Beckman XL-I analytical ultracentrifuge 
operating at 30,000 rpm and 4°C.  Initial protein concentrations ranged from 5 to 8 µM 
cytochrome c553-b (20 mM sodium borate, 100 mM KCl, pH 9.5). Partial specific 
volumes for the proteins were calculated from the residue-weighted average of the amino 
acid sequence using the method of Cohn and Edsall [42]. The estimated partial specific 
volume, u
—
 value, was 0.7364 ml/g.   The density, r, of the solvent buffer was 1.0509 g 
ml
-1
(20 mM sodium borate, 100 mM KCl, pH 9.5) as calculated using Sednterp [43]. The 
radial distribution absorbance scan data, collected at 425 nm, were fit to a single 
exponential using WinNonlin [44]. The buoyant molecular weight, Mb, was converted to 
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the average molecular weight of the molecular species in solution, Mr, with the following 
relationship: 
Mb = Mr (1 – u
—
 r)     (6.1) 
   
Heme affinity studies: Ferrous heme. Freshly prepared solution of 1.5 mM heme b 
in 0.1 M KOH was added in 0.05-0.1 equivalent aliquots through a septum into anaerobic 
protein solutions of cytochrome c-b (20 mM KPi, 100 mM KCl, pH 8.0) and cytochrome 
c553-b (20mM sodium borate, 100 mM KCl, pH 9.5).  The samples were maintained at a 
reducing potential by the addition of sodium dithionite prior to the start of the titration.  
The spectrophotometer was placed in an AtmosBag (Sigma-Aldrich) under a nitrogen 
atmosphere to ensure an anaerobic atmosphere.  The individual KdFe(II) values were 
obtained from fitting the absorbance at 
€ 
λmax
red  plotted against [heme]/[apo-protein] 
according to an equation for one binding site (Equation 6.8) using KaliedaGraph 




heme[ ] apo[ ]
holo[ ]
     (6.2) 
Consideration of mass balance gives the equation 
€ 
heme[ ]T = heme[ ] + holo[ ]
apo[ ]T = apo[ ] + holo[ ]
            (6.3)  
where [heme]T and [apo]T represents all forms of the heme and apo-protein. Substitution 





holo[ ]2 − apo[ ]T + heme[ ]T + Kd( ) holo[ ] + apo[ ]T heme[ ]T = 0 (6.4)  
In order to solve equation 6.4, the quadratic equation is used:  
€ 
holo[ ] = 12 (x apo[ ]T + Kd + apo[ ]T ) − (x apo[ ]T + Kd + apo[ ]T )
2 − 4x apo[ ]T
2( )  (6.5)  
where 
€ 
x = heme[ ]Tapo[ ]T
. Our observed absorbance at 425 nm is a function of both holo- 
protein and free heme, Equation 6.7,      
€ 
Abs425nm = Abs0 + εB holo[ ] + ε f heme[ ]T − holo[ ]( )                     (6.7)  
where εB is the extinction coefficient of the holo-protein at 425 nm εf is the extinction 
coefficient of free heme at 425 nm. Abs0 is the absorbance without any heme added. 
Substituting Equation 6.5 into Equation 6.7, Equation 6.8 is obtained. 
€ 
Abs = Abs0 +
εB
2 (x apo[ ]T + Kd + apo[ ]T ) − (x apo[ ]T + Kd + apo[ ]T )
2 − 4x apo[ ]T
2( )
+ε f x apo[ ]T −
ε f
2 (x apo[ ]T + Kd + apo[ ]T ) − (x apo[ ]T + Kd + apo[ ]T )
2 − 4x apo[ ]T
2( )
    (6.8) 
When absorbance is plotted versus x, and [apo]T is a constant, Kd, εB, and εf  can be 
determined by a fit of Equation 6.8. 
  Heme affinity studies: Ferric heme.  The ferric Kd experiment for cytochrome 
c553-b was conducted at 2.5 mM protein solution (20mM sodium borate, 100 mM KCl, 
pH 9.5).  Heme was titrated from one-hundredth of an equivalent to one tenth of an 
equivalent.  The Kd
Fe(III) value was obtained by fitting the absorbance at 
€ 
λmax
ox  (412 nm) 
plotted against [heme]/[apo-protein] according to an equation for one-to-one binding 
(Equation 6.8) fixing the extinction coefficient (εB) for the natural protein at 412 nm 




Naturation studies: Trimethylamine N-oxide (TMAO) was titrated into protein solutions 
of cytochrome c549-b (50 mM KPi, 15 mM KCl, pH 7.9) and cytochrome c553-b (50 mM 
KPi, 15 mM KCl, pH 7.9) containing 0.1 equivalent of ferric heme.  Also, ferric heme 
titrations were preformed with 5M TMAO into protein solutions of cytochrome c549-b (50 
mM KPi, 15 mM KCl, pH 7.9) and cytochrome c553-b (20 mM sodium borate, 100 mM 
KCl, pH 9.5).   
Redox potentiometry.  Chemical redox titrations were performed in an anaerobic 
cuvette equipped with a platinum working and a calomel reference electrode at 22°C.  
Ambient redox potentials (measured against the standard hydrogen electrode) were 
adjusted by addition of aliquots (<1 µl) of sodium dithionite or potassium ferricyanide.  
Titrations were performed on 150 µM cytochrome c553-b containing 0.03 eq. of heme in 
20 mM sodium borate, 100 mM KCl, pH 9.5.  A low protein-to-heme ratio was used to 
favor binding of Fe(III) heme. Electrode-solution mediation was facilitated by the 
following mediators at 0.2 µM concentration:  2,6-dimethylbenzoquinone, 
anthroquinone-2-sulfonate, anothroquione-2,6-disulphonate, duroquinone, phenazine 
ethosulfate, phenazine methosulfate, resorufin, 1,2-naphthoquinone-4-sulphonate and 
1,4-naphthoquinone.  After equilibration at each potential, the optical spectrum was 
recorded.  Oxidation of the heme was followed by the decrease in the Soret band 
absorption at 427 nm relative to a baseline point (700 nm).  Spectral intensity was plotted 
against potential, and the data were fit to a single Nernst equation with n = 1.0 (fixed).  
NMR Spectroscopy.  1H NMR Spectroscopy was performed in a J-young tube at 
298 K on a 800 MHz Bruker magnet at the New York Structural Biology Center in 
collaboration with Dr. Joel Butterwick and Prof. Art Palmer. (Columbia University)  
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Samples were prepared in an anaerobic environment.  Cytochrome c553-b concentration 
was 250 mM (2 mM sodium borate, 50 mM KCl, pH 9.5) with an equivalent of heme 
added in the presence of sodium dithionite.  The sample was centrifuged to remove any 
precipitants.  
6.3 Results and Discussion 
6.3.1 Initial Results 
The first goal of this project was to determine if cyt c553-b could bind heme and 
form a stable protein structure.  Secondly, combinations of spectroscopic and biophysical 
experiments were used to show that the mutant is similar to natural b-type hemes with 
His-Met ligation and has a similar structure to the wild-type cyt c553. The third goal was 
to perform a thermodynamic analysis on the mutant and other similar c-to-b conversion 
proteins: cytochrome c549 and cytochrome c from horse heart. 
6.3.2 Formation of a b-type Heme 
Initial spectroscopic characterization of this peptide, cyt c553-b, was conducted at 
5 µM peptide concentration and demonstrated that the peptide bound ferrous heme tightly 
under anaerobic conditions in the presence of dithionite.  As shown in Figure 6.4, the 
position of the Soret band, 425 nm, and its extinction coefficient, 125,000 M-1cm-1 are 
consistent with those expected for a His-Met ligated b-type cytochrome.  The distinct 
 α/β bands, at 562 nm and 530 nm, are superimposable with those of cyt b562 and 
indicative of a six-coordinate ferrous heme [45], compared to the wild-type  α/β bands at 
553 nm and 523 nm [38]. While ferrous heme was observed by optical absorption 
spectroscopy to bind in minutes, experiments at micromolar protein concentration did not 
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bind ferric heme even after 24 hours.  Therefore, the reduced protein was used for 
structural characterization.  In addition, pH experiments followed by optical absorption 
spectroscopy of the reduced protein showed that there is a narrow region of pH stability 
around pH 9.5.  Thus all experiments were conducted at pH 9.5 using a sodium borate 
buffer. The high pH is not unusual since Bacillus pasteurii is found in alkaliphilic soil 
and grows optimally at pH 9.2 in the presence of ammonium salts or urea [46-49]. 
 
Figure 6.4 – Apo-cytochrome c553-b is shown in blue and upon addition of heme under 
reducing conditions binds heme (green) and has similar absorbance bands to cyt b562, 
showing that cyt c553-b has a b-type heme. However, ferric heme does not bind under the 
same concentrations (pink), which is similar to the spectrum of free heme. 
 
6.3.3 Structural Studies 
  A combination of biophysical methods was used to study the apo- and holo-
protein.  The secondary structure of the protein was determined using circular dichroism 
(CD). CD studies (Figure 6.5) showed the apo-protein is consistent with a random-coil 
unfolded state, which is expected for c-type cytochromes.  The CD spectrum of the 
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reduced protein is similar to that of the wild-type cyt c553, which contains three alpha 
helices [36]. A heme titration, where the CD signal was monitored with addition of heme, 
showed the protein folding as a function of heme concentration. The oligomerization 
state of the holo-protein was measured using sedimentation equilibrium analytical 
ultracentrifugation monitoring the absorbance at 425 nm.  The experimental molecular 
weight determined was consistent with a 1:1 heme to protein stoichiometry. The raw data 
is shown in Figure 6.6. This is in agreement with titrations of ferrous heme into solutions 
of cyt c553-b monitored by optical absorption, as seen in Figure 6.9, the absorbance at 425 
nm as a function of ferrous heme added to protein shows a 1:1 stoichiometry. 
 
Figure 6.5 - CD spectra of apo-cytochrome c553-b (blue) and holo-reduced cytochrome 
c553-b(red).  As shown in the spectrum upon addition of heme under reducing conditions, 




Figure 6.6 - The fit of the raw data collected from analytical ultracentrifugation. 
Monitoring the absorbance at 425 nm helped determine the molecular weight of the 
complex and showed that the stoichiometry is 1:1.  
 
 A combination of methods was used to determine the effects of the cysteine-to-
alanine mutation on the cytochrome c-to-b conversion protein’s structure. In 
collaboration with Prof. David Tierney (University of New Mexico), the extended X-ray 
absorption fine structure (EXAFS) spectrum of the reduced protein was collected and 
analyzed.  The fit of the X-ray absorption data shows that the heme iron is bound by 5 
nitrogen/oxygen donors at 2.01 Å and one sulfur donor at 2.31 Å, as shown in Figure 6.7.  
These experimental distances are comparable to those seen in the crystal structure of the 
wild-type protein [36]. A 1H NMR spectrum of the reduced protein showed the protein is 
structured. The NMR spectrum (Figure 6.8) showed clearly defined methyl peaks with 
some chemical shifts below zero ppm, indicative of the methionine coordinated to the 
heme. The 1D 1H spectrum of the protein is in agreement with the previously published 
wild-type spectrum [37]. The NMR spectrum indicates that future NMR structural 
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characterization of the protein is possible. Since the NMR spectrum showed the reduced 
protein is structured, it indicates that it may be possible to crystallize the protein for 
structural studies.  Commercial crystal screens, including PEG/ion, were set up with the 
reduced protein in an anaerobic glove box in collaboration with Dr. Bomina Yu and Prof. 
John Hunt (Columbia University).  However, multiple crystal screens yielded no crystals.  
 
Fe-L distances (Å) EXAFS (Å) 
His 1.99 2.01 
Met 2.33 2.29 
NA 2.00 2.01 
NB 1.98 2.01 
NC 1.99 2.01 
ND 1.96 2.01 
 
Figure 6.7 - EXAFS data showing the coordination environment of the heme. Five 
nitrogens/oxygens are coordinated at a distance of 2.01 Å and sulfur at 2.29 Å.  The table 




Figure 6.8 - 1H NMR spectrum of cytochrome c553-b showing that the protein is well 
structured and the upfield shifts show heme is bound to methionine.  
 
6.3.4 Thermodynamic Studies of Heme Affinity 
Heme affinity, along with midpoint potential of the c-to-b conversion protein was 
determined in both ferrous and ferric oxidation states. Optical absorption titrations of 
heme into protein solutions in the range of 50 nM to 5 mM were conducted. Ferrous 
heme titrations have been performed at lower protein concentrations where the 
equilibrium constant can be determined from a fit of the absorbance data.  Titrations at 
multiple protein concentrations define the ferrous heme dissociation constant, KdFe(II), of 
the protein to be 446 nM as shown in Figure 6.9. In order to probe the ferric heme 
dissociation constant, KdFe(III), of the protein by optical absorption spectroscopy, it was 
determined that heme titration experiments at high concentrations (milimolar) needed to 
be performed.   
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The reduction potential of the bound heme, Em bound, is related to the reduction 
potential of unbound heme, Em free, by the ratio of the dissociation constants for the ferric 
and ferrous heme proteins, as shown in the following thermodynamic relationship derived 
from the Nernst equation: 
 
Em bound = Em free  + (RT/nF)•ln [KdFe(III) / KdFe(II)]  (6.9) 
 
where R is the universal gas constant, T is absolute temperature in Kelvins, n is the 
number of electrons, and F is Faraday’s constant.  Based on values for the reduction 
potential of the wild-type protein, +47 mV vs. SHE [50], the reduction potential of free 
heme, -190 mV [51], and our KdFe(II), using Equation 6.9 an estimated value of KdFe(III) is 
approximately 3 mM.  Therefore, we conducted a heme titration at a protein 
concentration of 2.5 mM to determine KdFe(III).  In order to optimize ferric heme binding, 
the titration was followed from 1/100 to 1/10 of an equivalent of ferric heme added to 
protein. The absorbance data at 412 nm, the λmax of oxidized cyt b562  [45], versus heme-
to-protein ratio was fit to a 1:1 binding isotherm using the extinction coefficient for the 
natural protein [38] (Figure 6.9).  The experimental KdFe(III) of the protein was measured 
to be 4.7 mM.  From the equation shown above, using our KdFe(II) (446 nM), KdFe(III) (4.7 
mM), and Em free of -190 mV, a value of Em bound of +45 mV vs. SHE can be calculated 
(Equation 6.9), which is very close to the wild-type value of +47 mV. Another study 
reports Em free as -50 mV [52], by substituting this number into Equation 6.9our calculated 




Figure 6.9 - Heme titrations for the reduced cyt c553-b (left) and oxidized (right). For the 
reduced m1 is the Kd =446 nM, m2 is the extinction coefficient of the holo-protein at 
425nm =121,410 cm-1 M-1, and m3 is the extinction coefficient of free heme = 28,542 
cm-1 M-1. For the oxidized heme, m1 is the Kd =4.7 mM and m2 is calculated 
concentration of protein used for the experiment =1.8 mM. 
 
Figure 6.10 - Redox titration starting with reduced cyt c553-b and adding an oxidizing 
agent, potassium ferricyanide. The optical absorption spectrum shows that upon 
oxidation, the Soret band at 425 nm decreases and the absorbance for free heme increases 
(380 nm), thus we are measuring the reduction potential of bound Fe(II) to unbound 
Fe(III). The fit of the curve shows the reduction potential to be -137 mV. 
 
Redox potentiometry followed by optical absorption spectroscopy was used to 
determine the Em bound of the heme protein in solution (Figure 6.10).  A midpoint potential 
of -137 mV was measured, which is far from that measured for the natural protein: +47 
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mV. However, the oxidation titration that is being measured is ferrous bound to ferric 
unbound, since KdFe(III) is weak. Therefore we are measuring the dissociation constant of 
ferric heme, which we experimentally determined to be 4.7 mM, which in millivolts 
(E=(RT/nF) ln KdFe(III))  is exactly -137 mV.  In order to accurately determine the 
midpoint potential, a higher concentration of protein needs to be used.  
6.3.5 Analysis of Other Cyt c-to-b Conversions 
In addition to fully characterizing the C32A/C35A mutant of cytochrome c553, it is 
important to compare it to other c-to-b conversion proteins to test the generality of the 
conclusions made. Two other proteins have been selected for study.  First, cytochrome c 
from horse heart has the same His-Met coordination as cyt c553, but a midpoint potential 
of +257 mV vs SHE. Chemical methods were used to remove the heme from cytochrome 
c from horse heart [40]. Heme titration showed that KdFe(II) was around 300 nM, similar to 
our modified cytochrome c553. The KdFe(III) was not measured because using Equation 6.9, 
KdFe(III) would be 10.7 M if Em free is -190mV or 46 mM if Em free is  -50 mV, both of 
which are too high to experimentally determine using our current methods. Since 
cytochrome c from horse heart and c553-b have similar Kd’s for Fe(II), it must be 
differences in stability of Fe(III) that causes their differences in redox potentials.  In 
addition, since both cytochrome c from horse heart and cyt c553-b, were unable to bind 
Fe(III), a reason for covalent attachment of the heme to the protein for His-Met 
coordination is to prevent the heme from dissociating and allowing electron transfer to 
occur.  
In order to probe the role of axial ligands in relation to the covalent attachment in 
c-type cytochromes, modified cytochrome c553 has been compared to a similarly modified 
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cytochrome c549, which is His-His ligated.  However, the only observed heme binding in 
modified cytochrome c549 occurs with ferric heme in the presence of trimethylamine-N-
oxide (TMAO).  TMAO is an osmolyte, a small organic solute, that responds to osmotic 
stress in the cell or in tissues. TMAO interacts with the protein backbone to destabilize 
the apo-unfolded state and force the protein to fold and increase its affinity for heme. 
  
Figure 6.11 – A titration of TMAO into cytochrome c549-b. As the concentration of 
TMAO increases, heme is able to bind, forming a characteristic optical absorption 
spectrum of a His-His coordinated b-type heme. 
 
TMAO experiments were conducted on both cyt c553-b and cyt c549-b.  A TMAO 
titration into Fe(III) heme and protein (8 mM) solution showed by optical absorption that 
upon addition of TMAO, ferric heme bound to both of the proteins (Figure 6.11).  
Binding was not observed for the same experiment without TMAO. A ferric heme 
titration in 5 M TMAO was conducted and showed that the KdFe(III) for cyt c553-b was 0.3 
mM, which is ten fold tighter than without TMAO (Figure 6.12).  The KdFe(III) for 
cytochrome c549-b was tighter than for cyt c553-b, which was expected since Fe(III) heme 
has a higher affinity for His-His ligation.   The main difference between the two modified 
proteins is that cytochrome c549 has a larger protein scaffold.  This comparison has 
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proven that the covalent attachment plays a role in guiding protein folding.  In order to 
probe the role of axial ligands and determine if they play a role in the covalent attachment 
the same protein scaffold is needed.  Site directed mutagenesis of M71H cytochrome c553 
could be performed. 
  
Figure 6.12 – Ferric heme titration into cyt c553-b with TMAO.  The KdFe(III) with TMAO 
is 0.3 mM, which an order of magnitude tighter than without TMAO (4.7 mM).  Since 
TMAO helps proteins to fold, apo-cyt c553-b with TMAO is partially folded, allowing 
ferric heme to coordinate. Without TMAO, apo-cyt c553-b cannot bind ferric heme 
because its heme affinity is too weak to induce protein folding, which is not the case in 
binding ferrous heme.  
6.4 Conclusions 
Modified cytochrome c553 was efficiently expressed and purified, thus enabling 
characterization. CD data, solution 1H NMR spectra, EXAFS results, and analytical 
ultracentrifugation experiments, showed that cytochrome c553-b has similar structure to 
wild-type cyt c553 coordinated by His-Met.  Optical absorption spectroscopy showed that 
it has a similar spectrum to cytochrome b562 indicating that it is a b-type heme. The 
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protein tightly binds ferrous heme anaerobically with a Kd around 500 nM and weakly 
binds ferric heme with a Kd of 4.7 mM.  From these values, a midpoint potential of +45 
mV has been calculated, compared to +47 mV for the wild-type. The reduction potential 
that was determined experimentally was -137 mV.  However, we measured the 
dissociation constant of ferric heme due to its weak binding and not the reduction 
potential. 
The weak binding of the ferric heme and the narrow range of pH stability indicate 
that the covalent attachment is necessary in order for reversible electrochemistry to occur. 
This is also true for cyt c from horse heart where the covalent bond is needed in order to 
prevent dissociation of ferric heme. However, cyt c549-b, which is His-His coordinated, 
was expected to bind ferric heme more favorably than ferrous heme.  This suggests that 
other factors besides heme affinity are involved in the necessity for covalent heme 
attachment.  
 In metal-induced folding, the strong affinity of the metal to bind the protein 
drives the holo-protein to fold. This was the case for cyt c553-b with ferrous heme, the 
protein was able to fold and bind heme, as shown by CD and optical absorption 
spectroscopy.  However, for cyt c553-b with ferric heme, and cyt c549-b with ferric and 
ferrous heme, heme-to-apo-protein affinity was not strong enough to induce folding.  In 
the presence of TMAO, however the protein is already folded, thus enabling heme 
binding.   Heme affinity and TMAO experiments have shown that the heme covalent 
attachment helps protein folding and anchoring of the heme, enabling it to bind both axial 
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Sequence of BMP 
 
Method and Results 
BMP with a hexa-histidine tag in a pPROEX-1 vector was sequenced by four designed 
primers which were purchased from Invitrogen (Carlsbad, CA). BMP was not able to be 
sequenced by commercial primers.  Only three primers were necessary for sequencing the 
protein, however a fourth primer was needed to sequence a gap between the regions of 
the first (BMPf) and middle (BMPM) primer. The table below shows what primers were 
used and what amino acids they sequenced. The nucleotide sequence is shown below 
where the protein nucleotides are in blue and the plasmid is in black. All sequencing was 
done at Columbia University’s Protein Core Facility (New York, NY). 
 
Primer Name Sequence Amino Acid # Seq 
BMPf GAGCTGTTGACAATTAATCATCCGGTCCG His-tag 1-191 
BMPM CGACGACCCAGCTTATGATG 208-435 
BMPend GGTACTTGGTATGATGCTAAAACAC 421-458 C terminus 




































Solutions for Defined Media 
 
10 x M9 salts without ammonium chloride (1 Liter): 
128 g of Na2HPO4 
30 g of KH2PO4 
5 g NaCl 
 
Metals 44 (100 ml stored in dark bottle): 
0.25 g EDTA 
0.522 g ZnCl2 
0.502 g FeCl2*4H2O 
0.18 g MnCl2*4H2O 
0.0185 g (NH4)6Mo7O24*4H2O 
0.0156 g CuCl2*2H2O 
0.0248 g Co(NO3)2*6H2O 
0.0114 g Boric acid 
 
Solution C (1 Liter pH 6.7): 
7.3 g KOH 
50 ml metals 44 
10 g nitrilotriacetic acid 
24 g MgCl2*6H2O 
3.335 g CaCl2*2H2O 
 
Vitamin stock (50 ml): 
100 mg nicotinic acid 
50 mg thiamine HCl 
10 mg p-aminobenzoic acid 
1 mg biotin 
 
 
 
 
